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Abstract 
Formation constants of Cu2+, Ni2+, Zn2+, Ca2+ and Gd3+ with the polyamine(amide) 
ligands N,N' -bis(2-hydroxyiminopropionyl) propane-1,3-diamine (L 2) and (1, 15)-
bis(N,N-dimethyl)-5, 11-dioxo-8-(N-benzyl)-l ,4,8, 12, 15-pentaazapentadecane (L
3
) as 
well as those ofGd3+ with 3,3,9,9-tetramethyl-4,8-diazaundecane-2,10-dione dioxime 
(L 1) were investigated by glass electrode potentiometry at 25°C and an ionic strength 
(I) of 0.15 mo! dm-3. 
There is a substantial variation in the reported equilibrium constants which 
follow the order Gd3+ ::::: Ca2+ < Ni2+ < Cu2+ > Zn2+. The indication from these 
constants is that Ni2+ and Cu2+ sit in a square-planar N4 arrangement of the L
2 donor 
atoms in the [ML2H_i] and [ML2H_2] species. In contrast, the corresponding [ML
3
H_i] 
and [ML3H_2] complexes have Cu
2+ in a distorted octahedral environment. Ni2+ does 
not seem to form the [ML3H_1], instead the neutral [ML
38-2] is produced which 
precipitates out of solution. 
The pronounced variation in the stability constants of Ni2+ and Cu
2
+ when 
compared with Zn2+, Ca2+ and Gd3+ are largely due to the inability of the latter metal 
ions to deprotonate the amide nitrogen donor atoms. Although Gd
3
+ forms stable 
[ML], [MLH_i] and [MLH_2] complexes with L
1
, the mixed-hydroxo [MLH_3] species 
precipitates out of solution. 
Ligand selectivities of 9-11 orders of magnitude have been observed in favour 
of [CuLR1], over analogous complexes of its in vivo competitors, Zn2+ and Ca
2
+. 




are able to mobilise Cu2+ in vivo at concentrations as low as 10-6 and 10-3 mo/ dm-
3 
respectively. In contrast, at these ligand concentrations the Zn2+ and Ca2+ p.m.i's are 
less than 0.01. L3 is devoid of any mobilising ability. The selectivity and mobilising 
ability is L1 > L2 > L3. This is an important result in the development of copper anti-




ligands are predicted to be able to increase the 1.m.w. copper fraction without altering 
the equilibria of in vivo Zn2+ and Ca2+. 
Vll 
UV-Vis spectrophotometric studies confirmed the square planar MN4 type of 
coordination for [MLH_i] and [MLH_2] complexes of Cu
2
+ and Ni2+ with L2. L3, on the 
other hand, is proposed to form tetragonally distorted octahedral [MLH_i] and [MLH_ 
2] with Cu
2+. These studies indicate that in both species the two amide nitrogens, the 
central and one of the terminal amines are coordinated. Furthermore, in [CuL3H.1t, 
the second terminal amine is protonated and the formation of the neutral [CuL3H.2]0, 
is due to the deprotonation of this group. Unfortunately, it has not been possible to 
predict the structure of the potentiometrically determined [NiL3H.2]
0 species due to 
precipitation. 
The cationic [NiL1H.1t species was crystallised as a perchlorate salt with a 
molecular formula C13H21ClN4Ni06, Mr=429.55 glmol. The crystal system is 
orthorhombic with space group-Pbca (#61) and unit cell dimensions a=13.3960(10), 
b=l2.3490(10), c=21.9330(10). The crystal and computer simulated structures of 
[NiL1H.1t and those of the corresponding Cu
2
+ and Zn2+ species also show a square-
planar geometry. 
As a measure of dermal absorption of the Cu2+ complexes, octanol/water 
partition coefficients were determined. The results indicate that 2-6% of all the 
[CuLH.1] complexes should permeate the skin when applied percutaneously. 
However, their IC50 values are 3-4 orders of magnitude higher than those of the native 
Cu-Zn SOD enzyme. Hence, these compounds are poor mimics of this enzyme. 
Biodistribution studies using 64Cu-labeled [CuLH.i] species injected 
intravenously on mice revealed a rapid clearance of these complexes from the blood 
circulatory system. In fact, only less than 1 % of the total injected activity was left in 
the blood lhr postinjection. The liver recorded significant uptake of Cu-64 throughout 
the 24hr investigation period. There was also an appreciable uptake of these 
complexes by the heart, lung and muscle. In contrast, the 64Cu[CuL2H_i] species is 
excreted exclusively by the renal system. 
Overall, these results are encouraging enough to merit further evaluation of the 
[CuLH.i] complexes ofL1 and L2 in chemotherapy and diagnosis. 
Figure 1.1: Structures and abbreviations of some important ligand systems 
mentioned in this thesis. 
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Figure 1.1 continues: Structures and abbreviations of some important ligand 
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CHAPTERl 
Introduction 
An overview of rheumatoid arthritis, its diagnosis and present 
therapy 
1.1 Origin of Rheumatoid Arthritis 
A fundamental unit of life, the living cell, throughout its entire life, is faced 
with the challenge of being able to survive the physiological imbalances occuring 
within and/or outside of it. If its cellular organization is destroyed through these 
processes, the cellular function is likewise altered. Although some vital functions such 
as enzymatic activities may persist, the cell becomes disorganized and dies. 




induced by such imbalances occuring in articular regions. 
The designation "rheumatoid arthritis" (RA) implies that the disease is an 
inflammatory process of auto-immune nature characterised by an invasive synovial 
hyperplasia, which leads to polyarticular destruction. 1-13 It afflicts about 5% of the 
western world's population of w4ich women are afflicted more than men, with a ratio 
of 2-3:1. Although there is no cure, it may, however, be controlled with immuno-




Although the etiology of RA remains unknown, and its pathophysiology 
poorly understood, recent results. show that rheumatoid synovial cells have a 
transformed phenotype.6-8 Immunohistological examination of the synovial membrane 
(SM) shows it to have all the hallmarks of a T-cell driven lesion: an accumulation of 
predominantly CD4 T-cells belonging to the memory phenotype, activated 
macrophages and synoviocytes or specialised synovial fibroblasts and lysosomal 
enzymes. 
The stimulatory interactions between these cell types lead to the release of a 
number of inflammatory cytokines and pharmacological mediators, which contribute 
to the development of synovitis, resorption of bone and cartilage that lead ultimately 






In addition to these cells, there is a vast amount of information suggesting the 
existence of tissue degrading enzymes, including metalloproteinases (MMPs) and 
serine proteinases. MMPs are members of a unique family of at least twenty 
proteolytic, structurally related enzymes that contain a zinc ion at their active sites. 
2 
These enzymes can degrade collagen, elastin and other macromolecules of the 
extracellular matrix. 10' 11 
Accumulating evidence indicates that oxygen free radicals such as the super-
oxide anion ('02-) and hydroxyl radical ('Off) derived from activated macrophages 
and granulocytes infiltrating arthritic joints are involved in the pathogenesis of RA. 12 
Nitric oxide, (NO), another free radical, is derived mainly from endothelial cells, but 
may also be produced by marcophages, neutrophils, synovial cells and chondrocytes. 
Although NO is recognised as a physiologic regulator of blood-pressure, its 
combination with ·02-, produces tissue destructive species particularly the 
peroxynitrite anion (ONOO} 13 
Exposure to these radicals leads to depolymerisation of hyaluronic acid, 
peroxidation of lipid, destruction of cartilage matrix, damage to DNA and induction of 
inflammatory cytokines and thereby destruction of joint structure. 12'13 All these factors 
point to the multi-factorial nature of RA. 
There is a need and desire to monitor and restore the proper functioning of the 
physiological processes using non-natural systems. Chemotherapy becomes the 
obvious choice at this stage of disease progression. Complicating such efforts is the 
recognition that it is often not a single sequence that is ideally targeted but rather an 
ensemble of physiological imbalances. This has resulted in the widespread use of 
combination therapy of two or more drugs directed at different imbalances. However, 
the side effects of combination therapy have been found to be additive. In spite of 
these challenges, the most interesting contributions to the past and recent year's 
literature1'6 on RA focus on the treatment of this difficult and disabling disease. 
1.2 Therapy for rheumatoid arthritis 
Ideally, a treatment should be highly efficacious and totally devoid of side 
effects, affordable and acceptable to the patient. Traditionally, 14 copper rich diets such 
as crayfish and peanuts were administered as a way of treating RA. Also, wearing of 
copper jewellery such as the famous copper bangle was also accepted as a standard 
3 
treatment. This traditional way of treatment14 has been slowly replaced by more 
scientific therapeuticals. 15-21 
A new approach in treatment of RA is to commence with non-steroidal anti-
inflammatory drugs (NSAIDs) and then move more rapidly to the slow acting anti-




In order to 
achieve sufficient suppression of rheumatoid inflammation, combination therapy of 
multiple SAARDs has been tried. The combination therapy has been found to be more 




The effectiveness of combination therapy has recently been questioned by Quinn et 
al. 15 and such assertion should be treated with caution. The reason for that probably 
originates on the additive nature of its side effects. 
1.2.1 NSAIDs 
NSAIDs are characterised by an absence of steroid moiety in their structure as 
the name indicates. They are frequently used as "first-line" agents in the treatment of 
minor to severe inflammation. 18·20 In addition to their anti-inflammatory activities, 
they also possess analgesic properties hence they remain the most frequently 
prescribed therapeuticals for RA. 
Although these drugs are generally well tolerated, they are associated with a 
wide spectrum of potential clinical toxicities. 18·20 The most common side effect of 
NSAIDs is gastrointestinal tract irritation (GTI). 15-20 Salicylates are not recommended 
for pregnant women, while imdomethacin and diflusinal induce premature closure of 
ductus arteriosus. 11-20 This might give rise to pulmonary hypertension in susceptible 
neonates. Because of this, it is not appropriate to use these drugs during both 
pregnancy and lactation periods. 11-
20 
Aspirin is the most difficult of the NSAIDs to use effectively. It has more side 
effects and the most complex dosing schedule. It has also more dangerous side effects 
if overdoses are taken and the complications tend to be dose related. 
4 
Pharmacodynamic investigations suggest that inhibition of prostaglandin (PG) 
synthesis in the synovial compartment is the dominant mechanism of action for most 
salicylates, if not all NSAIDs. 18•19 Because NSAIDs suppress PG synthesis, gastric 
acid production is increased whereas the production of gastric mucus and bicarbonate 
is decreased. The rate of cellular proliferation of the gastric mucosa is also decreased 
thus impairing the normal protective mechanisms of the stomach. This results in 
gastric irritation and the exacerbation of peptic ulcers. If gastrointestinal bleeding 
recurs, it is worsened, because NSAIDs decrease platelet adhesiveness and increase 
acid production in the stomach. 17"20 
PG inhibition is believed to mediate the anti-inflammatory effect of the 
drugs. 18•19 The mediator of their analgesic effect is not yet understood. Other NSAIDs 
like azapropazone would more likely operate by inhibiting lysosomal enzyme release 
and superoxide anion and interleukin- I (IL-1) production than by inhibiting PG 
synthesis. 18•19 
1.2.2 DMARDs 
DMARDs is a term for a group of medications with diverse mechanisms of 
action. They are also called "second-line" anti-rheumatic drugs, a term derived from 




Included in this 
broad category of drugs are slow-acting anti-rheumatic drugs (SAARDs) and 
remission-inducing drugs, the former requiring saturation of tissues (4 to 6 months) 
before a therapeutic benefit can be achieved. These types of drugs and their life 




and only a brief account will be given here. 
Anti-malarial drugs such as chloroquine and hydroxychloroquine are 
prescribed for patients with inflammatory arthritis including progressive, erosive RA 
and juvenile chronic arthritis. They are usually well tolerated despite the cutaneous 
side effects such as rash and changes in pigmentation as well as cramps, abdominal 
distention, nausea and diarrhea. 16·
20 
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Gold therapy is considered by some rheumatologists to be the best drug 
available to modify the cause of the disease and is indicated in the treatment of 
progressive, erosive RA. 
Sodium aurothiomaleate (Autm or Myochrysine) and aurothiosulphate (Auts 




Both Autm and 
Auts are highly water soluble, containing gold bound to the thiolate groups of 
thiomaleate and thiosulphate ligands respectively. Autm is oligomeric containing 
about 8 subunits while Auts is monomeric and both complexes inhibit the oxidative 
burst of polymorphonuclear leukocytes (PMN) by about 30% at concentrations above 
5µM. 
Auranofin (Ridaura), an oral preparation,11-20 1s monomenc with 
tetraacetylthioglucose and triethylphosphine ligands binding gold. It is thought to have 
less severe renal and hematopoetic toxicities than parenteral gold, but may be less 
effective than the intramuscular injected preparations. While the chemical structure of 
auranofin is known in much more detail than Autm and Auts, there is considerable 
uncertainty about the replacement of the ligands in vivo. 
Although gold compounds are considered the backbone of therapy for 
progressive RA, considerable concern must be exercised during their administration 
because of potential toxicity. Mild toxicities include stomatitis, pruritis and local rash. 
More serious toxicities include bone marrow suppression, thrombocytopenia, 




D-Penicillamine (D-Pen), a thiol and a product of metabolism of penicillin is a 




Pharmacokinetic studies have provided some support for associations between 
biotransformation at the S-H group of D-Pen and its toxicity and efficacy. 
Although it has been reported to be as effective as gold salts, it is, however, 
more toxic than other slow-acting and cytotoxic drugs. Side effects of D-Pen such as 
bone marrow suppression and nephropathy are comparable to those of gold whereas 
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the risk of thrombocytopenia from it is higher. Some of the side effects subside upon 
withdrawal of the drug. 18"20 
Sulfasalazine is quite effective for RA treatment. Toxicities include 
gastrointestinal intolerance and musculocutaneous toxicity. Apart from skin reactions, 
which can occur, more serious and potentially fatal conditions such as haemolytic 




Leflunomide, an isoxazole derivative is another DMARD currently in third 
stage of clinical trials. Kalden and co-workers23'24 and Cohen et al.
25 
have recently 
conducted long term treatments studies of arthritic patients with leflunomide. These 
studies provided firm evidence of its high efficacy in these patients compared with 
sulfasalazine and methotrexate. 
It is believed to exhibit its mode of action through a number of mechanisms. 
These include selective inhibition of dihydro-orotate dehydrogenase, a key enzyme in 
the de nova synthesis of pyrimidine and subsequent inhibition of RNA and DNA 
synthesis. Activated T-lymphocytes which are involved in the pathogenesis of RA are 
believed to synthesise pyrimidine by the same de nova pathway. Recent investigation 
indicates that leflunomide also inhibits reactive oxygen radicals, matrix 
metalloproteinases, polymorpholeukocyte chemotaxis and the migration of these cells 
into the synovial cavity.25 
1.2.3 Glucocorticoids in RA 
Glucocorticoids are used in the treatment of RA for their anti-inflammatory 
and immunosuppressive effects.26'27 The mechanisms by which these drugs produce 
such effects are exceedingly complex. Steroids are believed to inhibit phospholipase 
A2, which releases arachidonic acid from cell membranes. This is the first step in the 




They are administered as oral and parenteral preparations. The latter are given 
intra-articularly or at peri-articular sites of local inflammation, and are effective at 
relieving pain and swelling. 15-20'26'27 
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For prednisone and cortisone, hydroxylation to prednisolone and cortisol, 
respectively, at the C11 site is necessary for activity. In patients with faulty 
hydroxylation systems, active drugs such as prednisolone or methylprednisolone are 






Although they can produce dramatic results in acutely ill patients, the side 
effects from these drugs can be equally dramatic. The side effects vary directly with 
increasing doses of the drug and duration of use. Suppression of the pituitary-adrenal 
axis for about one week can occur in patients taking 50 mg of prednisone daily for 
only 5 days. They can cause gastritis, ulceration and severe myopathy. 
1.2.4 Some new and novel therapies for RA 
The best long-term hope for patients suffering from RA is the development of 
new therapies based on targets defined by concepts developed from the understanding 
of its pathogenesis. 16,28,29 Recent reports indicate that immunopathological features of 
RA synovial membrane and tissue reflect clinical disease activity; that is an 
accumulation of predominantly CD4 T-cells. 1-3,i 6,28,29 
It is the stimulatory interactions between these cell types that lead to the 
release of a number of inflammatory cytokines and pharmacological mediators. The 
new therapies should be directed against these defined targets. These include 
immunotherapy which makes use of immunologically specific agents, such as 
monoclonal antibodies and antigenic peptides, directed against the cell types. 
'Tolerance-inducing' immunotherapy is aimed at bringing about an end to the auto-




The 'anti-inflammatory' immunotherapy is directed against specific mediators 
in the inflammatory cascade such as inflammatory cytokines, which are released 
during rheumatoid synovitis. An example of the latter immunotherapy is antibody 
therapy directed against TNF or adhesion molecules and it does not induce 
tolerance. 11-20 
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Immunomodulation on the other hand utilises simple drugs, which either 
enhance desirable or suppress undesirable features of the immune response such as the 
those of metalloproteinases. Corticosteroids, the cytotoxics, cyclosporin A, 







the new therapies17-21 ,29 under investigation in the treatment of this refractory disease 
are discussed fully in the references cited therein. 
1.3 RA and its diagnosis 
Chemotherapy and its usefulness rest more on the proper diagnosis of the 
disease in question. Remarkable progress has been made in the development of 
diagnostic techniques based on immunoassays and MRI. MRI is now widely used to 
quantitatively assess the morphologic properties of the synovial joint, inflammatory 





RA. It has also been demonstrated to aid in the selection of site for biospy, monitor 




MRI exploits the differences in relaxation of water protons in tissues translating 
them into three-dimensional anatomical information. In general, excellent soft-tissue 
contrast is obtained without the use of contrast agents, but the difficulty in separating 
certain lesions from adjacent oedema and the monitoring of tissue function has led to 
the search for new contrast enhancement agents.37,
38 
MRI uses non-radioactive Gd3+, Fe2+ and Mn2+ complexes as contrast agents. 
The majority of these agents are based on gadolinium(III) and are used to increase 
image contrast between normal and diseased tissues. Gd3+, in particular, is ideally 
suited to this as it contains seven unpaired electrons and hence has a high relaxivity.
37 
1.3.1 Gd(III) based contrast agents in MRI 
Presently, the dimeglumine salt of Gd-DTPA (MAGNEVIST™, 
gadopentetate), Gd-[DTPA-BMA](OMNISCAN™, gadodiamide), Gd-DOTA 
(DOTAREM™, gadoterate) and Gd-[HP-D03A] (ProHance™, gadoteridol), just to 




DTPA-BMA is a 
derivative of DTP A where two carboxylates have been substituted by two amide 
9 
moieties and both are linear poly(amino/amido) polycarboxylates. The latter three 
contrast agents are based on tetraazacyclododecane.37,
38 
The choice of using these poly(aminocarboxylate) type ligands lies on their 
ideal properties of high water solubility, enhanced chemical stability and low toxicity 
in vivo. Because the majority of these ligands are octa-chelating in nature, the nineth 
co-ordination site of the metal ion is usually occupied by a single water molecule. The 
presence of this co-ordinated water molecule, which interacts with the bulk of solvent 
molecules increases the complex's relaxivity by an inner-sphere mechanism. 
In spite of the favourable properties exhibited by these ligands and resulting 
chelates, there are still factors that need to be fine-tuned and these require correlating 
aspects of the co-ordination chemistry of the complexes with in vivo behaviour. 
Although there are few absolute rules for such correlation, pertinent factors worthy of 
consideration include the thermodynamic stability, stereochemistry, charge and 
lipophilicity of the metal complex. In addition, the target organ or tissue to be imaged 
seems to dictate the desired characteristics of the agent. 
Although thermodynamic stability of non-radioactive metal complexes can help 
predict in vitro stability, it is often not indicative of in vivo stability. Although these 
agents are routinely used in MRI scans, the toxic effect of uncomplexed Gd
3
+ and free 
pro-ligand arising from dissociation of the metal complex in vivo is still one of the 
major concerns in MRI.37'38 
Such toxicity is associated with the accumulation of Gd(P04) in the lysosomes 





addition, it has been noted that another more important factor is the thermodynamic 
selectivity of the ligand towards Gd3+ over endogenously available metal ions such as 
Ca2+, Zn2+ and Cu2+. In particular, it has been observed that transmetallation with Zn
2
+ 
is highly predictive of acute toxicity.37,38 
It has long been recognised that lipophilic complexes generally have higher 
uptake in the liver or in fatty tissues and are able to cross the blood-brain barrier just 
like neutral species. It has also been observed that many positively charged ions 
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accumulate in the heart while negatively charged compounds tend to clear through the 
kidneys. 
Neutral contrast agents are preferred to ionic species because they have a lower 
osmolality and hence greatly reduced physiological complications. Contrast agents 
with an osmolality close to that of blood and the extracellular fluid (290 mmol kg-
1
) 
are more desirable. The conversion of two carboxylates in gadopentetate to two 
methylamides in gadodiamide has resulted in a decrease in osmolality from 1940 




It should be mentioned that these contrast agents are extracellular agents with 
non-specific bio-localization. Another challenge in this field is therefore the design of 
ligands and hence complexes which are able to target specific tissues and organs in 
the body.37,38 Stereochemistry is important when targeting complexes to specific 
receptors. 
1.4 Conclusion 
The presently available NSAIDs and DMARDs are rather unsatisfactory, being 
poorly effective and having considerable and sometimes, severe and life-threatening 
side effects. This may be due to lack of specificity in action of these drugs. Gold 
compounds are considered the backbone of therapy for progressive RA. However, 
because of inadequate gold elimination they can have quite severe side effects. 
Although glucocorticoids can produce dramatic results in acutely ill-patients, 
the side effects from these drugs can be equally dramatic. As a result of disease 
chronicity in the majority of RA patients, many may develop steroid dependency. The 
side effects vary directly with increasing doses of the drug and duration of use. 
Thus, the search for less expensive, more effective and safer therapies for this 
disease and/or the inflammation associated with it, is an urgent task to which 
considerable effort is being devoted. Elucidation of the key factors involved in the 
perpetuation of chronic inflammation in RA is essential to the design of effective 
therapeutic interventions. 
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Despite remarkable progress in the development of MRI contrast agents for 
disease diagnosis, there is still a need in the design and synthesis of new agents with 
high relaxivity and hence excellent tissue contrast. These should show high stability in 
vivo to circumvent the toxic effect of uncomplexed Gd3+ and free pro-ligand arising 
from dissociation of the complex, which is still one of the major concerns in MRI.37,38 
In addition the design of tissue and/or organ specific contrast agents is one of 
challenges facing co-ordination chemists. 
With the above-mentioned conclusion in mind, the thesis is centred on the 
solution chemistry of Cu2+, Ni2+, Zn2+, Ca2+ and Gd3+ with three polyamine(amide) 
ligands, 3,3,9,9-tetramethyl-6, 7-diazaundecane-2, 10-dione dioxime (L 1 ), N, N'-bis(2-
hydroxyiminopropionyl) propane-1,3-diamine (L 2), and 1, 15-bis(N,N-dimethyl)-5, 11-
dioxo-8-(N-benzyl)-1,4,8, 12, 15-pentaazapentadecane (L3) for possible use of copper 
and gadolinium complexes as anti-inflammatory in RA and as contrast agents in MRI 
respectively. However, to better obtain information from the solution chemistry of 
these ligands with the metal ions, a thorough investigation of the current trends in 
drug design is necessary which is the focus of chapter 2. 
12 
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CHAPTER2 
Background to this study 
Metal complexes in biomedical analyses - Recent advances in 
chemotherapy and diagnosis 
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2.1 Metal complexes in chemotherapy and diagnosis 
The use of metal complexes in chemotherapy and/or diagnostic medical imaging 
has grown impressively in recent years as the result of an advanced understanding of 
biological structure and function. However, metal complexes that will ultimately prove 
successful in chemotherapy and as contrast agents in MRI must meet numerous criteria 
including high efficacy and an overall image enhancement, low toxicity in vivo, tissue and 
organ specificity and rapid clearance by the biological system: 
2.2 Copper and RA - Present approach 
The traditional approach 1 of treating RA with copper was relatively effective, but 
has been slowly replaced by more scientific therapeuticals. However, these therapeuticals 
commonly used for treatment of RA have adverse side effects. In addition, in spite of 
accumulating evidence indicating the involvement of reactive oxygen free radicals on the 
pathogenesis of RA, there are few agents which have been specifically designed and 
directed at the modulation of the ill-effects of these radicals. Leflunomide is an exception 
as it has been observed to inhibit these oxygen radicals as one of its many functions.2 
Many articles,3-5 indicating that copper complexes can be effective in the 
alleviation of inflammation associated with the disease, have appeared in the literature. 
One common fact from these articles is that the ligands alone are not effective, but when 
complexed to copper they become more effective. Furthermore, it has been reported that 
some of the anti-inflammatory agents discussed in the preceding chapter are also more 
active when complexed to copper.3-5 
Recently, studies conducted by Berthon et al.6'7 using computer-aided speciation, 
indicated that the common assumption that copper-NSAIDs complexes represent active 
forms of NSAIDs is of little significance for salicylate.6'7 This is because the ternary 
Cu(II)-His-Sal complex does not exceed 0.1 % at drug plasma therapeutic levels and, in 
addition, is electrically charged. Salicylate is believed to reduce the inflammation by 
scavenging hydroxyl ("OH) radicals. 
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The extra anti-inflammatory activity of administered copper-salicylate is due 
probably to the increase in Cu(Il)-His complexes induced by administration of exogenous 
copper. On the other hand, anthranilate, which represents the inactive form is believed to 
mobilise copper in a pH dependent manner only in the inflammed site, i.e., as the pH 
decreases the more the inflammation and the more copper is bound to anthranilate. It is 
thus proposed that anthranilate may be regarded as a potential "OH-inactivating ligand 
(OIL). 
Some recent investigations have also shown that other copper(II) complexes have 
a high superoxide dismutase (SOD) mimetic activity when superoxide anion radicals are 
generated by the xanthine-xanthine oxidase system.8'9 It is believed that copper is 
responsible for all these activities. 
2.2.1 Possible modes of action of copper(II) complexes 
Although several possibilities exist, the mechanism of action by which copper 
exhibits its anti-inflammatory activity is not yet understood. Sorenson has discussed 
extensively, several modes whereby copper may exhibit its anti-inflammatory activity.
1 
These include the modulation of several enzymatic, histaminic systems, T-lymphocyte 
responses and prostaglandin syntheses, as well as stabilization of human gamma globulin 
and lysosomal membrane, and induction of lysyl oxidase and superoxide dismutase. The 
latter three activities deserve special elaboration as there is ample evidence indicating the 
involvement of copper in these processes. 
2.2.1.1 Stabilisation of Lysosomal membrane 
In addition to superoxide anions and several amines, the synovial fluid also 
contains lysosomal enzymes, which are destructive towards cartilage.1 Copper is reported 
to decrease the permeability of human synovial lysosomes, thus decreasing the release of 
free lysosomal enzymes into the synovial fluid. 1 
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2.2.1.2 Induction of Lysyl Oxidase 
Lysyl oxidase is a copper dependent enzyme responsible for repair of damaged 
tissues as a result of inflammation. 1'10 The process requires cross-linking and extracellular 
maturation of the connective tissue components, collagen and elastin. It has been 
demonstrated that copper(II) sulphate does induce lysyl oxidase activity in copper 
deficient chickens. 10 
2.2.1.3 Induction of Superoxide Dismutase activity and Superoxide Dismutase -
Mimetic Activity 
The cells of all aerobic organisms which have been tested, are found to contain an 
active metallo-enzyme known as copper-zinc superoxide dismutase (hereafter, 
cuCII)2znCII)2 SOD).
11 -15 This enzyme contains two identical polypeptide sub-units, each of 
which contains one copper and one zinc atoms bridged by the imidazolate group of a 
histidyl residue. It catalyses the dismutation of the superoxide anion to molecular oxygen 
and hydrogen peroxide. 11 -15 
The process involves stepwise and cyclic reduction and oxidation of Cu2+ to Cu+ 
and vice-versa by the superoxide anion radical ('02} 
11
-
15 The imidazolate group is 
believed to dissociate from the Cu+ ion and is immediately protonated. Other reports have 
indicated that it remains covalently bonded to Cu+. Although this mechanism of ·02-
quenching might seem appealing, there are other mechanisms which cannot be ruled 
out.16,11 
There is firm evidence indicating that charged residues at the entrance of the 
catalytic cavity produce an overall electrostatic field, which increases the rate of approach 
of the ·02- ion toward Cu
2+ to levels above the normal diffusion limit. 18-20 Arg-143 which 
is much closer to the copper ion probably assists the substrate in entering the cavity. Such 
a role was proposed on the basis of chemical modification experiments18-20 and recently 
demonstrated through site directed mutagenesis.21 ,22 
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Recent investigations23'24 have provided evidence that there is a pool of metal-
deficient Cu-Zn SOD inside living cells like human lymphoblasts and undifferentiated 
K562 cells. In addition, the activity of native SOD in synovial fluid of arthritic patients is 
significantly reduced when compared to patients with non-inflammatory arthropathy. 
Induction of the metal-deficient Cu-Zn SOD depends on its exposure to Cu2+ and Zn2+ 
ions.23,24 It should be added that Zn2+ in Cu-Zn SOD appears to be important in structure 
but not essential in the catalytic mechanism of the enzyme. 18-22 
In contrast, the synovial fluid of arthritic patients contains catalase, which 
decomposes hydrogen peroxide to oxygen and water.23 The two enzyme systems furnish 
disposal routes for superoxide and peroxide anions and ittums out that this protection is a 
pre-requisite for the adaptation of living cells to the utilisation of oxygen. 
Because of the efficient and uniqueness of the catalytic activity of Cu2-Zn2 SOD, 
it would be more useful to employ synthesised SOD as human therapeutics. Recombinant 
SOD proteins have been used in animal models of collagen induced arthritis (CIA) and in 
clinical trials, but the effectiveness is hampered by the relative short-half lives of proteins 
in the circulation.25 In addition to their immunogenicity, high cost and ready clearance by 
the kidney, SODs are impermeable to membranes due to their high molecular weight and 
hence are unable to enter cells and the synovial cavity, in particular.25 
These limitations have led many investigators to search for stable, non-toxic, low 
molecular weight complexes of copper(II) that have SOD mimetic activity (also called 
synzymes or synthetic enzymes), which could be substituted for SOD in clinical 
applications, with the desirable qualities of being low cost, reasonably permeable to cell 
and non-immunogenic.25 Ligands in these l.m.w. copper complexes would offer the 
possibility of being vehicles of copper, delivering it to the site of inflammation where the 
enzyme is inactivated. They may also act as intermediates, allowing insertion of metal 
ions into appropriate proteins and enzymes. 
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Recently, a large number of l.m.w. copper(II) complexes have been synthesised, 
characterised and have been found to exhibit high SOD mimetic activities when 
superoxide radicals are generated by the xanthine-xanthine oxidase system.8'9 
This SOD mimetic behaviour may suggest a much simpler mechanism that does 
not involve an enzyme. The extraordinarily efficient catalytic activity observed in both 
the enzyme and its mimetics has recently been accounted for by both the electrochemical 
potential of the pair Cu2+/Cu+, which is intermediate between potentials of the pairs 
0 2/02- (E = -0.16V) and 0 2-;ol- (E = 0.89V).22 In fact, it is believed that any redox pair 
with a potential intermediate between the above two values can act as a catalyst for the 
dismutation reaction.22 
Recently, SOD-mimetic copper complexes have been observed to down regulate 
nitric oxide synthase enzyme activity and hence decrease the synthesis of N0.26 This 
observation should serve as an impetus in designing more l.m.w. complexes which have 
modulatory functions on the cascade of ill-processes responsible for the pathogenesis of 
RA. Since the biological anti-oxidant systems can be consumed during oxidative stress at 
levels that can exceed their production, these synzymes can serve as human therapeutics 
to counteract the deleterious effects of these oxidising substances. 
2.2.2 Potential copper(Il)-complexes as anti-inflammatory drugs in rheumatoid 
arthritis 
In attempts to search for more effective and safer therapies, Jackson et al.27 used 
computer simulation in an attempt to study the complexing conditions occurring in vivo 
and to assess Sorenson's biological activity data for copper chelate antiarthritic agents. In 
the simulation of oral treatment, COMPLOT models involving the equilibria between 
drug and protons and metal ions were used. These models approximate administration on 
an empty stomach and are based on the assumption that the presence of dietary and 
digestive components can be omitted since (i) the drugs exist in relatively high 
concentrations, and (ii) the gastro-intestinal contents are likely to have a constant 
influence upon the series of agents under consideration. 
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For subcutaneous administration of charged and neutral copper complexes, 
attempts were made to correlate COMPLOT simulation studies of concentration of these 
complexes with Sorenson's biological response data. Unfortunately, no correlations were 
found. The reason was that the complexes were administered as suspensions, which were 
insoluble and solubility and rates of dissolution could not be incorporated into the model 
calculations. However, oral administration at pH 2 indicated a direct correlation between 
anti-ulcer activity and the concentration of neutral complexes. 
The blood plasma simulation studies using the ECCLES program, 27 revealed that 
all the administered copper complexes, with the exception of carboxyisoquinoline, release 
their copper to serum albumin. There were, however, ligands which encouraged a 
redistribution of the remaining copper amongst the l.m.w. ligand complexes present. 
In general, the therapeutic activity is enhanced by administering exogenous 
copper, thereby increasing the total labile copper concentration in the anti-rheumatic 
process. However, it is also more difficult to move transition metal ions through a series 
of biofluid compartments without binding to proteins. The equilibrium competition for 
copper ion of administered ligand with the endogenous labile protein containing copper 
ion seems a more promising way of effecting this increase. 
From their studies, Jackson et al.27 eventually reported a list of desirable 
properties for future design of rheumatoid arthritic agents and these properties included 
among others the following: 
• Powerful copper complexing properties as reflected by a high plasma mobilising 
index (p.m.i.). 
• A multidentate ligand containing predominantly nitrogen donor atoms, which would 
confer a high degree of selectivity towards copper in order to minimise competition 
with zinc and calcium. These latter metal ions are present in plasma in "large" 
concentrations. 
• The ligand must possess at least one dissociable proton and must not be easily 
metabolised. 
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Jackson and Kelly28 used computer simulation (ECCLES program) in order to 
identify those features of a ligand, which would make it an ideal vehicle for the delivery 
of copper to the anti-rheumatic process. The simulation studies indicated that an ideal 
ligand would be a linear dicarboxylate, diphenolate or dialkyl phosphate substituted 
polyamine. These substituted polyamines would lose two protons on co-ordination to 
copper to form neutral complexes. 
These results led to the synthesis of H2ttda (La) and H2dtda (Lb) (Figure 1.1) and 
investigation of their complexation equilibria with copper,29 zinc and calcium30 as 
potential competitors of copper. The potentiometric results revealed that Cu2+ formed 
more stable complexes than zn2+ and Ca2+ whereas the p.m.i. 's indicated that these two 
ligands were potential mobilisers of copper(II) in vivo. Dtda in addition, also caused some 
redistribution of zinc(II). Animal screens, however, showed that the copper-ttda complex 
was rapidly excreted into the urine. The complex remains intact in the blood stream and is 
too polar to effectively pass out of the blood into the tissue. 
Recently, a number of diamine diamide (Le derivatives)31 and triamine-diamide32 
(Ld derivatives - Figure 1.1) ligands have been investigated potentiometrically, the latter 
containing a central amine with benzyl- or phenylethyl- substituents. The presence of the 
central amine was initially thought to provide a fifth strong coordination donor atom for 
copper(II) resulting in an enhanced thermodymamic stability of the complexes. The 
benzyl- and phenylethyl- groups at this central amine were envisaged to increase the 
lipophilicity of these complex species. In spite of these morphological alterations on these 
ligands, it was observed that the resulting copper(II) complexes are more likely to 
dissociate in plasma. This is due to their low formation constants and hence low 
mobilising indices. Low octanol/water partition coefficients of these copper complexes 
indicated that they are likely to be of little utility as topical agents in RA chemotherapy. 
In an attempt to change the tissue distribution of these copper(II) complexes, 
tetramethyldiazadione dioxime ligands; PrAO (L1), EnAO (Lf) and BuAO (Lg) (Figure 
1.1) in which di one dioximes replaced the secondary amines and dicarboxylates of ttda 
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were considered. 33 In addition, solution, equilibria of Zn2+ and Ca
2




Potentiometric results showed the order of stability of the 11-1 copper(II) complex 
species dominant at pH 7.4 to be L1 > Lr> Lg. The Zn2+ formation constant with L
1 
for 
the same species was observed to be 11 orders of magnitude lower than that of copper 
while Ca2+ was found not to form any complex species with the ligand. 
Blood-plasma computer simulation studies revealed that increased low-molar-
mass copper(II) caused by L 1 was nearly the same as that caused by ttda. The blood-
plasma mobilising indices of both ligands were some orders of magnitude greater than e 
and Lg. At a ligand concentration of l.Ox10"6 mol dm"3 the Zn2+ p.m.i. is less than 0.01 
while that of Cu2+ is approximately equal to 1. Overall, these results indicated that the 






As a measure of the lipophilicity of the [Cu(L1)H.1t complex, octanol/water 
partition coefficients were determined.34 At pH 5.5-6.5 and 7.4, the pH range for the skin 
and plasma respectively, this species has a log Poet/water value of -1.01. This complex is 
reasonably lipophilic to predict that approximately 6% of it is likely to permeate both the 
skin and biomembranes when applied percutaneously and/or injected.
34 
It is also 
predicted that the [Cu(L1)H.1t complex should not decompose in vivo33 in the same way 
as was found for [Cu(ttda)H.2].
30 The presence of methyl groups in [Cu(L
1
)H.1t are 
believed to contribute significantly to the lipophilic nature of the complex in comparison 
with [Cu(ttda)H.2] and, it may therefore undergo slower urinary excretion. 
2.3 Recent advances in the design of gadolinium(Ill) based contrast agents in MRI 
Proper disease diagnosis plays a pivotal role in the design of chemotherapy and its 
usefulness for the disease in question. The use of contrast enhancement agents in MRI 
have revolutionised the technique by being able to highlight lesions that might otherwise 
be missed or overlooked on normal magnetic resonance images.
35 
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Gd3+ is ideally suited to the design and use of contrast agents in MRI since it 
contains seven unpaired electrons, and hence high magnetic moment and relaxivity. On 
the other hand, polyaminocarboxylate chelating agents are used primarily to enhance 
thermodynamic stability. An added advantage offered by these polyaminocarboxylates is 
their high water solubility, which is ideal for in vivo applications. The octa-chelating 
nature of these ligands allows a single water molecule to interact with the bulk of solvent 
molecules, thereby increasing the relaxivity of the chelates by an inner sphere 
mechanism. 35'36 
The different ways in which the relaxivity of a given contrast agent may be 
modulated can be appreciated by a consideration of the equations defining the water 
relaxation rate, RI. The paramagnetic contribution (eq. 2.1) to the overall relaxation rate 
is made up of outer-sphere, second-sphere and inner-sphere terms, of which the latter is 
usually the most significant.35'36 
R R os R ss R is Ip= Ip + Ip + Ip ---2.1 
---2.2 
The inner-sphere contribution is a function of four variables ( eq. 2.2), i.e., the 
concentration of the complex, c; the number of directly bound water molecules, q; the 
exchange lifetime of the coordinated H20 molecule, 'tm; and the longitudinal water proton 
relaxation time, T Im· T Im also depends on 'tr, the rotational correlation time. 
Optimization of these molecular parameters determining the relaxivity of Gd3+ 
chelates is an ongoing objective, of relevance to the development of new, more effective 
MRI contrast agents. 
The c and q variables can be modulated to a little extent since increasing the 
number of bound water molecules leads to a decreased in vivo stability of the complex 
and hence increased concentration and toxicity of hydrated Gd3+. Image contrast 
enhancements are desirable at low concentrations of the complexes due to the toxic 
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nature of Gd3+(aq), as well as the complications resulting from osmolality differences 
between the contrast agent and body fluids. 
The relaxivity of low molecular weight Gd3+ -containing contrast agents is mainly 
limited by their fast rotational motion. Since the relaxivity of sphere-shaped molecules 
increases approximately linearly with molecular weight, new-generation MRJ contrast 
agents will probably be complexes attached to, or incorporated in macromolecules. 
Caravan,35 Comblin36 and Reichert et al.37 have recently reviewed major efforts 
directed at the incorporation of gadolinium chelates in these large structures such as 
polymers, dendrimers, proteins, and micelles. In fact, the rotational correlational times of 
Gd3+ agents conjugated to ~-cyclodextrins,38 dendrimers,39 and micelles40 for example, 
have been found to be long enough for the water exchange to influence, or even limit, the 
overall proton relaxivity at imaging fields. 
To date, the commercially approved Gd3+ compounds and those at several stages 
of clinical trials are extracellular agents with non-specific biodistribution and have 
relaxivities in the range 1-50 mM-1s·1• It is hoped that this new generation of contrast 
agents under development will also enable targeting of macromolecules associated with 
specific tissues or disease states thereby localizing the agent to the site of interest. At the 
high concentrations of contrast agents normally tised in MRJ scans, imaging of receptors 
is virtually impossible since they can be easily saturated. Higher relaxivities of the order 
of 100-200 mM-1s·1 will allow one to obtain MRJ images with less contrast agent and 
could allow imaging of receptors as well. 35,36 
2.4 Structure and properties of skin and biomembranes in relation to dermal 
absorption and drug transport 
The skin through the horny layer (or the stratum corneum (SC))41 -45 and lipid 
bilayers of biomembranes,46-51 act as selective permeability barriers controlling the 
amount and nature of the substances that pass across them. The rigidity of the SC and 
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hence its ability to act as a barrier to drug translocation is due to the high levels of 
ceramides, glycosilceramides and cholesterol it contains.
44 
The initial process of drug's translocation across the skin involves partitioning of 
the penetrant into the surface lipids and lamellar domains of the SC.
44 
This process is 
followed by diffusion through the epidermis and dermis before gaining access to the 
systematic circulation through the cutaneous microvasculature.
44 
The ability of drugs to 
cross these biological barriers strongly affects their pharmacokinetic behaviour and 
capability to access the targets of interest such as the inflammatory sites and tumours. 
The synovial joint of arthritic patients is regarded as a peripheral compartment of 
distribution and the target organ of NSAIDs, DMARDs and glucocorticoid therapy 
mentioned in the preceding chapter and the envisaged copper(II)-based anti-inflammatory 
drugs required for the induction of copper-zinc SOD. Their concentration in this synovial 
fluid is, therefore, an important determinant of clinical response. 
These processes are depicted by the hypothetical model indicating the movement 
of drug from the epidermal surface through a series of body compartments before 
reaching the synovial fluid as given below. 
Drug 
--_,.. ---
epidermis underlyin membranes 
syn vial membrane 
---> ___ ,.. ---
dermis circulatory system 
Intercellular lipids (SC) 
Synovial 
cavity 
This joint is separated from the blood compartment by the synovial membrane, 
which can be likened to a double barrier consisting of the capillary endothelium and 
synovial tissue interstitium. Just like in percutaneous absorption, the trans-synovial 
transport of drugs is a process of limited diffusion. It is governed by the drugs' chemical 
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and physical properties such as the molecular weight, lipophilicity, protein binding and 
the joint space characteristics, for example, disease state and protein concentration.
48 
Since the pH of the skin41 '44 ranges between 5.5-6.5 while that of the blood-
plasma46-51 is 7.4, neutral species are desirable in this pH range for a larger concentration 
of the drug to reach the target site, the synovial cavity. Low molecular agents (Mr :::; 600 
g/mol) are ideally suited for passive diffusion since available evidence indicates that the 
primary penetration pathway is through the intercellular lipids and passage openings 
termed pores.44 
It has long been observed that percutaneous absorption as an initial permeation 
process, is enhanced in the diseased skin because the barrier zone (stratum comeum and 
to some extent the stratum granulosum) is defective.44'
45 
Furthermore, because the 
synovial membrane in particular is damaged in acute RA, permeation rate across it 
·increases resulting in higher concentrations of chemotherapeutic agents reaching the 
target site. 
There should be a balance between the lipophilic and hydrophilic nature of the 
drug in question. This is because although its lipophilicity enhances the initial 
partitioning into the epidermal intercelluar lipids, the inner viable underlying hydrophilic 
dermis can hinder the penetration of very hydrophobic agents.
44 
Hence, it remains bound 
in lipid bilayer. 
Drug translocation across the skin and membranes also depends on the membrane 




In fact, epidermal 
lipids such as phospholipids, which contain unsaturated fatty acids make the membrane 
more permeable to drugs. 
There is ample evidence indicating the presence of drug transporters in 
biomembranes, which facilitate drug translocation.45-50 The nature and functioning of 
these transporters are poorly understood but an important process may involve drug 





Much research work has been directed at the development of vehicles to enhance 
percutaneous absorption of metal ion containing chemotherapeutic agents.44 This is as a 
result of low observed permeation rates observed for these often charged hydrophilic 
compounds compared to normal organic compounds. This is actually one of the reasons 
why metal-based therapies have been of little interest to medicinal chemists and the 
pharmaceutical industries. 52 
Oil/water and dimethyl sulphoxide/water mixures have been extensively used as 
vehicles. These vehicles should exhibit reduced affinity for the drug to promote 
absorption. The use of water as a component of a vehicle mixture stems from its ability to 
increase membrane permeability to topically applied agents. 
Lichtenstein and Margalit52 have recently studied the thermodynamics and 
kinetics of drug encapsulation in liposome to improve delivery. Morganti et al.44 give an 
extensive review of the structure of skin in relation to drug transport and the latest 
research advancements in drug targeting. 
Presently, the reference parameter for the prediction of passive diffusion of drugs 
through biological barriers is the measure of their lipophilicity, expressed as the logarithm 
of the partition coefficient between 1-octanol and an aqueous phase. 54 
Besides being widely used to predict the lipophilicity of drugs, octanol/water 
partition coefficient investigations have been recognised in Quantitative Structure-
Activity Relationship (QSAR) studies54•56 to effectively correlate with various biological 
phenomena. These phenomena include the prediction of binding of solutes to biological 
molecules such as serum albumin and several purified enzymes. 54 Such studies are, as a 
result, essential in the initial screening process of drug bio-availability. 
2.5 Conclusion 
Metal complexes that will ultimately prove successful in chemotherapy must meet 
numerous criteria, including high efficacy in vivo, low metal toxicity, tissue and organ 
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specificity, rapid clearance by the biological system, and an overall image enhancement 
when applied to contrast agents in MRI. 
One real challenge pertaining to the design of functional metal ion diagnostic 
and/or therapeutic agents, lies among other features, in the need for a precise control of 
ligand coordination abilities. 
Relying upon these metal complexes for chemotherapy and diagnostic tools, 
researchers are striving to develop new non-natural ligand systems that simultaneously 
offer biomimicry, biostability, biocompatibility and bioactivity. Successful research in 
this area will be able to produce therapeutic agents and biomimetic agents that will be 
useful and safe for in vivo applications. In an attempt to make significant strides in this 
direction the aims and objectives of this study were set out as briefly discussed below. 
2.6 Aims and objectives of this study were: 
• To synthesise and characterise three poly amine/amide/dioxime ligands, L1 (PrAO), L2 
(H2pap) and L3 (BIDPAP), Figure 1.1. 
• To determine the formation constants of Gd3+ with L 1 and those of Cu2+, Ni2+, Zn2+, 
Ca2+ and Gd3+ with L2 and L3 using glass-electrode potentiometry at 25°C and an 
ionic strength of 0.15 mo! dm-3 NaCL The interest is centered on the possible use of 
Cu2+ and Gd3+ complexes in chemotherapy and as contrast agents in MRI 
respectively, while simultaneously gaining more insight on the potency of Zn2+ and 
Ca2+ as in vivo competitors. The Ni2+ solution equilibria are investigated for 
comparison since the metal normally forms stable complexes with ligands which 
coordinate strongly to copper. 
• To calculate p.m.i.'s based on the formation constants determined since a high 
selectivity of the ligand for a particular metal ion and its ability to mobilise it in vivo 
is usually reflected by a high p.m.i .. 
• To elucidate the structures of the various copper(II) and nickel(II) species present in 
solution, using spectroscopic techniques. 
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• To measure the octanol/water partition coefficient of the copper(II) complexes of L2 
and L3 as an indication of their lipophilicity. 
• To investigate the SOD mimetic activity of the copper(II) complexes and lastly, 
• To perform biodistribution experiments of radio-labeled 64Cu-L complexes on mice 
as animal screens in order to get an insight on their in vivo behaviour and stability. 
2. 7 Thesis structure 
• Chapter 1 is an introduction where the focus is centered on the origin of RA, its 
diagnosis using MRI and its present therapy. 
• Chapter 2 focuses on recent developments m copper chemotherapy m RA and 
contrast agents in MRI. 
• A literature review of the experimental techniques and design is the theme of chapter 
3 while chapter 4 details the experimental procedures and analytical methods to 
achieve the objectives of this study. 
• The results are given in chapter 5 together with the discussion whereas chapter 6 
outlines the major conclusions drawn from this study. 
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CHAPTER3 
A Theoretical Review of Literature 
Glass Electrode Potentiometry, UVNisible 
Spectrophotometry and Ancillary studies 
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3.1 Theoretical basis of solution chemistry 
Solution co-ordination chemistry continues to provide the fundamental design 
properties of metal complexes in chemotherapy and as contrast agents in MRI. The 
chemical nature and concentration of each species present under equilibrium 
conditions in solutions are related to formation constants. 1 These are some of the basic 
design properties of utmost importance in biomedical analyses, and this study 
concerns itself primarily with these design principles. 
3.1.1 Factors influencing complex stability and selectivity in aqueous solution 
Stability constants measure the degree of interaction of metal ions and ligands 
at equilibrium under specific conditions.1-5 Hancock and Martell2 have given a 
comprehensive review of the factors that influence complex stability and the ligand 
design for selective complexation of metal ions in aqueous solution. These include 
among others the nature of donor atoms comprising the ligand, its denticity,2'6 the 
extent of its preorganisation,7'8 the nature of the rings formed due to complexation and 
the metal ion concerned. 
In fact, it has been observed that subtle changes in the nature of the ligand 
backbone, its donor atoms and their arrangements can have a dramatic influence on 
the co-ordination behaviour of the ligand towards particular metal ions.2'3 These 
changes together with some other functionalities not involved in metal ion 
coordination can also determine the bio-availability of the metal ion(s) concerned. 
Ligand design and the development of its efficient synthetic procedures, as a result 
underlie much of modern co-ordination chemistry. 
It is well known that Cu2+ prefers ligands with nitrogen donor atoms, while 
Zn2+ on the other hand forms weaker complexes than Cu2+ with these ligands as 
predicted by the Irving-Williams series. 2'3 This is despite the borderline nature of both 
metal ions according to HSAB classification.9 
In contrast, these nitrogen atoms are poor electron donors for hard metal ions 
such as Ca2+ and Gd3+, but become better donors when hard negatively charged 
oxygen atoms are present. This is indicated by the high formation constants for 
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ligands of these metal ions with EDT A, DTP A, DOT A and related 
polyaminocarboxylates compared with en, diethylenetriamine and (12-14)aneN4. 
These metal ions form weak or no complexes at all with these latter ligands. 2'3 
Although these formation constants can be predicted fairly accurately for 
polyamines using appropriate equations,2'3 the predictions become less accurate for 
polyfunctional multidentate ligands. This is due to the uncertainty of the binding 
modes for these ligands and the nature of the species present in solution. These factors 
are influenced by the conformational aspects and preferences, hence their 
experimental determination becomes an obvious option. 
Experimental methods2-4 for their determination fall into two broad categories, 
namely: electrochemical and spectroscopic methods which are based on the 
observable that is proportional to the activity and number of molecules of a given type 
present, respectively. Glass electrode potentiometry (GEP) falls under the 
electrochemical methods and is usually supplemented by UV -visible 
spectrophotometry for structure elucidation. 
3.1.2 Glass electrode potentiometry 
GEP has been described1-4 as 'by far the most accurate and widely applicable 
technique currently available for the study of ionic aqueous equilibria'. In fact, 
approximately eighty percent (80% )3 of the reported stability constants in the 
literature5 have been determined by this technique. 
The ease of availability of the glass electrode, its linear Nemstian response, 
rapid reversibility and high sensitivity to aqueous hydrogen ions over a wide 
concentration range makes it an ideally suited technique for the study of these 
equilibria. Although a non-linear, non-Nemstian response could in theory be tolerated 
by using suitable calibration curves, such responses are often symptomatic of non-
reversibility. Solvents have been observed to play an important role in this 
reversibility and, in reality, a glass electrode that is reversible in one solvent is not 
necessarily reversible in another solvent.4,IO,ll 
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GEP employs measurement of an electrode potential (eq. 3.10) across the 
membrane and its variation with changing H+ aq concentration in the experimental 
solution. 1'4,JO,l l 
---3.10 
where E0 is the electrode response intercept and s the electrode response slope. The 
arrangement for such a cell may be represented as shown below. 10,11 
AglAgCllKC1(3M) I !test solutionlglass-membrane IHCl(O.lM) IAgcllAg 
External reference internal reference 
The external reference electrode can be placed in the same package as the pH 
electrode - forming a combined micro-electrode, which has some advantages for 
routine analysis of small volume samples. 
Its mode of functioning is very complex and an important stage probably 
involves the adsorption of H+ aq ions into the glass lattice. This may thus explain the 
questionable reliability at pH values below 2 and above 12, where probably 
infiltration of Na+ ions (if present) and anion surface adsorption, respectively, occurs. 
3.1.3 Experimental technique and design 
In order to obtain reliable values for the parameters of interest, e.g. formation 
constants, in an experiment, it must be well designed to 'define' the system as 
unequivocally as possible. This is because the agreement between the 'actual 
experiment' and the output data is influenced by the reliability of the input data. 
As a fundamental requirement, a glass-electrode must be checked for 
reversibility to H+(aq) ions before it can be used in any potentiometric work. 
Reversibility should always be checked by both increasing and decreasing the proton 
concentration and checking that both plots are superimposable within the 
experimental error. This constitutes an internal calibration of the electrode. In 
addition, it has been observed that E0 varies on a day-to-day basis due to an 
asymmetry potential, Ea. 1' 12-14 This potential may well originate in the different 
conditions of strain in the two surfaces separated by the glass-membrane. 1,12-14 
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Standard buffers are normally used to ensure the constancy of E0 over a selected range 
in what is known as external calibration. 
Mor~over, these acid-base calibration titrations are helpful in the evaluation of 
the electrode parameters such as the standard electrode potential, E0, the electrode 
response slope (s) and the autoprotolysis constant of water (Kw)· In fact, the 
determination of formation constants using iterative Newton-Raphson procedures 
requires that this set of initial estimates be very good. 
On the other hand, the second set includes ligand concentration and 
protonation constants, and both sets depend upon the degree of certainty in the 
determination of the concentrations of acid and base. Acid and base concentrations are 
obtained by analysing acid-base titrations in the location of the volume-end point 
using specific techniques like the differential methods15 and Gran plot procedure. 15•16 
Potentiometrically determined constants are affected by changes in ionic 
strength (J). To ensure constancy in this ionic strength, it is more proper to use a large 
excess of an inert background electrolyte which does not react with any of the metal, 
ligand, or metal-ligand species.4 Alternatively, low concentrations of metal and ligand 
can be used so that any change in their concentrations, as a result of their reaction 
together has an insignificant effect on the overall ionic strength of the medium. 
To correct for formation constants determined at various ionic strength 
conditions, the equation below which incorporates the extended Debye-Huckel 
formula is used, 17' 18 
logKc = [(A I Z+Z-1 (1) 112)/1 +Ba(J) 112] +cl+ log K1=o.o ---3.11 
where Z+ and z_ are the charges of the ions constituting the dissolved electrolyte and 
for water at 25°C where its density and relative permittivity are 0.997 g.cm-3 and 78.54 
respectively, the value of A is 0.509, a= l/B, c =0.3Az2 and I is as given below. 17,18 
I= 0.5 L: Ci z? ---3.12 
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However, formation constants are also affected by temperature as expressed by 
the van't Hoff equation 3.13. 18 
8lnK/8T = ~Ho /RT2 ---3.13 
The importance of this equation lies on the fact that it is easy to convert and 
compare formation constants determined at different temperatures if those 
temperatures and the value of ~H0 for the system are known. 
Thus, when carrying out potentiometric studies (clearly this applies to any 
method of determination), it is extremely important to control the temperature to at 
least ±0.05°C. 
It has been shown that if the error in the temperature is ±0.02°C, then the error 
in the activities will be 0.5z%, where z is the charge of the electro-active ion. Because 
of the close temperature control required it is advantageous, if temperatures far 
removed from room temperature are to be used, to use water-jacketed vessels and 
burettes.4 
3.1.4 Formation constants determination 
For a given ligand, all stability constant studies essentially involve competition 
between two metal ions (one of which may be H+). Probably the most accurate and 
reliable method for their determination potentiometrically is to titrate one solution 
(acid or alkali) with another (of constant total metal and total ligand with alkali or 
acid), the potential being determined after each addition of titrant.4 
The difficulty with this approach is for systems that form weak complexes. 
Here the change in potential consequent to dilution of the initial solution can be large 
relative to the change in potential due to complex formation. If a metal ion solution is 
being titrated with a ligand solution, then this difficulty can be obviated by making 
equal volume additions of ligand and metal solutions of exactly double the strength of 
the solution being titrated. This ensures that the total ion concentration remains 
constant.4 
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Although this method has been widely used to determine stability constants, 
there are a number of limitations. 
• It cannot be used under conditions of extreme pH, where at high pH the 
concentration of free ligand is insensitive to pH change and at low pH the free 
ligand concentration becomes negligible owing to virtually complete protonation. 
• At very low total metal concentrations (TM ~ 0), the method is inapplicable 
because the complex formation function (Z-bar) cannot be determined reliably. 
• The method is also inapplicable for very stable complexes because the protons are 
unable to compete effectively with such metal ions for such ligands. Such 
complexes may, however, be studied by replacing the proton with another metal 
ion that can compete effectively with the metal ion under test and be detected 
potentiometrically or by some other method. 
• Since aqueous solutions always contain hydroxide ions and most metal ions form 
not only hydroxo-species but also polynuclear species,4' 17' 18 care must be taken 
either to work in sufficiently acidic solutions that hydroxo-complex formation is 
negligible or to take these into account during data analysis. 
To get reliable stability constant values in potentiometric titration calculations 
such as non-linear least-squares procedures, the following few points are perhaps 
pertinent. 4 
• The potentiometric equipment should be tested by a well documented system to 
see if it is functioning properly. 
• Once that is done, the potentiometric titrations for the system of interest should be 
carried out at more than one total metal/ligand concentration. 
• Ideally each titration ought to be followed with two or more electrodes of different 
types. The large volume of data generated is a positive advantage in defining the 
system. 
• The residual sum of squares should be defined in terms of the observed dependent 
variable, emf, and not some function of it. 
• Suspect values or trends manifested in the form of error must be carefully 
investigated. 
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In any solution of constant ionic strength, containing metal ions, M, ligands, L, 
and protons, H+, a general equilibrium reaction can take place as described by 
equation 3.14 below, where p, q and rare the stoichiometries of the components in the 
complex. 19'20 
pM + qL + rH ---3.14 
The equilibrium constant for this reaction is then designated by the symbol ppqr 
given below. 
---3.15 
For convemence species MpLqHr is denoted by three stoichiometric 
coefficients given in the order M, L and H, i.e. 11-1 denotes the complex species 
MLH.1 with r = -1 referring to removal of a proton from either a coordinated ligand or 
a bound water molecule or an hydroxide ion addition to the complex. 19'20 
In an acidic solution many polydentate ligands give 'protonated complexes'. 
The name protonated complex denotes a complex in which some donor atoms of a 
polydentate ligand are co-ordinated to a metal ion while others are protonated, i.e. 
MpLqHr can be regarded as a protonated complex if r ~ 1. 4 
3.2 Theory of Data Analysis 
Stability constants are not directly measurable but are calculated from an 
observed response function of a fixed, but experimentally adjustable, variable, the 
emf. These parameters of interest are then calculated from the experimental data and 
the assumed functional form relating the dependent to the independent variables. 
It is this good mathematical model that is necessary in describing the data, 
otherwise the presence of further species in solution may be overlooked and 
inaccurate stability constants will be evaluated. The establishment and use of mass 
balance equations (m.b.e.'s) ensures that all possible complex species of a system in 
question are detected, and hence all their respective formation constants are 
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calculated.4 Chemical knowledge and experience can then be applied as a final check 
that the calculated parameters are reasonable. 
3.2.1 Equilibrium ~imulation for litration Analysis (ESTA) Program Library21 
The program EST A is a flexible computational tool for the determination of 
protonation and formation constants in aqueous chemical equilibria. In EST A, a 
Gauss-Newton method is used to minimise the objective function, Uobj, while the 
m.b.e.'s are solved in an iterative Newton-Raphson manner. 
This objective function is optimised by the task OBJE (optimisation with 
respect to the observed emf) within the EST A2 module. Optimisation with respect to 
the emf is more appropriate because the dynamic range of the emf change is large. 
Total concentrations are sometimes used in the optimisation but these are not as 
sensitive to speciation as the emf. 
To take full advantage of the large amount of data generated, ESTA calculates 
two other concentration variables (functions).21 Depending on the chemical systems 
being investigated, like ligand, the binary and ternary systems, these functions are 
defined differently for all of them. They are the formation function (Z-bar) and 
deprotonation function (Q-bar) calculated by tasks ZBAR and QBAR respectively 
within the ESTAl module. 
A model is assumed to be correct if there is a satisfactory fit between the 
observed and calculated functions as well as reasonable low standard deviations in 
logppqr's and Hamiltonian R-factor. 
This program library also incorporates the task SPEC within the same ESTAl 
module. This calculates the distribution of species taking part in an equilibrium 
system as a function of pH of the solution. 
3.2.1.1 The Objective Function (Uobj)21 
The objective function is described as the summation of all the squared 
residuals of the real parameter values from the calculated values. 
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This function is given by equation 3.16 below, 
U _ (N )-1 "" -I "" ( obs calc)2 obj - - np "-'Ile ..:.,Wnq Ynq - Ynq ---3.16 
where N is the total number of experimental points = 70 for a single titration, np is the 
number of parameters being optimised, Ile is the total number of electrodes (equal to 1 
in this study), and Wnq is the weight of the qth residual while Ynq is the electrode emf of 
electrode q both at the nth titration point. 
In order to minimise Uobj, a Gauss-Newton approach is used. The objective 
function assumes that the function is quadratic with respect to all the parameters, 
hence Uobj can be expressed as: 
Uobj =a+ ptb + (p1H p)/2 ---3.17 
where H, the Hessian, is given by Hsr = (a2Uob/8psDPr). 
If a system is well defined, by using a good set of initial estimates including 
the hydrolysis constants, the system will converge. Once Uobj is minimised, the 
standard deviation, the Hamilton R-factor and its limit and the correlation coefficients 
are then calculated and reported together with the optimised values of the stability 
constants.21 
3.2.1.2 Formation function (ZM-bar)21 and deprotonation function (QM-bar)21 
The complex formation function, ZM-bar, measures the average number of 
ligands bound per metal ion at each concentration of ligand. This function is usually 
plotted against pA, defined as -log[L]21 and is given by equation 3.18. 
---3.18 
where TL and TM are the total ligand and metal concentrations respectively and [L] is 
the free-ligand concentration. TL is given below by equations 3 .19. 
---3.19 
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On the other hand, the deprotonation function, QM, is the average number of 
protons released from the ligand per metal ion, as a result of complexation. 
---3.20 
where TH and TM are the total proton and metal concentrations respectively; TH* is the 
calculated total concentration of protons that would be necessary to give rise to the 
observed pH if no complexation took place. 
For the evaluation of T 8 *, one needs to solve for the free-ligand concentration 
using equation 3.19 as given above. This is followed by the total calculated proton 
concentration given below, 
TH* = [H] - [OH] + IrPoqr[L ]q[HY ---3 .21 
where [OH]= Kwl[H]. The summation is over all protonated ligand species. 
In binary systems, a formation function representing the number of protons 
that would be bound on the ligand in the absence of the metal ion, is simultaneously 
defined as n8 . This function nH is given by equation 3.22 below. 
ntt =(TH* - [H] + [OH])/T1 ---3.22 
The difference between n8 and QM gives the number of protons on the 
complex. This can be represented as: 
r = ( q X ntt) - (QM X p) ---3.23 
where p and q are the stoichiometric co-efficients of the metal and the ligand 
respectively. If p = q = 1, and nH =QM, then r =O and hence we talk of the ML species 
whose stability constant is given by P110. It is possible that r may be less than 0 (r<O) 
in which case either the deprotonation of the complex formed or the formation of the 
hydroxo species is envisaged. 
The degree of metal ion hydrolysis in aqueous solution depends on a number 
of factors, including the polarising power of the metal ion and the pH of the solution. 
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The contributing equilibria for hydroxide formation can be set out as follows 
for a divalent metal ion M2+: 17' 18 
M2+ == M (OH)+ == M (OH) 2° ==="" M (OH) 3- == M (OH)/-
1l 1l 
-- { M (OH) 2 • nH20} solid 
1l 1l 
Mp (OH) q(
2p-q) ~ {MO HO} . n 2 solid 
These equilibria have to be taken into account in the potentiometric 
determination of stability constants. Although most metal ions hydrolyse to form 
polynuclear species, in dilute solutions and in the presence of strong chelating agents, 
it is usually sufficient to consider the formation of mononuclear, monohydroxy 
complexes only. 
For the reaction, 
M(OH)i + iH ---3.24 
the overall stability constant pi* is introduced in accordance with the IUPAC notation: 
---3.25 
Polynuclear complexes arise whenever there is a ligand capable of bonding to 
more than one metal ion. Such ligands include hydroxide, carboxylate etc., as well as 
multidentate ligands that may act in a bridging fashion. In general the presence or 
absence of polynuclear species can be confirmed by making a series of measurements 
at two or more widely different metal ion concentrations. 
Analysis of these two or more sets of data should lead in the first instance to 
two or more identical sets of stability constants and then to two (or more) 
superimposable complex formation plots if polynuclear species are absent.4 If this 
does not occur, i.e. if two or more distinct formation plots that only merge at very high 
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and very low ligand concentrations are observed, then polynuclear species are 
probably present.4 
Such tests should always be carried out, even where polynuclear complexes 
are not suspected, to confirm their absence. Patterns in the residuals are also more 
easily seen if the calculated and observed curves formed by measurement of the 
dependent variable are plotted out. The residuals should always be examined and 
suspect values thoroughly investigated before a potentiometric model can be accepted. 
3.2.1.3 Standard deviations21 
When the estimates of the parameters being optimised are judged to be 
sufficiently close to the solution, the method of least-squares estimates the errors in 
the parameters of interest. The standard deviations are the errors of the parameters 
sought and may be calculated as shown below, 
O'r = [U x GrrlN - np ]°"5 ---3.26 
where G is the reciprocal of the Hessian, i.e., G = H-1• 
3.2.1.4 Hamilton R-factor4•21 
An important quantity which has been used in non-linear estimation situations 
is the Hamilton R-factor (RHr). 
In this procedure the RH r is defined by: 
---3.27 
and is compared with R Hlim calculated from: 
---3.28 
The symbols have their usual meaning as outlined in section 3.2.1.1. RHlim is 
the best possible R value based on the error in the analytical data and the number of 
variables. The closer RHr is to RH1im the better is the fit between the experimental and 
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calculated data. Clearly the continued refinement of the model once RHr < RHiim is 
meaningless. 4 
3.2.1.5 Correlation co-efficients4•21 
The correlation co-efficient between two parameters can be quantified as, 
---3.29 
where G is as indicated above. The correlation co-efficients have values between 0 
and 1, and provide a measure of the linear dependence of one parameter on another 
while the remaining parameters are fixed. 
Significant parameter correlation (ru ~ 0.9) has often been reported in the 
literature, particularly in potentiometric and spectrophotometric work.4 Highly 
correlated parameters are not desirable because they are not separately defined by the 
data and only a linear combination of them can be estimated from the data. This 
means that it is possible to have a good fit to the data even with one parameter 
erroneously estimated, as the error in this parameter can be offset by an appropriate 
change in the other. Reduction of the correlation co-efficients always improves the 
conditioning.4•21 
3.2.1.6 Species distribution curves 
The real use of formation constants lies largely in the prediction of the 
feasibility of particular reactions to occur under specified experimental conditions. 
Linder et al. 1 put it in simple terms as: "Even if no practical reason can be put forward 
for the determination of formation constants and the calculation of the concentrations 
of the species present at equilibrium, there is always a strong, albeit non-utilitarian, 
case 'for knowing what is going on"'. Recently, the formation constants have been 
extensively used in speciation calculations.' 
After analysis of the potentiometric titration data, the equilibrium distribution 
of a well defined system would be easily found by use of task SPEC within the 
ESTAl module.21 The knowledge of concentration speciation based on solution 
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equilibria investigations gives a much deeper understanding of the principles 
underlying analytical techniques. 
A distribution diagram represents a family of curves showing the relative 
proportions of the individual species taking part in an equilibrium system under 
different conditions. 18'21 
The distribution curves are defined by distribution co-efficient (8) functions 
and when multiplied by 100 will give the % distribution of the metal, ligand or both as 
particular species.21 The percentage distribution of these particular species is usually 
plotted against the pH of the solution. In the same way as the proton formation and 
complex formation functions as discussed above, the species distribution curves can 
be defined for proton-ligand equilibria and metal-ligand-proton equilibria. 
For calculation of distribution co-efficients, the expression used for stepwise 
protonation is: 18 
---3.30 
and for similar complexation equilibria, 
---3.31 
3.3 Theory on data error analysis 
The optimisation of formation constants is affected by the magnitude of 
random and systematic errors, which are not always inherent to the system. Suspect 
values or trends manifested in the form of these errors must be carefully investigated. 
Random errors usually cancel each other out as the number of titration points 
increases. Systematic errors do not, even when they are of equal and opposite 
magnitude. Because systematic errors cannot be quantified, it is through careful 
selection of parameters to be optimised that their ill-effects can be reduced (Monte 
Carlo technique) followed by proper weighting. 
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3.3.1 Weighting22 
The purpose of weighting is to reduce as much as possible the adverse effects 
on optimised parameters that arise because errors in values held constant during the 
calculation tend to propagate differently at different points. Through proper weighting, 
reliable values of the formation constants can be obtained. 
The appropriate weight of the qth residual at the nth titration point is: 
---3.32 
where ap is the standard deviation in the parameter p to be optimised. Starting with 
satisfactory estimates of optimized parameters, an excellent set of weights based on 
the particular model chosen can be calculated. These weights may then be applied as 
constants in a subsequent optimization. 
3.3.2 The Monte Carlo Analysis of Error Propagation23 
This technique examines the effects of errors applied in a Gaussian 
distribution manner to all the optimised parameters and through several optimisation 
cycles calculates minimised Uobj- It minimises the objective function with respect to 
the standard deviation of the optimised and fixed parameters. The Monte Carlo spread 
of optimised results obtained by repeated optimisation is likely to reflect the way the 
errors are propagated. If the spread is smaller, the errors associated with fixed 
parameters do not affect the optimisation of the parameters during the calculation. 
Using this technique it is easy to identify which parameters are better fixed 
during the optimisation and how much a particular optimised parameter is affected by 
error in the fixed parameters. This inter-parameter effect is called correlation and has 
been discussed in section 3 .2.1. 5. 
From this technique group parameters such as analytical errors in the titrant 
solutions, or the value of E0 can be adjusted to fit the experimental data since they are 
common to a particular potentiometric titration. This is an important technique in 
chemical 'model building' because often a better fit to the data can be obtained by 
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adjusting these group parameters, than by assummg the presence of another 
species.4•23 However, if these adjustments are much larger than the expected 
experimental error, or if they vary systematically in an implausible way, then it is 
likely that the model is incorrect and further species do exist.4 
3.4 UV-Visible Spectroscopy 
The interaction of electromagnetic radiation of wavelength 340-800 nm with 
Cu2+ and Ni2+ chelates in particular, gives rise to UV Nisible spectra of these 
complexes. 24•25 The interpretation of the spectra so produced can be used for chemical 
analysis, examining molecular energy levels and molecular structures. As a result, 
UV -Visible spectrophotometry is always regarded as a supplementary technique to 
glass-electrode potentiometry (GEP) when ionic equilibria are investigated. 
Besides establishing the reliability of GEP, it also provides an additional 
method for comparing several possible chemical models not sensitive to the former 
technique.4 In addition, the use of more than one method and, UV Nis in particular, is 
essential in better defining the chemical model prior to a computer analysis of both the 
potentiometric and spectrophotometric data. This ensures that errors in the data are 
initially screened making the computer analysis of data less time consuming. These 
errors may be due to slow kinetics and/or the presence of invisible precipitates, as a 
result of the factors already discussed in sections 3.1.4 and 3.2.1.2. 
UV Nis spectrometry has also been widely used to determine formation 
constants in addition to structure elucidation. However, because UVNIS spectra of 
most complexes contain broad overlapping absorption bands, parameter correlation 
arises, such that it is usually not possible to evaluate stability constants as precisely 
from spectrophotometric data as one would with potentiometric data. 
There is therefore a dichotomy that potentiometric data may lead to a more 
precise analysis of the wrong model, whereas spectrophotometric data will indicate 
the correct model but give a less precise analysis of it. Clearly, the best approach is to 
combine spectrophotometric and potentiometric data, using the former for defining the 
chemical model and the latter for evaluation of the stability constants. 
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Spectrophotometric data, as well as producing qualitative inferences as to the 
chemical model, also involve intensive factors and these are molar absorptivities. The 
computer calculated molar absorptivities of the species in the model may be examined 
when a fit has been obtained to see if they are reasonable. 
The molar absorptivities are characteristic of the molecular electronic spectra 
and by reasonable it is meant:4 (i) they should all be positive; (ii) when plotted as a 
function of wavelength, smooth curves should result and no sharp discontinuities 
should be present and (iii) the prediction of any isosbetic points should be borne out 
by experiment. 
In a typical M2+ chelate, the observed spectrum, in general, consists of a series 
of crystal field bands, which depend largely on the donor atoms of the ligand and on 
the metal ion itself. 24'25 
The Ni2+ ion with a d8 configuration exhibits a variety of coordination 
geometries with different electronic spectra characteristic of these geometries. Hence, 
it is normally easy to postulate the structures of the different species in solution from 
these spectra. 
Octahedral co-ordination is the most common geometry for this metal ion and 
is observed in a host of complexes with an extremely wide range of mono- and 
polydentate ligands. By far the majority of these six co-ordinate complexes have an 
approximately octahedral arrangement of donor atoms around the central metal ion. 
The absorption spectrum can often be assigned on the basis of the group Oh, but if the 
ligands are not all equivalent, as will often be the case, the actual symmetry is less 
than Oh. 
The degeneracy of E and T terms will be partially or wholly lifted. This 
splitting may be small resulting in increased bandwidth, or may result in several 
absorption peaks. Ni2+ chelates are normally green and exhibit three spin-allowed 
crystal field bands corresponding to v1 = 3T2g(F) -<-- 3 A1g(F), v2 = 3T1g(F) -<-- 3 A1g(F) 
and v3 = 3T1g(P)-<--
3 A1g(F) as would be expected in an octahedral field. 24 
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These absorption bands (v1 ,v2 and v3) generally fall within the ranges 7,000-
13,000; 11,000-20,000 and 19,000-27,000 cm-1 respectively, with intensities less than 
30 mor1 dm3 cm-1 in regular octahedral systems. The v1 transition corresponds to 
ligand-field splitting (1 ODq). 
In addition to the three spin-allowed absorption bands, two spin-forbidden 
bands are often prominent. The transition to the 1Eg state occurs near the second spin-
allowed transition, whereas the second, primarily, to the 1T2g, occurs between the 
second and third spin-allowed bands. Many Ni2+ complexes show spin singlet bands 
at 18,000-24,000 cm-1.24 Tetragonally distorted octahedral and five co-ordinate square 
pyramidal Ni2+ complexes such as Ni(TMC)(N3t also show at least three d-d 
absorption bands.24 
The configuration d8 of Ni2+ is especially prone to form diamagnetic square 
planar complexes, especially with stronger field ligands or where steric hindrance 
impedes higher co-ordination numbers. Diamagnetism is a consequence of eight 
electrons being paired in the four lower lying d-orbitals. Such low symmetry 
complexes usually exhibit a single band at 18,000-25,000 cm-1, of intensity between 
50-500 dm3 mor1 cm-1, and are often yellow, red, orange or brown in colour.24 
The ground state for Ni-L (where Lis a tetradentate ligand ofN4 type) systems 
of D4h symmetry is 
1 A1g. The two component bands constituting the broad band at 
18,000-25,000 cm-1 may be tentatively assigned as v1 around 19,000 cm-
1 





corresponds to 1 ODq. A second, more intense charge transfer band may be seen 
between 23,000-30,000 cm-1. Square planar complexes differ from those discussed 
above in that absorption below 10,000 cm-1 is not seen because the ligand field 
strength in these complexes is very high.24 
Even though Cu2+ can be dealt with as the equivalent of a one electron case, 
the detailed interpretations of its spectra and magnetic properties can be somewhat 
complicated. This is because of the relatively low symmetry (i.e., less that cubic) of 
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the environment in which Cu2+ is characteristically found. Unlike Ni2+, the geometry 
of Cu2+ complexes cannot be easily predicted from the UV Nis electronic spectra. 
Cu2+ complexes are generally blue or green due to the broad absorption band 
(half-width~ 5000cm"1) in the 540-800 nm region of the spectrum. The envelope of 
this band is unsymmetrical, seeming to encompass several overlapping transitions, but 
definitive resolution into the proper number of sub-bands with correct locations is 
difficult due to the large half-width.24·25 
In a tetragonally distorted octahedral system where Cu2+ is normally found, 
these sub-bands correspond to the three spin-allowed 2 A1g ~ 2B1g, 2B2g ~ 2B1g and 
2Eg ~ 2B1g transitions. These transitions can only be resolved unambiguously when 
polarised spectra of single crystals have been measured.24 
However, in parallel with Ni2+, Cu2+ systems with close to or square planar 
stereochemistry, will not have electronic absorption below 10,000 cm·1 due to the very 
high ligand field strength in these complexes.24·25 The square planar copper(II) 
complexes are generally brown or reddish in colour. For other weak field systems 
these colours are due to the strong charge transfer bands in the ultra violet region 
tailing off into the blue end of the visible spectrum. 24·25 
While systems such as the macrocyclic and open forms of N4 ligands readily 
form such square complexes, even ethylenediamine will form a square-planar 
[M(en)2]2+ species if a weakly co-ordinating counter-ion is used.24 Thus, diamagnetic 
square-planar M2+ can often be converted to regular or tetragonal distorted octahedral 
species by strong donor solvents such as water or by addition of strongly binding 
counter-anions like [Agh]". Under these conditions, the equilibria: 
between octahedral, square pyramidal and square planar M2+ complexes (and between 
square planar and tetrahedral) can be observed.24·25 Care should be taken in that an 
observed spectrum might represent a mixture of species. 
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Tetrahedral coordination is relatively uncommon for Cu2+ and Ni2+ when 
compared to the square planar geometry. Good n-donor ligands (i.e. weak field 
ligands) such as halides tend to stabilise tetrahedral geometries, e.g., [MC14]
2-, while 
n-acceptor ligands (strong field ligands) such as PR3 and CN- afford square planar 
geometries, e.g., [M(CN)4]
2-. Due to the low ligand fields exhibited by n-donor 
ligands, the corresponding complexes usually exhibit absorption bands below 10,000 
cm-1• 
Tetrahedral Ni2+ complexes are generally highly coloured (blue or green) with 
three expected d-d transition, i.e., V1 = 3T2(F)~3T1(F), v2 = 3 A1(F)~ 3T1 and V3 = 
3T 1(P)~ 3T1(F). The observed spectra, however, tend to be complicated by spin-orbit 
coupling effects.24 The presence of two or more nitrogen donor atoms around the 
metal ion usually enforces distortion toward square planar or octahedral geometries. 
Billo26 has proposed an equation for calculating the Amax for tetragonally 
distorted octahedral complexes of the type Nx06-x, 
Ymax = LVj ---3.35 
where Yi (103 cm-1) is the contribution of each of the four equatorial donor atoms. 
In many instances, the two axially sites are usually occupied by water 
molecules. According to Billo, the contributions of each peptide and amino nitrogens 
to the Amax are (4.85 ± 0.04)x103 cm-1 and (4.53 ± 0.07)x103 cm-1 respectively, while 
that of carbonyl oxygen, H20 and Off is (3.01±0.03)x10
3 cm-1 each. 
Jackson and Nakani2° have recently proposed a value of 3.48x103 cm-1 for an 
oxime nitrogen. Although this equation can predict Amax of several of these types of 
complexes with good accuracy, the equation cannot predict absorption maxima of 
mixtures wl}.ich are likely to be present in solutions containing axially co-ordinating 
solvent molecules such as water. 
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3.4.1 Experimental design 
Generally a solution of a metal ion and ligands will contain a number of 
different species at differing concentrations. The absorption spectrum will then be a 
weighted sum of all the species present. For this reason in labile systems it is difficult 
to obtain the spectrum of a single species. In this case spectral deconvolution 
techniques have to be used. 
If a solute is dissolved in a transparent medium, then the absorbance of light, 
A, (given by the Beer-Lambert Law, A=lcc), is proportional to the concentration of the 
solute. For a given concentration and path length, the actual absorbance depends on 
the molar absorption co-efficient of the species of interest.4 For the electronic 
absorption spectra of solutions containing more than one absorbing species the Beer-
Lambert Law can be expanded to give a linear combination of terms for each 
individual species. 
If the path length l is given in cm, then the absorbance per cm at wavelength /..., 
(Aobs"'ll) is given by: 
t..;z - ').. ').. t.. ').. Aobs - Et Ct + Ez Cz + E3 C3 + ......... +En Cn ---3.35 
where Et\ Ezt.. and Ent.. are molar absorptivitites of species 1, 2 and n at the same 
wavelength /...,, and Ct, c2 and Cn are their respective concentrations.4,t 9,20 If the 
concentration is given in mo! dm-3, then the molar absorptivity has the units dm3 mot1 
cm-1. The important feature of the above equation is the linear dependence of A0b/ on 
the concentrations of the various species present. Obviously, if a species present has 
an Et.. value of zero, that is, it does not absorb in the spectral region chosen, then it 
does not influence Aob/. 
If the UV NIS spectra of a number of solutions of differing metal and ligand 
concentrations and pH are recorded at a number of wavelengths, then by solving the 
set of linear equations 3 .3 5, the spectra of the individual species can be calculated. It 
is advisable to adjust the pH of the metal-ligand complex solutions with strong acids 
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and alkalis such as HCl and NaOH respectively, which do not absorb appreciably in 
the spectral region of interest.4 
3.5 Theoretical calculations - Molecular mechanics and Molecular dynamics 
simulations 
The UV NIS spectrophotometric technique can fairly accurately predict the 
structures of the copper(II) and nickel(II) complex species present in solution. 
However, it is of no use for non-coloured chelates such as the majority of zinc(II) 
complexes. X-ray crystal structure determinations may give some valuable 
information on the geometry of the species in question. 
However, it is sometimes difficult to grow crystals suitable for X-ray structure 
diffraction determinations. Furthermore, it is now recognised that the X-ray structure 
of a particular compound provides the average atomic positions, but the atoms exhibit 
fluid-like motions of sizeable amplitudes about these averages. Under these 
circumstances, molecular mechanics (MM) calculations and molecular dynamics 
(MD) simulations become the only choices. 
The latter two techniques also offer possibilities of selecting the lowest energy 
conformations. Such a freedom is not offered by spectroscopic and X-ray structure 
diffraction techniques. In fact, the importance of MD simulations in particular lies 
with its ability to: 
(i) determine or refine structures with data obtained from experiments such as X-
ray diffraction and nuclear magnetic resonance (NMR), 
(ii) determine thermodynamics of the system, and 
(iii) examine its time development (i.e. its actual dynamics). 
A crystal structure can serve as an initial model. However, in the absence of 
known crystal structures, model building of starting species of the ligands and 
corresponding complexes is necessary. This is usually accomplished by making use of 
fragments within the BUILDER module of Biosym/MSI's Insight II software 
package.27 
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The pnmary limitation of MD simulation methods is that they are 
approximate. This is because of the absence of perfect forcefield, (i.e., an empirical 
potential energy function) which also takes into account the effect of the solvent. 
Furthermore, the ESFF forcefield in particular, does not take into account the Jahn 
Teller distortion normally observed in octahedral copper(II) complexes. It is for these 
reasons that a true experiment is essential in validating the simulation method(s). The 
comparisons of simulated system with experimental data serve to test the accuracy of 
the calculated results and provide criteria for improving methodology. 
3.6 The blood plasma model 
It is difficult to get information from large chemical systems like biological 
fluids because of their complexity. On top of their complexity, the presently available 
analytical instruments cannot detect some of the species, which are present in these 
systems at very low concentrations. Even if they could, these instruments are likely to 
perturb the systems which are at equilibrium. Because of these two limitations 
computer models simulating these complex systems have been developed. 
One of these models is the blood plasma model,28•29 which simulates the 
complexing conditions occuring in biofluids. This model operates by determining a 
particular system under in vitro conditions at manageable concentrations and 
'diluting' the effects to in vivo conditions by using appropriate mass balance 
equations. 
Blood-plasma has a well defined composition and as a result the model 
contains all the species present in blood-plasma. The blood plasma model used in this 
study includes data for 10 metal ions and 42 ligand systems, giving rise to nearly 
5,000 equilibria. This model also includes the important ternary complex 
equilibria. 28•29 
Like all computer models, the plasma model has a limitation in that it does not 
take into account the kinetics of the system and the system is assumed to be at 
equilibrium which is not the case in many instances. Deliberate omissions in the 
present model are protein equilibria, which are ill-defined. 
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To understand the effect of a ligand (or drug as in this study) on the equilibria 
present in this model, formation constants for the ligand and the species of interest 
determined in vitro are incorporated into a database. This database, on inclusion of the 
drug concentration, is efficiently and conveniently interrogated by the ECCLES 
computer program to yield results pertaining to the influence of this drug on these 
equilibria. 
Because the protein equilibria are not included in this model, the concept of a 
plasma mobilising index (p.m.i.) is used. This is defined as the ratio of the total 
concentration of l.m.w. metal complex species in the presence of the drug to that in 
normal plasma. The p.m.i. is essentially a measure of an ability of the administered 
ligand to move metal ion from the protein bound fraction to the l.m.w. fraction. 
In this calculation, the free metal ion is assumed to be constant and hence 
results are largely independent of the protein equilibria. This concept depends on the 
fact that while the absolute concentration of the metal ions is dependent on protein 
binding, the distribution amongst 1.m.w. ligands does not, hence the percentage of 
metal appearing in a given species is constant, regardless of the exact free metal 
concentration. 
This 1.m.w. fraction of copper(II) is postulated to be involved in the transport 
of the ion across biomembranes to anti-inflammatory processes and can be 
manipulated in an attempt to increase the availability of the metal ion to the anti-
inflammatory processes.29 
3. 7 Partition Co-efficients 
Drugs' transport across the skin and bio-membranes, is in general, a process of 
limited diffusion. It is governed by the drugs' chemical and physical properties such 
as lipophilicity and protein binding. For percutaneous absorption, a drug's 
translocation depends on the disease state of the skin. Partitioning of the drugs in lipid 
bilayers of the skin's stratum comeum and biomembranes, is an initial step in this 
trans-location process. 30'31 
---
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Presently, the reference parameter for the prediction of drug's passive diffusion 
through these biological barriers is the measure of its lipophilicity, expressed as the 
logarithm of the partition coefficient between 1-octanol and an aqueous phase.30-33 For 
copper(II) complex as a drug, this is given as, 
Log Koct/water = log([Cu2+]orgl[Cu2+]aq) ---3.36 
The concentrations of Cu2+ in both phases can be determined by several 
techniques but in this study atomic absorption spectrophotometry was chosen because 
of its availability and reasonable sensitivity. A value of log Koct/water = 0.6 (or Koct1water 
= 3.98) indicates that the compound (drug) is reasonable lipophilic. 
The technique has been widely used despite criticisms that this simple two-
phase system seems to be an unrealistic model of bio-membranes. However, it has 
been observed that alcohol-water systems in general, and octanol-water system in 
particular, correlate well with the behaviour of biomembranes. This is not surprising 
since many NH and OH groups are present in membranes, enzymes and even 
biological transporters,31 which are present in these membranes. Furthermore, its 
widespread use as a reference system stems from the fact that it has the largest number 
of measured values containing the widest selection of functional groups.31 
Recent investigations34 have shown that water/sodium dodecylsulfate micelle 
partition co-efficients correlate well with those obtained by the classical two phase 
system. 
3.8 Superoxide Dismutase (SOD) Activity 
A number of copper complexes have been observed to exhibit SOD-mimic 
like activity and have been suggested to be alternative human therapeutics to 
counteract the deleterious effects of ·02- radicals. Measurement of this mimetic 
activity can indirectly reveal the amount of radicals generated and can be useful to 
predict the effect of these pharmacological agents on radical production in vitro and in 
vivo.35,36 
58 
Several methods are available for SOD activity determination and the UV /Vis 
spectrophotometric method is the most widely used technique. It is an indirect method 
based on two elements, a superoxide generator usually a xanthine-xanthine oxidase 
system and a detector, nitroblue tetrazolium (NBT).37 In the absence of an SOD-
mimetic agent (control experiment) the radicals react with the detector. If SOD 
mimetic is present (inhibition experiment), it competes with the detector for the 
superoxide anion. The systems are based on the following reactions. 
( + catalaye) Diformazan 
NBT 
. Xanthine-oxidase 
Xanthme + 0 2 .. Uric acid+ ·02-
SOD mim~ 
(+ catalase) H20 +Di 
The SOD activity is then measured by the degree of inhibition of the 
intermediate (INT) and hence diformazan formation in the above sequence of 
reactions. The absorbance readings at 560 nm are obtained at several incremental time 
points (~30 seconds) for a total period of 10-15 min for both the control and inhibition 
experimental solutions. For each set of readings corresponding to a control and 
particular concentrations of an SOD mimic (Cu2+ -L complex), the absorbance is 
usually plotted against time and the slope of the resulting plots computed. The 
%inhibition of the reduction of NBT to blue diformazan is calculated using the 
following equation: 
% Inhibition = [ (Scs - Sies)x 100]/Scs ---3.37 
where Sees and Sies are slopes of the control and inhibition experimental solutions 
respectively. 
In particular, the inhibitory concentration (IC5o) defined as the concentration of 
the drug in the culture medium required to reduce the number of living cells (cell 
viability) by 50% is easily read from the plots. 
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In these experiments the disodium salt of EDT A is usually present in excess 
amounts compared to other components of the reaction mixture for two purpose: 
(i) to simulate the competitive binding of endogenously available low molecular 
ligands,36'37 and 
(ii) to complex small amounts of metal ions such as Fe3+, that may be present in 
NBT and/or xanthine, which are known to catalyse the dismutation of ·02- as 
well.37 
It should be noted that Cu2+-EDTA complexes are inactive as SOD mimics.36 
3.9 Animal biodistribution experiments 
Since there are few absolute rules to correlate in vitro observations to the in 
vivo behaviour, it is always deemed necessary to perform biodistribution experiments 
on animal screens such as mice. Radionuclides of copper (6°Cu, 62Cu, 64Cu and 67Cu) 
have several properties, which make them attractive for biomedical applications such 
as radioimaging, therapy and biodistribution studies. 64Cu appears to be the only 
isotope for tracer studies as the others are short-lived or, in the case of 67Cu, 
production is only possible from rather rare zinc or nickel targets or high energy ( ~ 60 
MeV) proton flux.38 
64Cu has become a radionuclide of choice in these studies despite its short 
half-life. However, there is an advantage associated with its short half-life since the 
overloading of tissue with high activity over a long time is not possible. 64Cu emits 
positrons which travel a short distance before annihilating to produce two 511 ke V 
gamma rays. These rays travel in nearly opposite direction (180° apart) and are 
detected by detectors in positron emmiting (PET) scanners, which encircle the organ 
of interest or the animal as a whole. Since PET scanners are expensive and, hence 
unavailable in many laboratories, a gamma counter is sometimes used to detect this 
radiation. 
Mice are animal screens of choice because they are less expensive and are easy 
to handle compared to rabbits and baboons. The animals are always injected under 
anaesthesia with the radio-labelled complex through the tail vein.39 64Cu is used to 
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produce the most detailed distribution and clearance information for its complexes. 
These studies ultimately determine the clinical usefulness of the drug. 
3.10 Conclusion 
In order to obtain reliable results in any experiment, it must be well designed 
to 'define' the system as unequivocally as possible. This is of great importance among 
experimentalist in solution equilibria to determine meticulously the formation 
constants of metal-ligand systems. 
All the relevant points discussed in this chapter have to be adhered to in order 
to achieve the task. 
• Glass-electrode potentiometry has been selected for the determination of stability 
constants using the more convenient ESTA suite of computer programs for data 
analyses. It should be emphasised that any speciation conclusion based upon a 
computer model is only as good as the input data. Such good input data are needed 
and depend on a good experimental design (including good electrode calibration, 
proper model selection that adequately describes the data). 
• UV NIS spectrophotometry has also been selected as a supplementary technique to 
potentiometry to define the chemical model and to postulate the structures of the 
different copper(II) species in solution. 
Ancillary studies 
• The MM calculations and MD simulations were used to model the complexes in 
an attempt to get low energy conformations of these species. 
• The computer blood plasma model was used to calculate p.m.i.'s. 
• The lipophilicity and SOD mimetic activities of the copper complexes were 
determined using the shake-flask method and the NBT assay respectively. 
• Biodistribution studies of 64Cu-L complexes were carried out to produce the 
detailed distribution and clearance information for these complexes. 
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CHAPTER4 
Experimental and Analytical Methods 
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4.1 Physical measurements and analytical methods 
Solvents such as dichloromethane, hexane, methanol, ethanol, ethylacetate, 
acetonitrile and triethylamine were dried and freshly distilled using the normal 
procedures1 prior to use. All other reagents were commercially available and of 
analytical grade and were used without further purification unless noted otherwise. 
Reactions and the progress of chromatographic separations were monitored by 
analytical thin layer chromatography (TLC). These were conducted on silica gel 60 
F254 precoated TLC plates. The compounds were visualised on these plates by 
illumination with 254nm UV light. Alternative visualisation was accomplished by 
either staining with iodine vapour or by treatment with a solution of eerie ammonium 
sulphate in 10% H2S04. Column chromatography was performed using silica gel 60, 
230-400 mesh from Merck. 
Melting points were measured using a Reichert Thermovar melting point 
apparatus and are uncorrected. Proton (1H) and 13C NMR proton decoupled spectra 
were obtained on a VXR-200 or MERCURY 300 or UNITY 400 MHz Varian 
spectrometers. 1HNMR chemical shifts were referenced to TMS (0 ppm) as an 
internal standard using residual protio solvent peaks as external standards (singlets at 
8H of2.50, 4.8 and 7.24 for CD3SOCD3, D20 and CDCh respectively). 
Infra-red spectra were recorded on a Perkin-Elmer Paragon 1000 FT-IR 
spectrometer as KBr disks at room· temperature. Mass spectra of the ligands were 
obtained either on a VG-Micro Mass 16 F spectrometer in EI mode or on a VG 70-
SEQ mass spectrometer. Micro-analyses were done on an Elemental Analyser EA 
1108 CHNS-0 (Fisons Instruments) and are reported as an average of two 
combustions. 
4.2 Organic Synthesis - Preparation of ligands 
4.2.1 3,3,9,9-tetramethyl-6,7-diazaundecane-2,10-dione dioxime (PrAO) 
The ligand was synthesised according to the method of Vassian and 
Murmann2-4. Nitrosyl chloride was prepared from 52.0g of sodium nitrite (0.754 mo[) 
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added to 300 cm3 cone. HCl (3.00 mol) and was obtained in 12.16% yield (0.092 
moles). Since nitrosyl chloride is a gas, which decomposes above -5.0°C, the 
temperature was maintained at -20.0°C using an ice slurry (a mixture of 4 parts of 
crushed ice to 5 parts of solid CaCb.6H20) instead of the methanol baths used in 
previous studies.2-4 2-Chloro-2-methyl-3-nitrosobutane was prepared by the reaction 
of nitrosyl chloride (6g, 0.092 mole) added to an excess of anhydrous 2-methyl-2-
butene (7.014g, 0.10 mole, 10.60 cm-3). A rearrangement within 2-Chloro-2-methyl-3-
nitrosobutane resulted in the formation of 4.84g (0.0349 mol) of 2-Chloro-2-methyl-3-
butanone oxime in 38.1 % yield, m.p. 67.5-69.0°, lit. 68-69°. 
0.01745 mole (l.29g, 1.45 cm-3) of 1,3-diaminopropane was added to a 10% 
excess (0.0349 mole, 4.84g) of 2-Chloro-2-methyl-3-butanone oxime in 100 cm3 of 
ice-cold absolute methanol. The resulting solution was maintained between 0.0°C-
5.00C for 2 hr and at room temperature for another 2 hr; before refluxing it for 15 hr. 
After removal of solvent under vacuum, the solid was extracted with water and 
neutralised with an excess of saturated solution ofNa2C03 followed by several cm3 of 
10 mol dm-3 NaOH until a pH of 10-11 was reached. The solid was collected, washed 
with cold water and recrystallized from boiling methanol. 
The ligand crystallised as a white solid, yield l.25g (0.00459 mole, 26.24%) 
which gave melting point 181-182°C, lit. 180-181°c; 1H-NMR, 8H (D20), 1.44 (12 H, 
s, 3,3,9,9-CH3), 1.88 (2 H, m, 6-CH2), 1.98 (6 H, s, CH3) and 2.82 (4 H, t, 5,7-CH2) 
and micro analysis - Observed (Cale. for C13H2s02N4): C, 57.21 (57.32); H, 10.23 
(10.36); N, 20.38 (20.57). 
4.2.2 N, N'-bis(2-hydroxyiminopropionyl) propane-1,3-diamine (H2pap) 
The ligand N,N'-bis(2-hydroxyiminopropionyl) propane-1,3-diamine was 
synthesised analogously to the methods reported by Gutche et al. 5 and Kozlowski and 
coworkers6 for its ethane-1,2-diamine analogue except that ethyl pyruvate instead of 
pyruvic acid was used as the starting material. This resulted in the elimination of the 
alkylation step using methanol5 or ethanol6 in the presence of sulphonyl chloride 
(SOCb) as reported by these authors. 
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To a solution of 20g of ethyl pyruvate (0.1722 mo[) in 8.61 cm3 of water was 
added 12.022g of hydroxylamine hydrochloride (0.173 mo[) in 17 .1 cm3 of water. The 
mixture was shaken at room temperature for 4 hours, and the white precipitate was 
collected, washed with water and filtered at the pump. This gave 16.453g (0.1525 mo!, 
88.56% yield) of ethyl pyruvate oxime as a white powder in pure form, m.p. 94.5-
96.00C, 1H-NMR, DH (CDCh) 1.35 (3H, t), 2.10 (3H, s) and 4.30 (2H, q). 
Ethyl pyruvate oxime, (16.453g, 0.1525 mo[) was dissolved in methanol (63 
cm3), then 4.40 cm3 (3.9lg, 0.053 mo[) of 1,3-diaminopropane was added. The 
reaction mixture was set aside for 24 hours at room temperature, then the solvent was 
removed on a rotary evaporator. The addition of water (15 cm3) to the obtained oil and 
cooling of the mixture at 0.0°C overnight resulted in the precipitation of the crude 
product. This crude product was filtered at the pump under vaccum washed several 
times with water and had m.p. 193-196°C. 
Recrystallisation from water gave the pure oxime in the form of colourless 
single crystals, yield 8.5g (66%), m.p. 195-196°C, 1H-NMR (300 MHz, [2H6]dmso), 
DH: 1.564 (qnt, 2H, ~-CH2), 1.859, (s, 6H, CH3), 3.142 (q, 4H, a-CH2), 7.930 (t, 2H, 
NH) 1 l.632(s, br, 2H, OH). FT-IR (v in cm-1) 3328 v(N-H str., s); 3215 v(O-H str., 
br); 2981, 2965 2943, 2872 v(C-H, s); 1670 v(C=N str., m,); 1655 v(C=O str., amide 
I, s); 1542 (N-H bend, amide II, m), 1304 v(C-N str., m), and 1024 v(N-0, str., w). 
Anal. Found (Cale. for C9H16N404): C, 44.51 (44.25); H, 6.88 (6.62); and N, 22.93 
(22.94). EI-MS, molecular ion peak (M+) situated at m/z = 244 agrees with the 
calculated molecular mass of the compound, which is 244.2448 glmol. 
4.2.3 (1,15)-bis(N ,N-dimethyl-5,11-dioxo-8-(N-benzyl)-1,4,8,12,15-
pentaazapentadecane (BIDPAP) 
The ligand was prepared by a procedure similar to those reported before for 
similar ligands.7'8 
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4.2.3.1 Bis (N,N-ethyl propionate)benzylamine 
2.4 cm-3 (3.38g, 0.019 mo[) of ethyl bromopropionate was added dropwise 
with continuous stirring to 1.02 cm-3 (I .OOg, 0.0087 mo[) of benzylamine in 
acetonitrile and the Huenigs base ( diisopropyl ethylamine) for 30min in a 
cycloaddition tube. The mixture was heated under reflux at 120°C, while monitoring 
the reaction progress by TLC. 
After a 24hr period of continuous heating under reflux, the TLC confirmed the 
absence of starting materials. It also revealed the presence of the mono- and bis(N,N-
ethylpropionate) benzylamine, with Rf values of 0.5 and 0.8 respectively in 4:1 (v/v) 
hexane-ethyl acetate eluent mixture. The reaction mixture was concentrated on a 
rotary evaporator. The hydrobromide salt of diisopropyl ethylamine was dissolved in a 
saturated solution of Na2C03 and the organic components of the mixture were 
extracted three times with ethyl acetate. The combined organic layers were dried over 
anhydrous magnesium sulphate, filtered and concentrated on a rotary evaporator. 
Column chromatography using the same eluent as for TLC yielded the oily 
mono- and bis(N,N-ethylpropionate) benzylamine in pure forms. Monoalkylated form, 
yield 0.3055g, 20.4%; 1HNMR (200 MHz) DH (CDCb) 1.25 (3H, t, R-CH3), 1.85 (IH, 
s, R1NHR2), 2.45 (2H, t, ROOCCH2-R1), 2.85 (2H, t, RCH2-NR1R2), 3,79 (2H, s, 
NR1R2-CH2-Ar) 4.25 (2H, q, -COO-CH2-R), 7.30 (5H, m, Ar-H); dialkylated form, 
yield 2.464g, 79.2%, DH (CDCb) 1.22 (6H, t, RCH3), 2.5 (4H, ROOCCH2-R1), 2.85 
(4H, t, RCH2-NR1R2), 3.53 (2H, s, N(R2)2-CH2-Ar), 4.14 (4H, q, R1-COO-CH2-R), 
7.30 (5H, m, Ar-H). 13C NMR (75,45 MHz), DH (CDCb), 14.077 (CH3RNRCH3), 
32.714 (ArCH2N(R1)2), 49.173 (ROC=OCH2R1), 58.230 (R1R2NCH2R3), 60.177 
(RCH20C=OR1), 128.085 (C-Ar), 139.050 (ArCH2N(R1)2), 172.382 (R1C=OR2). 
4.2.3.2 1,15-bis(N ,N-dimethyl-5,9-dioxo-7-(N-benzyl)-1,4,8,12,15-
pentaazapentadecane 
To 2.221g (0.0072 mo[) of bis(N,N-ethylpropionate) benzylamine was added 
l.60g (2 cm-3, 0.0181 mo[) of N,N-dimethylethylenediamine in a cycloaddition tube. 
The reaction mixture was heated under reflux at 80°C for 24 hours while 
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simultaneously monitoring the reaction progress using TLC. After this 24hr period, 
the TLC in dichloromethane-methanol-triethylamine, 9:5: 1 ratio (v/v) revealed the 
absence of bis(N,N-ethylpropionate) benzylamine, one of the starting materials. The 
excess N,N-dimethylethylenediamine was then removed on a vaccum pump. The 
resulting residue was then dissolved in a minimum amount of dichloromethane. On 
column chromatography with the same eluent as for TLC, 2.464g (0.0063 mo!, 87% 
yield) of the product BIDPAP was obtained. 
In contrast to the earlier syntheses of related ligands,7'8 the compound BID PAP 
was obtained in a form suitable for analysis and potentiometric titrations. This 
resulted in the elimination of the hydrochloridation step involving the bubbling of 
dried HCI gas over the BIDP AP solution. The higher molecular weight of BIDP AP 
compared to its previously synthesised analogues is probably the reason for the 
compound to be obtained in the solid form. 
The compound was dissolved several times in dichloromethane followed by 
filtration to remove impurities. The excess solvent was removed initially on a rotary 
evaporator and by drying the compound on a vaccum pump. After these purification 
steps, BIDPAP was recovered in 90% yield, m.p. 198-200°C. 1HNMR (300 MHz), OH 
(CDCb), 2.22 (12H, s, (CH3)2NRN(CH3)2), 2.40 (4H, m, R-NHCH2-CHrN(R1)2), 
2.76 (4H, m, (R2HNOC=OCH2R1)), 2.88 (4H, m, R1CH2N(Ar)CH2R1, 3.25 
((R1)2NCH2CH2RCH2CH2N(R1)2), 3.80 (ArCH2N(R1)2), 7.30 (7H, m). 13C NMR 
(75,45 MHz), OH (CDCb), 33.87 (ArCH2N(R1)2), 45.07 (R1(CH2)N(CH2)R1), 49.91 
(ROC=OCH2R1), 58.23 (R1R2NCH2R3), 60.18 (RCH20C=OR1), 128.30 (C-Ar), 
139.47 (ArCH2N(R1)2), 172.11 (R1C=OR2). 
It should be mentioned that some carbon signals were observed to exist in 
pairs, indicating the presence of the cis and trans forms or a mixture thereof. The 
higher than expected number of carbon signals is expected for compounds containing 
the amide moiety.9 However, this behaviour was not observed for H1pap and related 
compounds, which were studied before. 8 The presence of the extra methylene groups 
in this compound may have enhanced this cis/trans isomerism. 
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FAB-MS gave m/z values, Found (Calcd.), M+ = 391.5426 (391.5546 for 
C21H31Ns02), M+H+ = 392.54259 (392.5541 for C21H3sNs02) and M+Na+ = 414.55 
(414.5453 for NaC21H3sNs02). Anal. Found (Cale. for C21H37Ns02): C, 63.20 (64.42); 
H, 8.68 (9.52); and N,15.81 (17.89). The discrepancy between the observed and 
calculated values is probably due the hygroscopic nature of this compound. 
The purity of these three ligand systems was also confirmed by acid-base glass 
electrode potentiometric titrations at 25°C and I= 0.15 mo! dm-3 and were found to be 
greater than 95% pure. This was reflected by an excellent fit, which was obtained 
between the calculated and experimental observed protonation function (ZH). 
4.3 Preparation of Solutions 
All solutions were prepared in glass-distilled, or deionised water which had 
been passed through a Milli-Q water purification system (Millipore Corp.). The 
distilled and/or purified water was then boiled to remove dissolved C02 and cooled in 
a container protected by a "Carbosorb" (BDH) carbon dioxide trap. 10-12 
These solutions were made up to an ionic strength of 0.15 mo! dm-3 with 
sodium chloride in order to ensure isotonicity with blood-plasma. All other reagents 
such as CuCh.2H20, NiCli.6H20, ZnCh, CaCh.2H20, GdCh.9H20, NaCl, HCl, NaOH 
and EDT A (Merck) were commercially available and of analytical grade. These were 
also used without further purification. 
Solutions of 0.100 mo! dm-3 NaOH and 0.100 mo! dm-3 HCl were prepared 
from Merck Titrisol ampoules and were stored in polyethylene plastic bottles in 
Metrohm exchange units. Solutions of hydrochloric acid were then standardised by 
titration with sodium tetraborate using the standard methods of Vogel. 13 Carbonate 
free-sodium hydroxide solutions were also standardised by titration with potassium 
hydrogen-phthalate. 
The 0.100 mo! dm-3 NaOH solutions prepared were further standardised 
against standard 0.100 mo! dm-3 HCl solutions. These acid-base titrations were also 
used to check the carbonate content of the sodium hydroxide titrant solution using the 
Gran method. 14 Otherwise these standardised solutions were used within a short 
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period of preparation and were discarded whenever there were signs of carbonate 
contamination. 
4.4 Standardisation of Cu2+, Ni2+, Zn2+, Ca2+ and Gd3+ solutions: Direct titrations 
usingEDTA 
The accurate concentrations of standard metal ion solutions are necessary for 
the initial estimates in data analysis. These initial estimates were determined by direct 
titrations using EDT A. 
The 0.02 mol dm-3 solutions of the divalent cations were prepared from 
CuCh.2H20, NiCh.6H20, ZnCh, CaCh.2H20 and GdCh.9H20 salts at the indicated 
ionic strength. 5 cm3 portions of the 0.02 mol dm-3 solutions of the divalent metal ions 
were titrated against a 0.01 mol dm-3 standard solution of the disodium salt of 
ethylenediamine - tetraacetic acid using the standard methods of Vogel. 13 The 
concentrations of these metal ions ranged between 0.0195 and 0.021 mol dm-3. 
4.5 Potentiometric titrations 
4.5.1 Conditions and Equipment 
The final adjustments were made to an ionic strength of 0.15 mol dm-3 with er 
(Na+) in all solutions for the potentiometric and UVNIS measurements. 
The potentiometric titrations were performed using a Radiometer PHM 84 
research pH meter and Metrohm Dosimat 665 piston burette, which were linked and 
controlled by a computer. The pH meter was equipped with a Metrohm 6.0130.100 
separate glass electrode and 6.0726.100 Ag/ AgCl reference electrode with a 
renewable liquid junction of 0.15 mol dm-3 NaCl. 10,1 1 In some instances, with 
UV /Visible titrations in particular, a Metrohm 6.0204.100 combined micro glass-
electrode was used. 
The electrode(s) were immersed in the solution S contained in a double-walled 
titration vessel thermostated at 25.0 ± 0.1°c by circulating water from a constant 
temperature Haake thermostat bath. The titrant T was delivered to the titrated solution 
71 
S through an immersed capillary tip from a Metrohm Dosimat 665 piston burette 
using a Pascal program developed in this laboratory to monitor the electromotive 
force (emf) and the volume of T added for each titration point. These titrations were 
carried out at least in duplicate. 
During the titration, stirring was effected with a Teflon magnetic stirrer bar. 
Throughout the titration, the magnetically stirred solution was protected from the 
intrusion of atmospheric oxygen and carbon dioxide by passing a continuous flow of 
high purity nitrogen stream over it. The double-walled vessel was sealed apart from a 
small exit for this nitrogen stream. The gas was first bubbled through a series of 
solutions; 
• 50% w/w potassium hydroxide to remove carbon dioxide impurities, 
• Fieser's solution to remove traces of 02, 
• excess glass wool in empty container, 
• distilled water and 
• background electrolyte of ionic strength 0.15 mo! dm-3 (Cr) to humidify the gas. 
The last three traps were thermostated at 25°C in accordance with titration 
conditions. 
The glass electrode was calibrated as an H+ probe using three standard buffer 
solutions. The Nemstian slope of the glass electrode was checked against these buffers 
over the pH range 2-11, and was found to vary between 59.14 and 58.75. After 
calibration using buffers, precision calibration of the instrument was carried out by 
titration of 0.100 mo! dm-3 NaOH (2 cm3) from the autoburette against 0.100 mo! dm-3 
HCl (1 cm3) in the vessel and vice versa in the same pH range 2.0-11.0. 
The value of the response intercept, E0, was found to vary from 415-418 mV 
while an average pKw value of 13. 73 was evaluated from these acid-base titrations 
before each protonation and complexation titration. The measurement of these 
constants at the beginning of each experiment was also used to verify the correct 
functioning of the electrode, the reliability of the potentiometric measurements as well 
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as to ensure the reproducibility and reversibility of equilibria. These parameters were 
fixed in the computation and refinement of log ppqr's. 
It should be emphasised that many workers15-19 have previously reported 
autodissociation constants of the solvent which vary from 13.78 to 13.69 for titrations 
performed under exactly the same experimental conditions as employed in this study. 
At 0.1 moldm-3 (Cr) ionic strength, pKw values of 13.76-78 have also been reported. 
It is believed that a value of 13.73 should be appropriate for pKw at 25°C and I= 0.15 
mol dm-3. 
4.5.2 Protonation and complexation titrations with 0.02 mo/ dm-3 solutions of the 
divalent cations 
About 0.015g of ligand L (L=L1, L2 or L3) was dissolved in a calculated 
volume of 0.100 mol dm-3 (~ 1-1.5 cm3) HCl or NaOH (L2 was observed to be 
insoluble in hydrochloric acid). The minimum initial volume required to cover the 
electrode(s) was made with 0.15 mol dm-3 NaCl in a double-walled titration vessel. 
The solution was titrated against 3.0 cm3 of0.100 mol dm-3 NaOH (HCl). 1.0-2.0 cm3 
of 0.100 mol dm-3 HCl was added to bring the pH down to about 2.5 before addition of 
V cm3 of metal ion solution. This was done to prevent the hydrolysis of metal ions 
under strongly alkaline conditions. 
The resulting solution was titrated with 3.0 cm3 of0.100 mol dm-3 Na0H. This 
constituted an in situ calibration of the electrode system. The procedure was repeated 
with varying initial concentrations of solutions of the metal ions. 10' 11 The titrations 
were terminated at the first visual sign of precipitation. 
The following hydrolysis constants obtained from the data of Baes and 
Mesmer20 and Kragten21 at 25°C were corrected for ionic strength I= 0.15 mo! dm-3 
where necessary. They were used in the computation and refinement of the formation 
constants. All the species given below are solvated in aqueous solution. 
For copper(II), 
Cu2+ + 2H20 
Cu2+ + 3H20 
Cu2+ + 4H20 
For nickel(II), 
Cu(OH)2 + 2H+; log K10-2 = -14.33 
Cu(OH)3- + 3H+; log K10-3 = -27.80 
Cu(OH)l-+ 4H+; log Kio-4 = -39.03 
Ni2+ + H20 ~ Ni(OHt + H+; log K10-1 = -10.20 
Ni2+ + 2H20 ~ Ni(OH)2 + 2H+; log K10-2 = -19.20 
Ni2+ + 3H20 ~ Ni(OH)3- + 3H+; log Kio-3 = -30.00 
Ni2+ + 4H20 ~ Ni(OH)l+ 4H+; log Kio-4 = -44.00 
2Ni2++ H20 ~ Nh(OH)3+ + H+; log K10-1 = -10.5 
4Ni2++4H20 ~ Ni4(0H)4
4+ + 4H+; log Kio-4 = -27.30 
For zinc(II) hydrolysis, 
Zn2+ + 2H20 
Zn2+ + 3H20 





Zn(OH)2 + 2H+; log K10-2 = -17.l 
Zn(OH)3- + 3H+; log Kio-3 = -28.4 
Zn(OH)l- + 4H+; log Kio-4 = -40.7 
Zn2(0H)3+ + H+; log K20-1 = -8.9 
Ca2+ has a slight tendency to hydrolyse and its only hydrolysis constant is, 
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Just like Cu2+ and Zn2+, gadolinium(III) also undergoes extensive hydrolysis in 
aqueous solution and the contributing equilibria are, 
Gd3+ + H20 - Gd(OH)2+ + H+; log K10-1 = -8.0 
Gd3+ + 2H20 - Gd(OH)2+ + 2H+; log K10-2 = -16.4 -
Gd3+ + 3H20 - Gd(OH)3 + 3H+; log K10-3 = -25.3 -
Gd3+ + 4H20 - Gd(OHk + 4H+; log Krn-4 = -34.4 
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4.5.3 Data Analysis 
All the data collected from each titration were imported into a preformatted 
data file for the calculation of electrode parameters, protonation and formation 
constants, log ppqr· These parameters of interest were calculated using the task OBJE 
within the EST A2A module of the ESTA library of computer speciation modelling 
programs. 
The analysis was performed by fitting these constants to the titration data, 
based upon minimisation of the objective function, Uobj, with respect to emf. No other 
variables such as E0, [H]\essJ, [L ]vessl and [M]vessl were refined in addition to logppqr's 
sought. The results are presented in Table 5.1 and 5.2. 
To take full advantage of the large amount of data generated, complex 
formation and deprotonation functions were calculated from the determined log ppqr 
values using the tasks ZBAR and QBAR respectively within the ESTAl module of 
EST A. These functions were then used as criteria for testing the validity of the 
potentiometric model proposed in the analysis of data. 
Finally, the task SPEC within the same ESTAl module, was used to determine 
the distribution, as a function of pH, of all the MpLqHr species present in solution over 
the pH range 2 to 11. 
4.6 UV-Visible electronic spectra of Cu2+ /Ni2+ complexes 
UV-visible electronic spectra of a 3.0 cm3 aqueous solution containing a ratio 
of Cu(II)/Ni(II): L2 or L3 = 1 :3, in a cuvette, were taken over the pH range 2.00-11.00. 
Small amounts of 0.100 mo! dm-3 HCl and NaOH were used to adjust the pH during 
the titration. The temperature of the solutions was kept at 25.0 ± o.1°c. 10-12 
Spectrophotometric measurements were taken manually at 10 nm intervals in 
the range 340-800 nm using a Unicam SP 1700 Ultraviolet Spectrophotometer with 
slit and band widths set at 0.4 mm and 1.2 nm respectively. 
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4. 7 Crystal structure determination, MM calculations and MD simulations 
4. 7.1 Synthesis and crystallisation of [NiL 1H-1tCl04-
0.1 g (0.367 mmol) of L1 was dissolved initially in 5.00 cm-3 of O. lM HCl and 
10.00 cm-3 of absolute methanol was added. To this ligand solution was added 18.3 
cm-3 of 0.02 moldm-3 NiCb.6H20 followed by 5.00 cm-3 of O.lM NaOH to adjust the 
pH to 7.15. 
The mixture was stirred at room temperature for two hours during which time 
a yellow complex was formed. Addition of an excess of NaCl04 solution to this 
yellow mixture resulted in the formation of a colloidal precipitate. After five (5) days 
the desired orange-yellow complex crystallised out of solution. The crystals were 
filtered off, washed with small amounts of acetone and dried over anhydrous CaCb. 
Yield 0.08g (51%). 
4.7.2 Crystal-structure determination 
An orange-yellow crystal(~ 0.25 x 0.23 x 0.20 mm) of [NiL1H-1tCl04- was 
mounted on an Enraf-Nonius Kappa diffractometer equipped with a graphite-crystal 
monochromator situated in the incident beam for data collection. Unit cell 
determinations and data collections were performed with Mo-Ka radiation (A. = 
0.71073 A) at 197(2) K. A Lorentz-polarisation correction was applied to the data, as 
well as an empirical absorption correction22 following the DIF ABS procedure 
(minimum and maximum absorption transmission were 0.7445 and 0.7875 
respectively). 
The structure was solved by direct methods (SHELXS-90, 1990)23 and refined 
using full-matrix least-squares on F2 (SHELXL-97, 1997).24 Non-hydrogen atoms 
were treated anisotropically while hydrogen atoms were placed in geometrically 
calculated positions and linked to common thermal parameters. Pertinent crystal and 
structure refinement data are discussed in chapter 5. 
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4.7.3 MM calculations and MD simulations 
Model building of ligands and the corresponding starting complexes in 
particular, was based on known or related crystal structures of these species or from 
UV Nis spectrophotometric data. This was accomplished by making use of fragments 
within the BUILDER module of the Biosym/MSI's II software package.25 Structures 
were then optimised prior to dynamics runs to remove the strain using the SHAKE 
algorithm with the default ESFF force fields. The optimisation procedure in essence 
constrained all the bond lengths to their equilibrium value while a constant 
temperature algorithm was used to keep the temperature at 298 K. 
MD simulations of the complex species were performed by the DISCOVER _3 
module (98 Version) which is run as an application in the INSIGHT II package.25 
Hydrogen bonds were not restrained during the simulation since molecular dynamics 
is a more natural and ideal way of simulation. These MM calculations and simulations 
were performed on a Silicon Graphics Indigo computer. 
4.8 Octan-1-ol/water partition coefficients 
Partition coefficients were measured using the shake flask method.26'27 The 
organic solvent was purified by double distillation after reflux for 5 hrs using standard 
methods. 1 25.0 cm3 of 0.007 mol dm-3 Cu2+-L2/L3 solutions were prepared. Because of 
the low solubility of the ligand L 2 in HCl, it was initially dissolved in an appropriate 
amount of 0.1 mol dm-3 NaOH followed by an addition of a calculated amount of 0.1 . 
mol dm-3 HCl before the addition of the metal ion. Into eighteen, 10.0 cm3 glass vials, 
1.0 cm3 portions of the metal-ligand solution were pipetted. The first vial was left at 
pH 2.5 and the rest of the vials were adjusted to 0.5 pH increments apart using a 
highly concentrated solution ofNaOH.26,27 
Into each vial, 1.0 cm3 portion of water presaturated octan-1-ol was added. 
Each vial was then stoppered, shaken by hand for about a minute, swirled gently to 
collect droplets from the sides of the vial and set aside to allow the two phases to 
separate. The temperature was maintained at 25.0 ± 0.1°C using a temperature 
controlled water bath. The organic phase was then removed, by Pasteur pipette, into 
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10.0 cm3 of 0.100 mo! dm-3 HCl for extraction of the partitioned solute back into the 
aqueous phase while the aqueous solution was diluted 100 fold with the same· 
concentration of the acid. 
These solutions were then analysed for copper(II) ion content using a Spectr 
AA-5 atomic absorption spectrophotometry (AAS). The air-acetylene flame was used 
for atomization while the wavelength and slight. width were set at 324.7 nm and 0.2 
nm respectively. 
4.9 Determination of Cu2+ -L SOD Mimetic Activity 
The superoxide dismutase mimetic activity of Cu2+ -L (L = L 1, L 2 and L3 
complexes were determined using the NBT assay as described by Fridovich28 and 
Auclair and Voisin29 to assay tissue homogenates. 
Standard solutions of i) 0.0004 M xanthine, ii) O.OOOlM EDTA, iii) 0.0001 
g!cm3 of catalase, iv) 0.018 unitslcm3 xanthine oxidase and (v) O.OOOlM solutions of 
Cu2+-L in a 0.05M phosphate buffer pH 7.80 were prepared. 
In a four (4) cm3 cuvette, 0.6 cm3 of xanthine, 0.2 cm3 EDTA, 0.2 cm3 NBT, 
0.1 cm3 catalase and 2.9 cm3 of a 0.05M phosphate buffer were added and this 
constituted a blank solution. In a control experiment, in addition to these components, 
0.4 cm3 xanthi1w oxidase and 2.4 cm3 instead of 2.9 cm3 buffer were added, while in a 
test solution varying amounts of Cu2+-L complexes were added prior to the addition of 
xanthine oxidase. 
The absorbance readings at 560 nm were obtained at 30 seconds intervals for a 
total period of 15 min for both the control and experimental solutions. For each set of 
readings corresponding to a control and particular concentrations of an SOD mimic 
(Cu2+-L complex), the absorbance was plotted against time and the slope of the 
resulting plots were computed. The %inhibition of the reduction of NBT to blue 
formazan was calculated using equation 3.37 and IC5o values
28
•
29 similarly determined 
from a plot of%inhibition vs the concentration of the Cu2+-L complex. 
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4.10 Biodistribution experiments of 64Cu-L on mice 
The biodistribution studies on mice were approved by the Research Animals 
Ethics Committee of the University of Cape Town (permission number 01/060). The 
authority to possess and use the radioactive nuclide 64Cu was granted by the 
university's radiation protection and health safety committee in conjunction with 
Department of Health (authority number 33/3/01/0327) . 
. 
64Cu-labeled [CuLH_i] complexes were prepared by spiking 14.8 cm3 of Cu2+ 
(0.001 mo! dm-3) - L (0.003 mo! dm-3) solutions with 7.5 mCi of 64CuCb. The copper 
complexes of these ligands were found to be kinetically and thermodymamically quite 
stable in vitro once given enough equilibration time because slow kinetics have been 
observed in these systems. No assumptions were made on the !ability of the copper 
complexes in vivo. Radio-TLC indicated that the copper(II) species ofL1, L2 and L3 
were 93%, 97% and 90% radio-labeled respectively. 
A total of 48 female Balb/c mice of age 6-8 weeks weighing between l 9-22g 
were used in these experiments. The mice were housed in groups of four ( 4) mice per 
Macrolon cage and were given food and water ad libitum during the investigation 
period, with sawdust provided as bedding prior to injection. 
Three (3) groups of 4 halothane-anaesthetised mice (12 in total) were injected 
intravenously via the tail vein with 0.2 cm3 of 5 µCi of 64Cu-L (L = L1, L2 or L3).30-34 
Another group of mice was injected with 64CuCb(aq) to serve as a control experiment. 
The mice were individually placed in Macrolon cages containing paper towelling for 
urine absorption. 
After 1, 6 and 24 hours post-injection, these groups of mice (3 per time point) 
were deeply anaesthetised by halothane inhalation. Blood samples were immediately 
collected by puncture of the inferior vena cava.30-34 This resulted in the death of the 
animals. 
The mice were dissected and the liver, muscle, tail, heart, lung, kidney, 
intestines, spleen, brain, head and carcass were excised, rinsed with NaCl-0.9%,30 
blotted dry and weighed. The radio-activity in these tissue samples was counted in a 
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Minaxi Auto-Gamma Counter (5000 Series-Packard) using a window set at 350-550 
keV.30-34 The urine impregnated towelling was extracted with 100 cm3 of 10% v/v 
HCL Diluted aliquots of the injectates served as standards for calculation of the total 
injected dose. Radio-activities of the 10 cm3 standard diluted aliquots of the injectates, 
the urine extract and samples of the droppings were also counted. 
The percentages of radio-activity dose per gram (g) tissue and/or per organ 
were computed from the corresponding mean wet organ weights after correction for 
radio-activity decay. 30•34 
4.10.1 Radiation protection 
Although much less activity of 64Cu was used in these experiments, the high 
tissue penetrating abilities of high energy positrons and gamma radiation resulting 
from their annihilation necessitated adherence to the following precautionary 
measures. 
• During these experiments, disposable gowns, face masks, gloves and radiation 
badges were worn. 
• Preparation of 64Cu-L complexes as well as the injection of mice with the radio-
labeled species were performed behind lead bricks inside a fume-cupboard. 34 
• Aqueous stock solutions of these 64Cu-L complexes (or 64CuCb) were kept in 
closed containers in the refrigerator. 
• Since the half-life of 64Cu is reasonably short, the syringes and needles which were 
used during injection, the disposables, the sacrificed animals together with the 
organs excised were initially kept in a refrigerator for two weeks to allow the 
radioactivity to decay before being incinerated. 
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5.1 Glass electrode potentiometry 
5.1.1 Protonation constants 
The protonation constants for H+-L equilibria were evaluated in the pH range 
2-11 where the ligands were found to take up two or three protons. Reversibility of the 
reactions was confirmed by complete overlap of titration curves obtained by titrating 
the experimental solution in both directions with hydrochloric acid and sodium 
hydroxide solution. The logPoqr values of the ligands L 1, L 2 and 1 3 are given in Table 
5 .1, together with literature values. 
Table 5 .1: LogPoqr' s of L1 , L2 and L3 determined at 25°c and I = 0 .15 
mol dm- 3 (Cl-) Na+. O"pqr denotes the standard deviation in logPoqr; RH is 
the Hamiltonian R-factor and RHlirn is its limit, nT and np are the 
number of titrations and points respectively. The general formula of 
a complex is MpLqHr denoted by the stoichiometric coefficients pqr 
where p=O. 
L p q r log Poor O"oar RH Rtt.Lim nT (np) Lit. 
Li 0 1 1 8.968 0.002 0.001 0.001 5(703) 8. 97 1 
0 1 2 16.175 0.004 16.18 
L2 0 1 1 10.408 0.001 0.004 0.003 9(975) 10.38 4 
0 1 2 20.072 0.001 19.99 
L3 0 1 1 8.823 0.010 0.012 0.010 8 ( 943) 
0 1 2 17.254 0.008 
0 1 3 24.152 0.012 
5.1.1.1 H+ -L 1 system 
Figure 5.l(a) shows the proton formation function, Zwbar for 1 1 plotted 
against the pH. This function rises to two for this system indicating simple stepwise 
protonation of two basic sites. An excellent agreement between the experimental and 
theoretical curves at different total ligand concentrations illustrates the reproducibility 
of the experimental protonation procedure. 
The secondary amino groups of L 1 are protonated in this pH range of 2-11, 
with pKa1 = 7.207 and pKa2 = 8.968. A difference of 1.761 between the two pKa's 
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indicates that proton addition to the second amine of an already protonated ligand is 
difficult compared to the protonation of the neutral ligand. This is because of 
electrostatic repulsion between two charged sites and the close proximity of these 
amino groups to each other. Furthermore, this difference can be explained in terms of 
the decreased number of available sites for proton addition to occur once a first proton 
has been attached to one of the amino groups. These amino groups are observed to be 
less basic compared to the nitrogen donor atoms of 1,3-diaminopropane. This 
decrease in basicity is expected as one moves from primary to secondary amines due 
to steric hindrance and solvation effects that override the positive inductive effect of 
the carbon chain. 
Figure 5 .1: (a) Experimental ( [L1 ] T=3x10-3 (.) ' sx10-3 (*) and 8x10-3 (x) 
mol dm-3 ) and theoretical (line) ZH-bar (b) calculated L1H0 + species 
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For L1, this base weakening has also been attributed to the electron-
withdrawing properties of the oxime group with a possible contribution from 
intramolecular hydrogen-bonding interactions originating from the same oxime 
group. 1-3 The pKa values of this ligand agree quite well with those that have been 
determined in previous studies. 1'2 The oxime groups in L1 have been observed to 
exhibit pKa values in the range 12-13, hence cannot be evaluated under the conditions 
J 
84 
of the present study. However, co-ordination of these groups to metal ions such as 
copper and nickel facilitates their ionisation process. The degree of the deprotonation 
of the oxime groups of L1 has been observed to be metal ion dependent.2 Figure 5.l(b) 
shows that in the pH range 4.0-8.0 the protonated forms of this ligand predominate 
while above this pH range the neutral deprotonated ligand exists. 
5.1.1.2 H+ -L 2 system 
The Zwbar function given in Figure 5.2(a) levels off at 2 indicating that just 
like L 1, L 2 also exhibits two measurable acid dissociation constants. The 
superimposability of the experimental and calculated Zwbars at different [L2h 
confirms the validity of the proposed protonation model. 
Figure 5. 2: (a) Experimental ( [L2 h=3x10·3 ( +) , 5x10-3 (•) and Bxl0-3 (•) 
mol dm-3 ) and theoretical (line) Z8 -bar (b) calculated L
2Hn+ species 
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Unlike with L 1, the two acidity constants correspond to stepwise deprotonation 
of the terminal oximes with pKa1=9.664±0.001 and pKa2=10.408±0.001. The observed 
pKa's are 0.02-0.03 log units higher than those determined previously by Kozlowski et 





constants when corrected for 10mc strength usmg the extended Debye-Huckel 
equation. 
A difference of about 0.744 between pKa1 and pKa2 indicates that the 
deprotonation steps of these two oxime groups are almost independent of each other. 
The linear nature of the ligand reduces the repulsion between these negatively charged 
deprotonated oxime groups. 
These values are three orders of magnitude lower than those of normal oximes, 
a point which may be explained in terms of the electron withdrawing effects of the 
amide groups at the alpha(a)-positions. For oximes such as L1, the loss of these 
protons is usually metal ion assisted.1-3'5'6 Figure 5.2(b) reveals that deprotonation of 
the ligand begins above pH 6.5 while the dinegative deprotonated form predominates 
in highly basic conditions. 
5.1.1.3 H+-L3 system 
Figure 5.3(a) indicates that L3 contains three protonation sites as revealed by 
the levelling off of the Zwbar function at 3. 
Figure 5. 3: (a) Experimental ( [L3 ] T=3x10-3 (.) I 5x10-3 (*) and ax10-3 (•) 
mol dm-3 ) and theoretical (line) Z8 -bar (b) calculated L
3Hn+ species 
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An excellent agreement between the experimental and theoretical functions 
supports the L3 protonation model. The three protonation constants correspond to 
proton additions to the tertiary amines with logK1=8.823±0.007, logK2=8.43 l±0.007 
and logK3=6.898±0.010. 
The difference between the first and second protonation constants is 0.39 log 
units. These constants are close to each other and refer to proton additions to the two 
terminal tertiary amines. The difference in the protonation constants of these similar 
sites is due to the difficulty of proton addition to a molecule already containing a 
protonated site. The third protonation constant is 1.92 and 1.53 log units smaller than 
logK1 and logK2 respectively. This indicates the protonation of the less basic 
benzylamine. Proton addition to this central amine is also difficult due to the already 
protonated terminal nitrogen donor atoms as a result of electrostatic repulsion. 
Furthermore, on statistical grounds, there are few available basic sites for proton 
addition to occur. 
The terminal amino groups of L3 have pKa2=8.431 and pKa3=8.823, which are 
both one order of magnitude lower than those of N,N,N',N'-
(tetramethylethylenediamine) and other tertiary amines. This is due to the electron 
withdrawing effect of the amide groups at the beta(p)-positions, which equally affects 
the basicity of these amines. Steenland et al.6 have recently observed a similar electron 
withdrawing property of an amide group in the dioxomacrocylic analogues ( Li and U) 
ofL3. 
The central benzylamine of L3 is 1.93 and 1.53 log units less basic than the 
terminal amino groups due to an extra electron withdrawing property of the benzene 
ring. This amine is also 2.36 to 3.70 orders of magnitude more basic than similar sites 
of recently studied Ld1, Ld2, Ld3 and Ld4 ligands8 where logK3's are 4.54, 3.2, 3.63 and 
3.44 respectively. L3 contains an extra methylene group on each side of the amine, 
which due to their inductive effect increase the basicity_~(!his,. central amino group. 
Figure 5.3(b) indicates that deprotonation of the triple protonated L3 ligand 
begins around pH 4.0 while in more basic conditions the neutral form of the ligand 
predominates. Due to the strong overlap between the deprotonation of the acidic 
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groups of the ligands, the real acidity of the individual groups can be obtained only 
through the complete evaluation of the microscopic scheme of the ligands. It should 
be mentioned that the amide nitrogens in both L 2 and L3 are too acidic to be 
protonated under the conditions of this study. Jubert et al.9 and Martell and 
coworkers10-12 have also observed that protonation of the amide moiety is not possible 
in the pH range 2-11 nor is its deprotonation. In fact, the deprotonation of the amide 




5.1.2 Complex formation and Deprotonation functions 
The reliability of the evaluated log~pqr values was confirmed by two functions, 
which are derived from the experimental data and quantitatively related to the 
log~pqr's. The complex formation function, ZM-bar, measures the average number of 
ligands bound per metal ion due to complexation. This function is plotted against the 
negative logarithm of the ligand concentration (pL ). 
The deprotonation function, Q-bar, which indicates the average number of 
protons released on complexation is plotted against the pH of the solution. The Q-bar 
is compared with the n-bar function, which measures the average number of protons 
that would be bound to the ligand in the absence of complexation. 
Based on the results reported here, and by analogy with related ligands, 
structures for the various metal complex species are postulated here. However, these 
structures will be discussed later in relation to spectroscopic evidence and 
computational evidence. 
5.1.2.1 Cu-L systems 
Figure 5.4(a) shows the ZM-bar function for the Cu-L2 system plotted against 
pL. The levelling off of the ZM-bars at a value of one indicates the existence of 
mononuclear complexes of 1: 1 M:L ratio. The fanning back of this complex formation 
function at pL values less than five suggests the formation of hydroxo- or mixed 
hydroxo complex species of 11-1 and 11-2 stoichiometry. 
Figure 5.4: Experimental (with Cu2+:L2 ratios of 1:3(•), 1:4(A) and 
1:5(+) and theoretical (line) (a) ZM-bar and (b) Q-bar 






















The Q-bar function given in Figure 5 .4(b) increases from zero to two in the pH 
range 2.4-4.4 indicating that 2 protons have been released into solution due to 
complexation. The slight levelling off of the Q-bars in this pH range is due to 
accumulation of the 110 species. Above pH 4.4, this function rises again to three 
indicating an extra proton loss, which is ascribed to the formation of the 11-1 
complex. 
As seen from Figure 5.4(b), this function rises above the n-bar value of 2 
confirming the presence of these hydroxo complex species. Above pH 9.00, the Q-bar 
decreases signifying that complexation is complete. Instead, in this pH range the 11-1 
species undergoes a further loss of a proton, which is believed to be metal ion assisted 
to a little extent to yield the 11-2 complex. This is because the ligand has been 
observed to ionise by releasing both oxime protons in solution above pH 6.5. 
It should be mentioned that a number of researchers have reported similar 
observations before. 1'2' 19'20 The excellent agreement between the observed and 
calculated complex formation and deprotonation functions supports the potentiometric 
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model used in data analysis. EST A analysis of the data yielded the results given in 
Table 2. The previously determined formation constants of L1 with copper(II), 
nickel(II) and zinc(II) are included for comparison. Calcium(II) was found not to form 
complexes with the ligand, L1. 
Copper(II) forms relatively stable complexes with L2. The enhanced sta~ility 
of Cu2+-L2 complexes is reflected by logP110, logP11-1 and logP11-2 equal to 14.076, 
9.903 and 1.625 for the 110, 11-1 and 11-2 species respectively. Kozlowski et al.4 
have recently reported logp values of 9.95 and 2.08 for the aforementioned 11-1 and 
11-2 complexes. The formation constants of copper with L2 determined in this study 
decrease with increasing ionic strength of the medium in accordance with the Debye-
Huckel equation. However, a good agreement is observed when these formation 
constants are corrected for ionic strength despite the different background electrolytes 
used in these investigations. 
In addition, these authors4 reported the presence of the 111 complex. In 
contrast, no 111 species has been observed in this study, instead a 110 complex was 
detected. Furthermore, although the reported 111 species is chemically possible and 
its formation constant (logpm=l9.61) equally reasonable, the reported structure is 
incorrect. These authors proposed that the non-coordinated oxime nitrogen is 
protonated. In fact, protonation of the oxime nitrogens is not possible under the 
investigated conditions. The proposed 111 species can only result from the co-
ordination of one amide and one oxime nitrogen donor atom. 
The 110 complex reported in this study is postulated to result from the loss of 
one of the oxime protons. It has been postulated that the high acidic nature of both 
dione dioxime groups in this ligand is enhanced by the amido groups at the alpha-
positions. However, the co-ordination of the metal ion to the amide and oxime 
nitrogens should further enhance their acidity. The formation of the presently reported 
110 species is as a result of this acid enhancement. In fact, the co-ordinated oxime 
nitrogen is believed to release its proton into solution. 
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Table 5.2: Log~pqr's ofL1, L2 and L3 with the metal ions at 25°C and I= 0.15 mo/ dm-3 (Ci-) Na+. The 
other symbols have their usual meaning as explained in Table 5.1. 
L Metal ion p q r Log ~nor O'ocrr RH 
R/1m nT (np) Lit. 
Li cu<+ 1 1 0 14-223 0.010 0.002 0.001 3 ( 176) 
1 1 -1 11.345 0.008 
1 1 -2 0.221 0.024 
Ni 2+ 1 1 0 11.531 0.060 0.008 0.006 4 ( 60) 
1 1 -1 7.623 0.032 
1 1 -2 -2.201 0.030 
zn2+ 1 1 0 5. 011 0.070 0.003 0.003 3 (160) 
1 1 -1 0.261 0.002 
1 1 -2 -8.790 0.006 
Gd3+ 1 1 0 15.530 0.030 0.008 0.007 4 ( 984) 
1 1 -1 7.640 0.033 
1 1 -2 0.270 0.006 
L2 Cu2+ 1 1 0 14.076 0.030 0.008 0.001 6(656) 
1 1 -1 9.903 0.030 9. 95 4 
1 1 -2 1. 625 0.053 2.08 
Ni 2+ 1 1 1 15. 4 60 0.035 0.017 0.015 6 ( 656) 
1 1 -1 2.842 0.010 1.14 4 
1 1 -2 -8.368 0_035 -7.05 
Zn2+ 1 1 0 6.736 0.020 0.007 0.006 4 ( 444) 
1 1 -1 -3.360 0.008. 
1 1 -2 -14.498 0.052 
ca 2+ - - - - - - -
Gd3+ 1 1 -1 -0.836 0.050 0.021 0. 011 4 ( 509) 
1 1 -2 -7.833 0.010 
1 1 -4 -22.876 0.034 
L3 cu2+ 1 1 1 15.020 0.022 0.034 0.013 6 ( 389) 
1 1 0 8. 911 0.018 
1 1 -1 -0.896 0.039 
1 1 -2 -8.677 0.042 
Ni z+ 1 1 2 23.280 0.072 0.032 0.015 5 ( 4 65) 
1 1 1 16.100 0.103 
1 1 0 7.570 0.014 
1 1 -2 -9.640 0.117 
Zn2+ 1 1 2 19.920 0.045 0.030 0. 013 6(697) 
1 1 0 3. 4 62 0.147 
2 1 -2 -9.018 0.044 
1 1 -2 -13.20 0.027 
ca 2+ 1 1 2 19.636 0.034 0.022 0.012 6(674) 
1 1 1 10. 808 0 .116 
1 1 0 2.424 0.046 
1 1 -1 -8.857 0.052 
Gd3+ 1 1 2 21.333 0.037 0.065 0.022 4 ( 509) 
2 2 -2 0.305 0.045 
1 1 -2 -9.695 0.030 
1 1 -3 -19.343 0.036 
1 1 -4 -30.924 0.074 
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Furthermore, the deprotonation of the free ligand begins to occur at pH 6.5 
while the formation of the 110 occurs throughout the pH range 3.5-7.0. This is 
revealed by the Cu-L2 speciation plots in Figure 5.5(a). The calculated Cu2+ assisted 
deprotonation constant (pKML-oH) associated with the formation of the [CuL 
2
H_i] is 
defined as the difference between logP110 and logP11-1. The calculated pKML-oH=4.173 
is approximately four and five log units lower than the first hydrolysis constant of 
copper(II) and the first pKa of the ligand, which are 7.8?21 and 9.66 respectively. This 
value is in the range expected for the deprotonation of the amide proton. 10-
13 
Figure 5.5: Calculated speciation of Cu
2+(0.001M)-L(0.003M) (L=L2 (a) 
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However, the formation of the 11-2 from the 11-1 species would be expected 
to be metal ion assisted to a small extent since the ligand's oxime protons dissociate 
above pH 6.5. The calculated pKML-oH=8.278 is 2.13 log units lower than the 
dissociation constant of the free ligand but higher than the first hydrolysis constant of 
Cu2+. The latter point excludes the ionisation of an axially coordinated water 
molecule.21 Furthermore, considering the fact that this proton is believed to be 
involved in a hydrogen bond, this value is low enough to propose a Cu2+ assisted 
deprotonation of this pseudomacrocycle. 
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Figure 5.6: Proposed structures for MHL, ML, MLH_1 and MLH_2 complexes of 
Cu2+ and Ni2+ ions. The axially co-ordinated water molecules are omitted in these 
representations for clarity. 
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Although the stability constant of the 110 complex of Cu
2
+ with L 
1 
(logp 11 o = 
14.22) is close to that of the corresponding L2 species, the value of the [CuL
1
H_i] 
(logp 11 _1 =11.35) is 1.5 log units higher than that of the [CuL
2
H_i] complex. This may 
be due to the strong hydrogen bond responsible for the pseudomacrocycle in the L 
1 
complex. In contrast, the 11-2 L 1 complex is 1.5 log units lower that of corresponding 
L2 complex. This reversal in stability of the 11-2 complexes may be due to the 
stronger donating ability of two deprotonated oxime groups in the L
2 
complex. The 
weak hydrogen bond bridging the oximato oxygens in the 11-1 L
2 
species is believed 
to break while the formation of the 11-2 species in an L
1 
system is postulated to be as 
a result of the ionisation of an axially coordinated water molecule. Hence, the 
pseudomacrocyle in the L1 system remains intact (Figure 5.6(c)). 
The complexation chemistry of the Cu2+-L3 system 1s characterised by 
exclusive formation of mononuclear species of 1: 1 M:L stoichiometry. This is 
indicated by the levelling off of the ZM-bars at a value of 1 (Figure 5.7(a)). The 
formation of either hydroxo and/or mixed-hydroxo complexes also characterises this 
system as evident from the fanning back of the ZM-bars at pL values less than 4. 
Figure 5.7: Experimental (with.Cu2+:L3 ratios of 1:3(+) ,1:4(•) and 
1:5(&) and theoretical (line) (a) ZM-bar and (b) Q-bar 
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The Q-bar function, on the other hand, rises to an average value of 2.7 in the 
small pH range of 5.5-6.5. This is an indication that approximately three protons have 
been released due to complexation. Ideally, 2 and 3 protons are supposed to be 
released due to the exclusive formation of 111 and 110 complexes respectively. The 
obtained average Q-bar=2.7 is due to the simultaneous formation of these two species 
as seen from the speciation plots given in Figure 5.5(b). 
Another feature, which is worth noting from Figure 5.7(b), is the fact that the 
Q-bar never rises above the n-bar plot below pH 8.0. This is because of the presence 
of protonated nitrogen donor atoms on the ligand in the acidic to weakly basic 
conditions. An excellent agreement between the observed and calculated ZM-bars and 
Q-bars gives confidence to the proposed complexation model. 
The four proposed 111, 110, 11-1 and 11-2 complexes (Figure 5.6 (h), (i), (j) 
and (k) in their respective order) comprising the Cu2+-L3 system have logp values 
equal to 15.020, 8.911, 0.896 and -8.677 respectively. The 111 species is formed by 
deprotonation and co-ordination of both the benzylamine and one of the terminal 
tertiary amines. It should be mentioned that there is little or no stabilisation of this 





the presence of the fused six and seven membered rings in the 111 complex species, 
the chelate effect is not observed due to the low basicity of the carbonyl oxygen. 
The deprotonation of one of the amide nitrogens with pKML-OH = 6.11 results in 
the _J_LO species, which is subsequently converted to the 11-1 complex by 
deprotonation of the second amide group (pKML-OH = 8.02). The loss of a proton from 
the first amide group is approximately 2 log units much easier than the deprotonation 
of the second amide moiety or the hydrolysis of an axially coordinated water 
molecule. The 110 species is stabilised by the formation of 5- and 6-membered rings. 
The formation of the 11-1 results in two contiguous six-membered rings which 
destabilise the complex compared to 5,6,5-chelate rings. 
For the formation of the neutral 11-2 species, several co-ordination 
possibilities exist. Two key contributions to the thermodynamic stability of two likely . 




benzylamine, one terminal amine and both amide nitrogens would result in the 
formation of two contiguous less stable six-membered rings. The formation of these 
six-membered rings will destabilise the 11-2 complex. Moreover, the decreased 
basicity of the central anchoring amine should further lower the thermodynamic 
stability of [CuL3H-2]. 
In contrast, the co-ordination of the more basic terminal amine should yield a 
more stable [CuL3R 2] complex. However, this increased stability is offset by the 
formation of a ten-membered ring, which destabilises the complex. 
Because of these two factors, there should be little or no difference in terms of 
stability between these two proposed [CuL3R2] species. In fact, the presence of 
varying amounts of these two species in the same solution cannot be ruled out. 
A third possibility is that of co-ordination of the three tertiary amino and the 
two amide nitrogens. This will result in a five co-ordinate species where either the 
central amine or one of the terminal amines occupies an axial position. However, it is 
known that Cu2+ prefers six co-ordinate tetragonally distorted species where two 
weak ligands such as the water molecules occupy the axial positions. In these species 
the equatorial plane is defined by the four nitrogen donor atoms of the ligand. The 
third possibility is unlikely for this 11-2 complex. 
The calculated Cu2+ assisted deprotonation constant (pKML-OH) associated with 
the formation of the [CuL3R 2] is defined as the difference between logp 11_1 and 
logp 11 _2. The calculated pKML-oH=7.78 is 0.65 log units smaller than the second 
deprotonation constant (pKNH) of the tertiary amine and quite close to the ionisation 
constant of an axially co-ordinated water, which are 8.431 and 7.87 respectively. The 
pKML-OH value is compared to the second deprotonation constant of the free ligand 
because of the decreased basicity of this amino group due to the presence of the metal 
ion. In fact, the actual pKa2 value of the ligand should be less than 8.431 because of 
the di positive nature of the metal ion compared to the proton. From the potentiometric 
data it is difficult to propose with certainty the origin of this proton loss, but in both 
cases, the involvement of the metal ion is suggested together with the parallel 
formation of the two proposed isomers. Consequently, the deprotonation function 
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never nses above the n-bar plot in this L3 system as was observed m the 
corresponding L 2 system discussed above. 
Since Cu2+ is not known to form stable complexes when bigger membered 
rings are involved, it is more likely that the second terminal tertiary amine remains 
uncoordinated in this species. Steenland et al. 7 have postulated a similar kind of co-
ordination for the macrocyclic analogues (Li and U) of L3 towards Cu2+. This kind of 
coordination should be more feasible for L3 compared to Li and U because of the close 
proximity of protonated site to the coordinated metal ion as a result of electrostatic 
repulsion in the latter ligands. 
Steric requirements also rule out the co..:ordination of both terminal tertiary 
amino groups to the same metal ion. This is because of the sp2 hybridised nature of 
the deprotonated amide nitrogens which co-ordinate in the square-planar fashion in 
addition to the coordinated central anchoring amine and a terminal amino group. 
Although copper forms stable complex species with L3, the reported constants 
are 1-1.5 log units lower than those of the previously investigated systems. 8 
Furthermore, the increased basicity of the central amine in L3 is not reflected in the 
formation constants of Cu2+ with the ligand. This may be due to the formation of two 
less stable contiguous six-membered rings on deprotonation and co-ordination of the 
two amide groups. 
Steenland et al.7 have reported logPllo's of 8.5 and 10.1 for Cu2+ with the 
dioxomacrocycles they investigated. A logPuo of 8.5 is close to the one reported in 
this study for the same species. The presently reported constants for 11-1 and 11-2 are 
4-5 log units lower than those reported by these authors7 (logp 11 _1 = 4.6 and 3.3, 
logp 11 _2 of -4.3 and -5.9). This is due to the strain introduced by having two 
0 
contiguous six membered rings instead of five- and six-membered rings. In fact, these 
systems are believed to be stabilised by having alternating five and six membered 
rings. 
He Bu et al. 13 have recently reported Cu2+ and Zn2+ complexation equilibria 
with two mono- and dioxo-cyclam ligands containing 2-pyridylmethyl groups. Quite 
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contrary to expectations, copper(II) does not seem to facilitate the deprotonation of the 
amide groups. In fact, the crystal structure of the 110 complex of Cu2+ with one of 
these ligands indicates that the ligand is co-ordinated to the metal ion through the 
appended pyridylmethyl nitrogens and the backbone amino and carbonyl oxygen 
atoms. This is because the pyridyl nitrogens are more basic compared to hard nitrogen 
donor atoms of the amide moiety. 
Santos and coworkers14 have also revealed the binding of the oxygen donor 
atoms of the appended hydroxamate moiety towards Cu2+ at neutral pH. The pH 
driven translocation of Cu2+ from one ligand compartment (containing predominantly 
nitrogen donor atoms) to another (which contains amide groups)
16 
is also evidence of 
the difficulty associated with the deprotonation of the hard amide moiety. It should be 
mentioned that in basic conditions the metal assisted ionisation of the amide groups 
occurs with ease. Another notable feature about these dioxo-macrocycles is the 
presence of the 11-1 as a minor species. This may mean that this complex is rather a 
mathematical than a physical form. It may also be an intermediate species, which is 
converted to the thermodynamically stable 11-2 by the deprotonation of the second 
amide group. 
5.2.2.2 Ni-L systems 
Figure 5.8(a) below shows the complex formation function of the Ni2+-L
2 
system, which levels off at a ZM-bar value of 1.5. This is because the ML
2 
species is 
not the predominant or only species in this system as observed by Witt et al.
23
. In fact, 
hydroxo species predominate in its equilibria. The fanning back of the ZM-bar at low 
pL values of 4 is indicative of these hydroxo species. These plots, however, do 
confirm the presence of mononuclear species of 1: 1 M:L ratio. 
The Q-bar function given in Figure 5.8(b) increases to a maximum value of 3 
in the pH range 6.0-7.5 indicating the simultaneous dissociation of three protons due 
to metal ion co-ordination. This function rises above the n-bar plot to suggest that the 
complex releases an extra proton compared to the number of protons postulated to be 
attached on the ligand. Above pH 8.5, the Q-bar decreases and runs parallel to then-
bar to indicate that complexation is complete at these basic conditions. 
Figure 5.8: Experimental (with Ni2+:L2 ratios of 1:3(+), 1:4(•) and 
1: 5 (•) and theoretical (line) (a) ZM-bar and (b) Q-bar 













8 13 4.5 6.5 8.5 10.5 
pl pH 
98 
It should be emphasised that slow kinetics was observed m this Ni2+-L
2 
system. Despite the known limitations associated with slow kinetics, there is an 
excellent agreement between the observed and calculated functions. This validates the 
potentiometric model used in the data analysis. 
The ligand L 2 seems to co-ordinate strongly to the Ni2+ ion as indicated by 
logP111=15.460, logP11-1=2.842 and logP11-2=-8.368 for 111, 11-1 and 11-2 species 
respectively. In order to make these formation constants more explicit, the distribution 
curves of the three species are plotted in Figure 5.9(a). The speciation plots indicate 
that the metal ion does not exceed 5% as the 111 species indicating its minority in 
these equilibria. The 11-1 complex predominates in the pH range 7-10 while above 
pH 10.00, the 11-2 becomes the dominant species. 
The ligand is believed to be co-ordinated to the metal ion through one amide 
and one oxime nitrogen atoms in the 111 complex. The proposed structure of this 
species is depicted in Figure 6( d). Ni2+ appears to sit in a square-planar arrangement 
of the ligand donor atoms in the 11-1 and 11-2 species (Figure 6(f) and (g) 
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respectively), hence the observed reasonably high formation constants. The metal ion 
also appears to have a high affinity for oxime containing ligand systems as it has been 
observed with L1 and similar, previously studied, ligands.2'6 
Figure 5.9: Calculated speciation of (a) Ni2+(0.00023)-L2 (0.0008M) 
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The presently evaluated Ni-L2 constants are two log units higher than those 
reported by Koslowski et al.4. These authors reported that the equilibria are reached 
instantaneously in this system. This is in sharp contrast to the slow kinetics observed 
in the present investigations, where long delays were required between titration points 
in order to allow the system to come to equilibrium. 
The previously reported formation constants of the 11-1 (logP11-1=7.68) and 
11-2 (logp 11_2=-2.43) Ni
2+-L1 complexes are 5 log units higher than those observed for 
the corresponding L2 species. This is due to the stronger hydrogen bond in [NiL1Ri] 
compared to the L2 complex. Since the formation of the 11-2 complex for both L
1 
and 
L 2 is due to the breaking of the hydrogen bond, the stability of the L 1 complex should 
reside on the three 5,6,5-chelate rings. 
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In contrast to the Ni2+ -L2 system mentioned above, the metal ion appears to co-
ordinate weakly to the L3 ligand. This is revealed by the ZM-bars (Figure 5.lO(a)) 
which remain close to 0.5 throughout the ligand concentration range investigated. The 
fanning back of the ZM-bars at low pL values is indicative of hydroxy and/or mixed-
hydroxy species formation. 












1: 2 (•) and theoretical (line) (a) ZM-bar and (b) Q-bar 
and n-bar (line) both plotted against pH. 
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The Q-bars plotted in Figure 5.IO(b) increases from to 0.2 to 1.00 in the pH 
range 2.7-5.0 indicating the loss of one proton due to complexation. Above pH 6.0, 
the function decreases probably due to an onset of hydrolysis. In the pH range 7 .5-9 .0, 
this function rises to two indicating another proton loss. 
The titration procedure was terminated or the data above pH 9.00 discarded at 
the visual sign of precipitation. The ZM-bars and Q-bars remain lower than the 
expected values of 1 and 3 respectively in support of this weak binding ability of L
3 
towards Ni2+. There is, however, a good agreement between the observed and 
calculated ZM-bars and Q-bars in support of the evaluated constants. 
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One of the reasons for this weak binding is related to the difficulty associated 
with the deprotonation of the amide nitrogens. As indicated by the speciation plots 
(Figure 5.9(b)), the protonated 112 (logP112=23.28) and 111 (logPm=l6.10) species 
dominate in the pH range 2.5-8.3. The deprotonation of either a co-ordinated water 
molecule or an amide nitrogen occurs above pH 7.0 leading to the formation of the 
110 species with logp llo=7 .57. The 110 species can also be formed by the 
coordination of the three tertiary amines. The calculated pKML-oH=8.53 is close to the 
second deprotonation constant of the ligand (pKa2=8.43) and 1.5 log units lower than 
the hydrolysis constant of the metal ion (pKM-o8 =10.20)2
1
. This indicates that the 
proton is more likely to have been released from the amide group. The deprotonation 
of the amide moiety of the ligand by Cu2+ has been observed to be 2 log units much 
easier than the hydrolysis of a coordinated water molecule. 
Another noticeable feature about the complexation behaviour of this system is 
the absence of the 11-1 species. Instead, above pH 8.5 the 11-2 complex species with 
logP11.2=-9.64 predominates. This can be explained in terms of the pH delayed co-
ordination of either the second amide nitrogen or both amide groups if the terminal 
nitrogens are coordinated in the 110. If the latter assumption is true, this behaviour is 
reminiscent of complexation solution chemistry of macrocyclic dioxo tetraamine 
ligands. 10-13 In cases where there is a 11-1 species formed in these macrocycles, it is 




If the neutral [NiL3H.2] is formed by deprotonation of the amide groups, it is 
believed to be further stabilised by the co-ordination of the fifth terminal nitrogen in 
an axial position. However, this increased stability is further offset by the formation of 
contiguous six-membered rings due to the co-ordination of the second amide nitrogen. 
It should be mentioned that the pH range of investigation was limited to pH 9.0 due to 
precipitation of probably the neutral [NiL3H.2] species. 
Amendola et al. 15 have recently designed and studied the solution chemistry of 
a two compartmental ligand capable of binding Ni2+ in a pH dependent manner. In 
weakly acidic or basic conditions, the metal ion resides in a compartment containing 
two quinoline nitrogens and two amino nitrogen donor atoms. Above pH 8.0, Ni
2
+ 
translocates into amide and amino groups containing compartment after deprotonation 
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of the amide moieties. The development of these ditopic ligands is important in 
keeping the metal ion in solution until a high pH is reached for the ionisation of the 
amide groups to occur. These observations support the solution behaviour observed 
for Ni2+ with L3. The neutral [NiL3H_2] which precipitates above pH 9.0 may also be a 
mixture of the above proposed species or a mixed-hydroxo complex. 
5.1.2.3 Zn-L systems 
Figure 5.ll(a) shows the ZM-bars of the Zn-L2 system. The function levels off 




ratio. The fanning back of the complex formation function is indicative of hydroxo 
and/or mixed-hydroxo species. 
Figure 5.11: Experimental (with Zn2+:L2 ratios of 1:3(+) ,1:4(•) and 
1:5(£) and theoretical (line) (a) ZM-bar and (b) Q-bar 
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The Q-bar function (Figure 5.1 l(b)), on the other hand, increases to an average 
of three in the pH range 6-8. This is attributed to the simultaneous release of three 
protons into solution in this weakly acidic to basic region. The Q-bar function rises 
above the n-bar plot further confirming an additional proton loss compared to the 
neutral ligand. Between pH 8.5 and 10, the Q-bar and n-bar curves are parallel 
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indicating that no further complexation takes place in this pH range. Above a pH of 
10, the Q-bar function continues to increase indicating an extra proton loss due to the 
formation of the 11-2 species. The complete superimposability of the experimental 
and theoretical complex formation and deprotonation functions for various M:L ratios 
lends support to the potentiometric model used in data analysis. 
A logP110 value of 6.736 for the 110 complex indicates a reasonably strong co-
ordinating ability of the ligand towards Zn2+. The ligand is postulated to be co-
ordinated to the metal ion in this species through the two oxime nitrogens, the 
hydroxide ion and the water molecule(s) or the carbonyl oxygen. One of the oxime 
oxygens is deprotonated in the 110 complex. The arrangement of the ligand's donor 
atoms is such that a tetrahedral or an octahedral environment around Zn
2
+ is 
preserved. Figure 5.12(a) indicate that the 110 species is present in small amounts in 
the pH range studied. 
Figure 5.12: Calculated speciation of the Zn2+(0.001M-L(0.003M) 
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Since Zn2+ is not known to deprotonate amide nitrogens, 13 the formation of the 
11-1 complex (logP11-1=-3.360) may be due to ionisation of the co-ordinated water 
molecule. At pH values above 9.5 dissociation of the second oxime proton occurs to 
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yield the 11-2 (logP11-2 = -14.498) species and both the 11-1 and 11-2 complexes 
predominated in the basic pH range (Figure 5.12(a)). 
The calculated first and second pKML-oH's are 10.12 and 11.0 respectively. The 
first pKML-oH=l0.12 is quite close to the first hydrolysis constant of the metal ion and 
the ionisation constants of the ligand. The second pKM-oH=l 1.0 is approximately 1.5 
log units higher than the first pKa of the ligand indicating that the proton loss may 
originate from the hydrogen bond of the pseudomacrocycle. These pKM-oH's support 
the assumption of the inability of the Zn2+ ion to deprotonate the amide moiety. 
The complex formation behaviour of the Zn2+-L3 system is shown in Figure 
5. l 3(a). The ZM-bar remains close to zero throughout the investigated pH range. This 
system seems to be characterised by the formation of hydroxo species as revealed by 
the fanning back of the complex formation function at high ligand concentrations. The 
Q-bar curve (Figure 5.13(b)) rises to two at pH 8.0 indicating the release of two 
protons. 
Figure 5.13: Experimental (with Zn2+:L3 ratios of 1:3(+) ,1:4(A) and 
1:5(•) and theoretical (line) (a) ZM-bar and (b) Q-bar 
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The Q-bar function never rises above the n-bar plot indicating that there is a 
proton still attached on one of the ligand's donor atoms. A notable feature about these 
curves is an excellent agreement between the calculated and observed ZM-bars and Q-
bars, which is in support of the validity of the proposed Zn2+ complexation model. 
The presence of protonated 112 with logP112=19.920 (Figure 5.1 l(b)) in the 
pH range 5.0-8.0 is an indication of the lower binding strength of this ligand towards 
Zn2+. A 110 complex with a logp 110=3.462 occurs to a small extent and is 
subsequently converted to the 21-2 (logP21-2=-9.02) and 11-2 (logp 11-2=-13 .20) species 
by the hydrolysis of co-ordinated water molecules. 
The 110 species is formed by co-ordination of the central amine, one terminal 
amine, the hydroxide ion and one or both oxo groups (or binding of water molecules). 
In the 21-2 complex, the ligand is postulated to be co-ordinated to the two zinc(II) 
ions through the terminal amines and oxo groups in a bidentate and bridging fashion. 
Two hydroxide ions, one on each metal ion and the water molecules complete the 
tetrahedral and/or octahedral co-ordination environment. Elimination of this species in 
the speciation model yields greater standard deviations in logpts of the other 
detectable species as well as a higher RHf indicating its importance in the model. 
Unlike divalent copper and nickel, zinc(II) appears to deprotonate the amide 
nitrogens of these ligands with difficulty. 13 ' 14 The low stability constants of Zn2+ with 
L2 and L3 are partly due to the afore-mentioned phenomenon. Furthermore, it is 
known that Zn2+ prefers more or less a tetrahedral geometry. This has been observed 
in a majority of simple ligand systems, for example, 1,5,9-triazacyclododecane.24 The 
metal ion seems to adopt the same co-ordination geometry in biological metallo-
enzymes. These include enzymes such as carbonic anhydrase,24 carboxypeptidase A,25 
copper-zinc SOD26 and phosphate esterases.27,28 
In fact, complexes of zinc(II) with 1,5,9-triazacyclododecane have been used 
as models for the active site of carbonic anhydrase.24 While the biological functions of 
zinc in these proteins varies considerably, their active zinc sites exhibit a common 
pseudotetrahedral structural motif. These zinc centers contain nitrogen and oxygen 
donors, the latter mostly being derived from solvent (water) molecules. Hence, the 
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low stability constant values of Zn2+-L2 complexes may also be due to the postulated 
square-planar arrangement of nitrogen donor atoms forced on the metal ion by the 
ligand. The subsequent bonding of two axial water molecules results in octahedral 
zinc(II) species. This leads to a further decrease in thermodynamic stability. A similar 
behaviour has been observed for the previously investigated Zn2+-L1 system.2 
5.1.2.4 Ca-L systems 
Unlike the metal ions discussed above, calcium(II) does not form complexes 
with L 2. This was observed previously with L 1.2 In contrast, Ca2+ seems to have a low 
but measurable affinity for the donor atoms of L3. This is confirmed by the complex 
formation function (Figure 5.14(a)) for the Ca2+-L3 system, which does not increase to 
significant levels in the pH range investigated. 
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Furthermore, the Q-bar function (Figure 5.14(b)) remains almost constant at a 
value close to zero. This indicates the absence of significant complexation in this 
system. Consequently, both these functions never rise to the expected ZM-bar and Q-
bar values of 1 and 3 respectively. Despite this insignificant complexation, there is, 
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however, a good agreement between the observed and the theoretical ZM-bar and Q-
bar functions to validate the proposed model. 
In fact, as seen from Figure 5.15(a), the Ca2+-L3 system is characterised by the 
formation of protonated complexes. Because this metal ion has a slight tendency to 
hydrolyse, such a behaviour is expected. There appears to be a little difference 
between the calculated speciation of the L3 ligand (Figure 5.3(b )) and that of its Ca2+ 
system. 
Figure 5.15: Calculated speciation of (0.00lM) (a) ca2+- (b) Gd3+-
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The evaluated constants with logP112=19.636, logP111=10.808, logP110=2.424 
and logP11-1=-8.857 for the 112, 111, 110, 11-1 complexes respectively is an 
indication of this weak co-ordinating ability of L 3 towards Ca2+. The formation of 111 
from 112 and 110 from 111 are due to an insignificant metal ion assisted 
deprotonation of the terminal amino groups with pKML-OH of 8.83 and 8.39 
respectively. On the other hand, the third calculated pKML-OH of 11.28 resulting in the 
formation of 11-1 from 110 is one log unit less than the metal ion's only hydrolysis 
constant, which is 12.45. The weak complexes formed by this system may have been 
facilitated by the presence of two carbonyl oxygens and the hard nitrogen donor 
atoms. 
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It should be emphasised that there are no reported constants of this metal ion 
with the majority of ligands containing nitrogen donor atoms, such as 1,3-
diaminopropane, triazanonane and other linear and macrocyclic polyamine ligands.
29 
This behaviour for calcium, which is classified as a hard Lewis acid (HSAB 
theory),30 is expected as this metal ion prefers ligands with hard negatively charged 




are known to be strong cr-donors in a deprotonated state. However, this metal ion is 
not known to be capable of deprotonating the amide nitrogens. The calculated pKML-
08's attest to the aforementioned phenomenon. Hence, the absence of any reported 
formation constants of this metal with L 2 and the formation of weak complexes with 
L3 is as a result of this behaviour. 
5.1.2.5 Gd-L systems 
Figure 5.16 (a) shows the complex formation function of the Gd3+:L
1 
system 
plotted against pL. The function rises and levels off at one indicating the formation of 
mononuclear species of 1: 1 M:L ratio. 
Figure 5.16: Experimental (with Gd3+:L1 ratios of 1:2(+) ,1:3(•) and 
1:4(•) and theoretical (line) (a) ZM-bar and (b) Q-bar 
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As expected for a metal ion which undergoes hydrolysis with ease, the ZM-bar 
curves fan back to indicate the formation of either hydroxo and/or mixed-hydroxo 
species. The Q-bar curves given in Figure 5.16(b) increases to 2 in the pH range 2.0-
3. 0 suggesting the loss of two protons due to the formation of the 110 species. In the 
pH range 3-6, the Q-bar and n-bar curves are parallel indicating that no change in 
complexation takes place. 
The Q-bar function rises above the n-bar plot to an average of 4 between pH 
7. 0-8. 5 before the onset of precipitation. This is due to the loss of two extra protons as 
a result of the simultaneous formation of the 11-1 and 11-2 species (Figure 5.l 7(a)). 
An excellent agreement between the observed and calculated complex formation and 
deprotonation functions supports the validity of Gd3+ -L 1 complexation model. 
Figure 5.17: Calculated speciation of (a) Gd3+(0.00062)-L1 (0.0022M) 
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The three complex species formed by Gd3+ with L 1 have logpts of 15.530, 
7 .640 and 0.240 for the 110, 11-1 and 11-2 complex species respectively. The first 
pK0ctL-OH of 7.89 associated with the formation of 11-1 from 110 is close to the first 
hydrolysis constant of Gd3+ which is 8.10. The second pK0ctL-OH = 7 .3 7 leading to the 
formation of 11-2 is 5 log units slightly less than the acid dissociation constant of an 
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oxime group of a free ligand. The 11-1 and 11-2 complexes may originate from metal 
assisted stepwise dissociation of protons from a co-ordinated water molecule and an 
oxime nitrogen respectively. 
In the three species mentioned above, it is postulated that the metal ion is co-
ordinated to the four nitrogen donor atoms. Since the metal ion prefers co-ordination 
numbers 8 and 9, it would seem therefore that Gd3+ in these complexes 1s co-
ordinatively unsaturated. The remaining co-ordination sites are believed to be 
occupied by water molecules. 
The formation of a whitish colloidal precipitate above pH 10.00 may well 
originate in the dissociation of either a proton involved in the terminal oxime 
hydrogen bond or a co-ordinated water molecule. This gives a neutral mixed-hydroxo 
11-3 species. The extent of this hydrolysis has been observed to depend on the metal 
ion concentration.21 A 0.001 mo! dm-3 Gd3+ ion solution will begin to precipitate as 
Gd(OH)3 (logKsp is -15.6 at 25°C)
21 around pH 7.6, while a higher concentration of 
the metal ion will precipitate at a lower pH. The above-mentioned concentration of the 
metal ion is the highest used in these studies. Although, no attempts were made to 
filter and characterise the precipitate, the ability of the species to precipitate at pH 
values above 10.0 is evidence of an existence of a neutral mixed-hydroxo complex 
rather than a Gd(OH)3. 
In contrast to the above-mentioned Gd3+-L1 system, the complex formation 
function in the Gd3+-L2 system (Figure 5.18(a)) levels off at a ZM-bar value of2. This 
is because the ML species is not the predominant or only species in this system.23 In 
fact, mixed-hydroxo species predominate in the equilibria of this system as indicated 
by the fanning back of the ZM-bars at pL values below 4. 
Attempts were made to include mononuclear species of M:L ratio of 1 :2 but 
the model did not converge indicating the absence of such complexes in the system. 
Futhermore, since gadolinium(III) prefers negatively charged oxygen donor atoms, the 
possibility of co-ordination of two or more ligands to the same metal ion was 
considered but no evidence of such species could be obtained from the complex 
formation function. 
Figure 5.18: Experimental (with Gd2+:L2 ratios of 1:3(A), 1:4(•) and 
(a) 
1:5(+) and theoretical (line) (a) ZM-bar and (b) Q-





























There seems to be a correlation between the extent of metal ion hydrolysis and 
the levelling off of the ZM-bars above the expected value of 1. The out-of-plane co-
ordination with respect to the four amino/amido nitrogens of two ligand molecules 
toward Gd3+ is possible. However, the resulting complex would be too strained to 
remain stable in aqueous solution. This is due to the high concentration of co-
ordinating water and hydroxide-ion ligands containing hard oxygen donor atoms. 
The deprotonation function (Figure 5.18(b)) increases sharply between pH 7.0 
and 8.5 from zero to four indicating simultaneous dissociation of 4 protons. Above pH 
8.5 the Q-bar decreases indicating that complexation is complete in this pH range. 
Despite the levelling off of the ZM-bars at 2, these plots, however, do confirm the 
presence of only mononuclear species. An excellent agreement between the ZM-bars 
and Q-bars gives validity to the proposed Gd3+-L2 complexation model. 
Figure 5.l 7(b) indicates that complexation in this system begins above pH 
7.00 and hydroxo and mixed-hydroxo complexes are the predominant species in this 
system. The logP11-1, logP11-2 and logP11-4 of -0.836, -7.833 and -22.876 for the 11-1, 
11-2 and 11-4 complex species respectively have been determined. These values 
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indicate a low binding affinity of the ligand towards Gd3+. The ligand is postulated to 
be co-ordinated to the metal ion through the carbonyl oxygens and the oxime 
nitrogens. 
Deprotonation of one oxime oxygen, and at least two water molecules results 
in the formation of 11-1, 11-2 and 11-4. Furthermore, the weak complexes formed by 
Gd3+ and its extensive hydrolysis around pH 7.0 may contribute significantly to the 
levelling off of the ZM-bar value at 2.0. 
The ZM-bars given in Figure 5.19(a) for the Gd3+-L3 system do not reach 
appreciable levels indicating the low binding ability of the ligand towards the metal 
ion. The fanning back of the complex formation function at low pL values is 
indicative of either loss of a proton from the ligand due to complexation or co-
ordination of hydroxide ion. 
Figure 5.19: Experimental (with Gd3+:L3 ratios of 1:3(&) ,1:4(+) and 
1:5(•) and theoretical (line) (a) ZM-bar and (b) Q-bar 
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This assumption is verified by the Q-bar (Figure 5.19(b)), which reaches a 
maximum value of 2 indicating the loss of two protons due to complexation. A good 
agreement between the observed and calculated complex formation and deprotonation 
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functions supports the validity of the evaluated constants. The speciation plots given 
in Figure 5.15(b) confirm that protonated 112, mixed-hydroxo 22-2, 11-2 and 11-3 
and 11-4 complexes predominate in the aqueous solution of Gd3+ with L3. In fact, 
logWs of 21.333, 0.305, -9.695, 19.343 and -30.924 for the 112, 22-2, 11-2, 11-3 and 
11-4 complexes respectively have been obtained. 
The mixed hydroxo species are formed by the hydrolysis of the coordinated 
water molecules. In the 22-2 complex, one Gd3+ ion is believed to bridge the two 
ligand molecules by coordinating through the carbonyl oxygens and terminal amines. 
In all these species the ligand is believed to be coordinated to the metal ion in an 
"exo" nature. 
Gd3+ forms weak complexes with both L 2 and L3. This is due to the inability of 
the metal ion to deprotonate the amide nitrogens. In fact, in gadodiamide, a contrast 
agent used in MRI scans,31 the ligand is co-ordinated to the metal ion by the carbonyl 
oxygens rather than the nitrogen atoms of the amide moieties. 
This is an extra-destabilisation of the complexes since both the carbonyl 
oxygen and the amino nitrogen are known to be poor donors for lanthanides. 31 The 
negatively charged oxygen donors as in carboxylates, are used as anchors thereby 
enhancing the thermodynamic stability of these contrast agents. 
It should be noted that the aqueous chemistry of Gd3+ parallels in many ways 
that of Ca2+. This is not surprising in view of the fact that both metal ions have nearly 
the same ionic radii. 32 They are also "hard" in terms of the HSAB theory30 and hence 
prefer hard negatively charged oxygen donor atoms. In fact, the Gd3+ ion has been 
used to probe the structural and functional behaviour of Ca2+ in in vivo systems. 
5.1.3 Discussion - Formation constants 
On the basis of the complex formation and deprotonation curves, the 
formation constants reported in Table 5.2 were selected as the best possible to 
describe the equilibria observed in this study. Furthermore, the reasonably low 
standard deviations in the constants and Hamiltonian Rwfactors support the 
complexation model used in data analysis. 
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The possibility of formation of polynuclear MpLqHr. p~2 species, was checked 
but only the 21-2 and 22-2 complexes reported for the Zn2+- and Gd3+-L3 systems 
respectively were found under the conditions of this study. This is in spite of both the 
'endo' and 'exo' nature of the co-ordination modes, which can be exhibited by these 
dioxo L2 and L3 ligands. In fact, the formation of these binuclear species is possibly 
due to the inability of the two metal ions to deprotonate the amide groups, hence 'exo' 
binding of the ligand in a bridging fashion becomes the only possibility. Furthermore, 
metal to ligand (M:L) ratios of 1 :2-5 were used because at 1: 1 and 2: 1 M:L ratios, 
these investigations were hampered by precipitation in all systems. 
In general, the presence of polynuclear species is confirmed by making a series 
of measurements at two or more widely different metal ion concentrations. Analysis 
of these two or more sets of data should lead, in the first instance, to two or more 
different sets of stability constants. Secondly, two (or more) distinct complex 
formation plots that only merge at very high and very low ligand concentrations will 
be observed if polynuclear species are present. 
Kozlowski et al.4 have observed that at Cu2+ /Ni2+:L2 ratios greater than 1 :5 
these complex species precipitate out of solution. In contrast, it has been observed in 
this study that precipitation is a transient process leading to the formation of the 
neutral 110 species. However, this species is not stable enough and is immediately 
converted to the 11-1 species. Furthermore, at 1: 1 M:L ratios the dissolution of the 
precipitate has been observed to occur on further equilibration of the system. 
However, under these conditions care must be taken to ensure that the system is at 
equilibrium. 
It should also be mentioned that the loss of the first amide proton in these Mn+ -
L 2/L3 systems is kinetically slow compared to the deprotonation of the second amide 
moiety. This process has been noticed as a potential drift in the pH range 3.5-7.0.33 
This phenomenon can be attributed to the required orientation of the nitrogen lone 
pair of electrons towards the metal ion. This is followed by simultaneous bond-
formation and proton release. The proximity of the remaining amide nitrogen makes it 
statistically favourable to complete the reaction resulting in the formation of higher 
species such as the MLR2. 
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In contrast to these linear diamide ligands, the deprotonation of amide groups 
in macrocyclic analogues has been observed to occur cooperatively. 10-13 This is due to 
the close proximity of the amide moieties in these macrocycles. 
In light of the foregoing discussion, it is proposed that the slow kinetics of 
both Cu2+ and Ni2+ with L2 and L3 observed in this study is a consequence of both 
steric hindrance to complexation and the conformational changes demanded by the 
metal ion. It is, therefore, the presence of the metal ion, which reorganises the ligand 
to adopt a conformation that will promote complexation. 34 This ability is a property of 
a particular metal ion and will differ from one metal to another. 
Furthermore, the drastically decreased binding of these less pre-organised 
ligand systems can in part be attributed to the differences in their solvation. A 
significant entropic cost has to be paid to organize the ligand binding sites of the 
flexible ligand to a conformation involved in metal ion complexation.34 
It should be emphasised that in H2L 
2 ligand, the donor atoms bearing the two 
ionisable protons are not involved in metal ion co-ordination. This, as a result posed 
another problem in the calculation of accurate formation constants in these Mn+_H2L
2 
systems. This is in contrast with the analogous L 1 and L3 solution equilibria where 
complexation is a direct replacement of the proton by the metal ion. 
The data in Table 5.2 can be summarised in terms of selectivity factors given 
in Table 5.3. 
Table 5.3: Selectivity factors of the studied ligands towards cu2• 
compared with the other investigated metal ions. 
Ligand ZnL+ caL• Ni L+ Gd".,. 
L1 11. 08 ~ 11. 35 3.53 3.732 
LL 10.30 ~ 11.1 6.00 11. 31 
Lj > 4.48 > 8.60 7.04 ~ 11. 35 
Selectivity for Cu2+ is defined35 as the difference in the formation constant of 
[CuLH_J] with that of the corresponding species for a particular Mn+_L system. 
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Although the formation constants2 of Cu2+, Ni2+, Zn2+ and Ca2+ with L1 were 
not determined in the present study, they are however reported in Table 5.2 and are 
discussed extensively in section 5.2.l and hence a comparison will made because of 
the similarity of this ligand to L2 and L3. These factors give an insight about the 
overall contribution of several factors that might have a bearing on the determined 
constants. 
The studied ligands are highly selective for copper compared to Ni2+, Zn2+, 
Ca2+ and Gd3+. This is borne out by the calculated selectivity factors, which are in the 
range of 6-9 orders of magnitude in favour of Cu2+. In fact, the stability order is Gd3+ 
~ Ca2+ < Ni2+ < Cu2+ > Zn2+. This is the Irving-Williams stability order normally 
observed for the first row of the transition elements. 
The higher formation constants of Cu2+ with these ligands are due to ease 
with which the metal ion deprotonates the amide groups. Furthermore, the increased 
stability of these complexes is as a result of the square-planar ligand field created by 
both L1 ~nd L2. Although L3 is postulated to form tetragonally distorted octahedral 
species, the donor atoms of the ligand continue to define the close to or equatorial 
metal co-ordination. This leaves two axial sites occupied by water molecules, which 
constitutes a tetragonal co-ordination environment. Both geometries are preferred by 
C 2+ u . 
It is possible that Cu2+ in both the tetragonally distorted octahedral (0.87 A) 
and square-planar (0.71A) environments32 may have the optimum size to fit better into 
the ligand's 'bite' cavity than the other studied metal ions. However, it is believed that 
the L3 cavity may be too big for Cu2+ and Ni2+, hence the observed low equilibrium 
constants. The ability of Gd3+ and Ca2+ to form complexes with the L3 ligand may be 
related to their large ionic radii.32 
As discussed in section 5 .2.1, no significant metal assisted ionisation of the 
oxime groups has been observed in the Mn+_L2 systems. Instead, metal promoted 
deprotonation of the amide groups (pKM-CONH) given by the differences between 
log~110 and log~11-1 have been predicted from the evaluated constants. The following 
pKM-CONH values of 4.01, 5.03, 9,6 and 8.0 for Cu2+, Ni2+, Zn2+ and Gd3+ systems 
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respectively clearly indicate that the protons are released from the amide moiety in the 
copper(II) and nickel(II) species. For Zn2+ and Gd3+, these values correspond to the 
deprotonation of the co-ordinated water molecules. This should be expected in view 
of the inability of the latter two metal ions to deprotonate the amide groups. 
In contrast, significant metal promoted deprotonation of the dione dioxime 
groups (pKM-NOH) has been observed in L 1 systems. This is indicated by the calculated 
first pKM-NOH values for L1 with Cu2+, Ni2+, Zn2+ and Gd3+ which are 2.897, 3.92, 
4.747, 7.30 respectively. This signifies that the [CuL 1(0H2)2]2+ complex is more 
acidic than the analogous Ni2+, Zn2+ and Gd3+ species. These pKM-NOH values further 
indicate that the proton is indeed lost from a terminal oxime group rather than from an 
axially bound water molecule. 
Similar trends have been observed with H2tmdddo,
5 (L\ Figure 1.1) an 
analogue of L 1• Co-ordination of H2tmdddo to copper(II) was also observed to 
increase the acidity of the oxime proton by nine orders of magnitude. For H2tmdddo, 
pKN-oH=12.3, while for its complex with copper(II) the value is 3.24. 
In L2 systems, the formation of the [MLH_2] complex species from [MLH_i], is 
due to proton loss as a result of the breaking of the hydrogen bond. The formation of 
this species in the previously studied Ni2+-L1 system2 is due to the metal ion promoted 
dissociation of the oxime proton involved in the hydrogen bond. However, the 
formation of the same [MLR2] is associated with the ionisation of the axially bound 
water molecule for Cu2+-, Zn2+- and Gd3+-L1 systems. 
The pKML-OH values associated with the deprotonation of the amide groups in 
L3 systems are 6.10 and 8.53 for Cu2+ and Ni2+ respectively. These values are 1.5 and 
2.0 log units lower than the hydrolysis constants of the metal ions. This indicates that 
the deprotonation of the first amide group is easier than losing a proton from a 
coordinated water molecule probably due to the higher donating ability of a 
deprotonated amide group. For Zn2+, Ca2+ and Gd3+ these pKML-oH's correspond to 
deprotonation of axially coordinated water molecules confirming the inability of these 
metal ions to facilitate proton loss from the amide moieties. 13,14 
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5.2 UV NIS spectroscopy 
During solution studies of the Cu2+/Ni2+-L2/L3 systems, distinct colour changes 
were noted as the titrations progressed. This is because the speciation of the solution 
changes with pH, and the different complex species have differing absorption spectra. 
To gain more insight about the co-ordination geometries of these species, individual 
species spectra were calculated. This was achieved 'by analysis of the UV Nis data 
using a Local BASIC program to solve for the expanded Beer-Lambert Law equation. 
5.2.1 Cu-L systems 
Figure 5.20 (a) shows the UVNis spectra of the Cu2+-L 2 system as a function 
of pH. A band at 690 nm is seen to initially increase with pH and then decrease in 
intensity. Above pH 5.8 a band at 470 nm develops in intensity while at pH values 
above 9.45 the intensity of this band decreases. 
Figure 5.20: (a) Electronic and (b) calculated species absorption 
spectra of solutions containing 0. 0008 mol dm-3 Cu2+ and 
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The wavelength absorption maximum (Amax) at 780 nm with low molar 
extinction coefficients at the acidic pH range of 2.5-3.0 is easily seen in this Cu2+ 
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system (Figure 5 .20(b) ). This absorption is due to the uncomplexed octahedral 
[Cu(OH2)6]2+ (100) complex species with the molar extinction coefficient (E) of 15 
motl dm3 cm-1.36,37 
Between pH 3.5 and 6.0, copper(II) exists as a 110 species with a Amax of 690 
nm. The ligand in this species is postulated to be co-ordinated to the metal ion in a 
bidentate fashion through one of the nitrogen donor atoms of the hydroxyimino groups 
and the amide moieties. The other four co-ordination sites are believed to be occupied 
by water molecules. The molar extinction coefficient of this 110 complex is 90 mot1 
dm3 cm-
1 (Figure 5.20(b)), which is typical of Cu2+ in an octahedral environment. 
In the pH range 6.0-8.0, Amax shifts to 470 nm due to the predominance of the 
11-1 complex species of MN4 co-ordination. A blue shift of about 210 nm is due to 
the binding of the extra two nitrogens and the change of the metal ion co-ordination 
sphere from an octahedral to a square-planar geometry. An increase of Emax from 90 to 
165 mot1 dm3 cm-1 is in support of this change in co-ordination. 
There is an observed 10 nm increase in Amax above pH 8.0, which is due to the 
accumulation of the [CuL2R2]2- complex with E = 125 mot1 dm3 cm-1. Despite the red 
shift in the absorption maximum and a decrease in E, there are no significant changes 
in the spectra of this system above pH 8.0. It has been observed that the loss of a 
proton from a co-ordinated water molecule results in an red shift of Amax by 
approximately 50-90 nm. 1 The 10 nm increase in Amax is believed to be associated with 
the loss of a proton involved in the hydrogen bond in the [CuL2H_1r complex. This is 
an indication that the proton loss from 11-1 species to form a 11-2 complex does not 
lead to a significant destabilisation of the latter complex and above this pH 
complexation is complete. It is also a confirmation of an earlier hypothesis that the 
pseudomacrocylic (CuL2H_1r complex is not stabilised by the hydrogen bond as it has 
been observed in other oximes. 1'2'5'6 
It has been observed that an incorrect potentiometric model yields to disjointed 
species spectra. The continuous calculated electronic spectra of the individual species 
are in further support of the potentiometric model used in the analysis of the data. The 
broad band observable between pH 7 .11 and 11 .4 for Cu2+ is characteristic of purely 
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square-planar d9 [ML2H_1r and [ML
2R2f complexes. This absorption band is made 
up of three spin-allowed transitions namely: 2 A1g~2B 1 g, 2B2g ~2B 1 g and 2Eg~2B 1 g. 
Two of these transitions are indicated by humps in the absorption spectra at pH values 
below 7.00 (Figure 5.20(a)) and in the species spectra of 100 and 110 (Figure 5.20(b)). 
Unlike L2, electronic spectra of copper complexes with both PrA01 and 
H2tmdddo
3 indicate that dissociation of an oxime proton causes a small increase in the 
donor strength of the oxime nitrogen atom. This is observed as the blue shift in Amax 
on formation of the pseudomacrocyclic species. This should be expected in view of 
the fact that L2 behaves as a weak diprotic acid in neutral to strongly basic pH range 
7.0-10.5. In fact, the ligand loses both protons in the afore-mentioned pH range 
whereas the loss of this (these) proton(s) in PrAO, H2tmdddo and dimethylglyoxime is 
(are) usually metal ion assisted. 2'6 
Billo38 predicts a Ymax (Amax) of 18760 cm-1 (526 nm) for [CuL2R1r and 
[CuL2R2]2- complex species of N4 co-ordination type involving two amido and two 
amino nitrogens. This Ymax value is 2073 cm-1 less than the Ymax observed in this study. 
The discrepancy is possibly due to the higher than predicted donating ability of the 
hydroxyimino groups. The YN-OH = 4.4lxl03 cm-1 of an oxime nitrogen predicted by 
Jackson and Nakani1 is still too low to account for the observed Ymax of these species. 
Furthermore, it has been observed that the presence of the alpha-amide groups 
in L 2 increases the acidity of the hydroxyimino ( oxime) nitrogen by nine orders of 
magnitude compared to other related oximes as discussed in section 5.1.1.2. It is more 
likely that the basicity of the oxime nitrogen is enhanced due to the electron 
withdrawing effect of this amide, hence the increased value of Ymax· The NH-
COCHN-OH moieties in this ligand can be viewed as electron sinks for metal ions 
such as Cu2+, which are capable of deprotonating the hard amide groups. 
Figure 5.21(a) is a plot of the Cu2+-L3 solution UVNis spectra as a function of 
pH. At pH values below and up to 3.54, an absorption band at 780 nm predominates. 
The absorption spectrum at pH 5.55 seems to encompass at least two Amax, one at 780 





an evolution of a single band which increasing intensity as the pH increases while 
above this pH range the intensity of this band decreases. 
Figure 5.21: (a) Electronic and (b) individual species absorption 
spectra of solutions containing 0. 001 mol dm-3 Cu2+ and 
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Complexation in this system begins above pH 3.54 since the hydrated Cu2+ 
species predominates below this pH. The Amax at 780 nm with low E values ( <20 mot1 
dm3 cm-1) is due to this complex. The 111 species (Amax= 620 nm, c=40 mot1 dm3 cm-1) 
seems to predominate in the pH range 3.54-5.55. The 160 nm blue shift in the 
absorption maximum is due to the co-ordination of the central amine, one terminal 
amino group and probably one carbonyl oxygen (Figure 5.6(h)). Co-ordination of one 
amide nitrogen leads to the 110 with Amax at 580 nm and c=l 15 mot1dm3cm-1• The 40 
nm blue shift in Amax and the three fold increase in the molar extinction coefficient of 
the 110 species is ascribed to the strong donating ability of the deprotonated amido 
nitrogen. 
The 11-1 and 11-2 complexes exhibit Amax values of 560 nm and 540 nm with 
E values of 120 and 110 mot1dm3cm-1 respectively. The former species is formed by 
binding of the second amide nitrogen to Cu2+, while the latter is due to the 
deprotonation of the terminal amine. The molar absorption coefficients of the two 
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species are typical of Cu2+ in a distorted tetragonal environment. The continuous 
individual spectra given in Figure 5 .21 (b) are in support of the potentiometric model 
used in data analysis. 
The broad absorption band observed for the 111, 110, 11-1 and 11-2 
complexes envelopes the expected 2A1g~2B 1 g, 2B2g~2B1g and 2Eg ~2B 1 g transitions 
which are spin-allowed. Two of these transitions are prominent in the calculated 
spectrum of the protonated 111 complex (Figure 5.21(b)). 
The 11-1 and 11-2 species are observed to have absorption maxima which are 
20-40 nm less than the values predicted by Billo's equation.38 This is probably due to 
the destabilisation of the complexes by the formation of the two contiguous six 
membered-rings (Figure 5.6 G) and (k)). In fact, the 20-60 nm increase as one moves 
from 111 to 11-2 is due to the destabilisation of the 11-1 and 11-2 on the formation of 
these contiguous rings. The stability of these species is further decreased by the low 
basicity of the coordinated central anchoring amino group, which leads to the 
formation of six-membered rings. Co-ordination of both terminal amines will also 
reduce the thermodynamic stability of these species due to the formation of a bigger 
ten-membered ring.39 
Square-pyramidal and trigonal bipyramidal Cu2+ complexes of N5 co-
ordination usually exhibit two bands at 728 and 900 nm. 18'37'39 Jubert et al.9 have 
observed a broad band around 700 nm which they attributed to six co-ordinate CuN6 
species. The axial co-ordination of amino groups in these Cu2+ complexes causes a red 
shift of the Amax of approximately 100 nm compared to the absorption maxima 
observed in this study. This is an indication of the absence of axially co-ordination of 
amino groups in the [CuL3H_i] and [CuL3H_z] species. 
Instead, UVNis data reveal an insignificant blue shift in Amax (~Amax=20nm) 
and a decrease in the molar absorptivity due to·the formation of the [CuL3R 2] from 
[CuL3H_i]. This blue shift is probably due to the slight stabilisation of the contiguous 
six-membered rings of the 11-2 following the deprotonation of the second terminal 
amme. 
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Cu2+ prefers six co-ordinate tetragonally distorted species where two weak 
ligands such as water molecules occupy the axial positions. In these species the 
equatorial plane is defined by the four nitrogen donor atoms of the ligand. It is 
predicted. therefore that both amide nitrogens, the central amine and one of the 
terminal tertiary amines are co-ordinated. The second terminal amine is protonated in 
the [CuL3H.1t species while the formation of the [CuL3H.2] may be due to its 
deprotonation. There is no evidence from UV Nis data of co-ordination of this amine. 
On the basis of the above observations and taking into account the ligand 
structure, the co-ordination of the fifth nitrogen is unlikely. A similar structure was 
suggested by Steenland et al. 7 for the macrocyclic diamide analogues (Li and 0) of L3• 
5.2.2 Ni-L systems 
The absorption spectra of a Ni2+-L 2 solution at various pH values are given in 
Figure 5.22(a). In the pH range 3.5-10.73, there is only one band centred at 350-370 
nm. At pH values below 3.00 (Figure 5.22 (a)-Insert), a band at 580-740 nm is easily 
seen in addition to the band tailing off in the visible region. 
Figure 5.22: (a) Electronic and (b) calculated species absorption 
spectra of solutions containing 0. 00023 mol dm-3 Ni 2+ 
and 0. 0008 mol dm-3 L2 • 
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At pH values below 3.00 the solution is composed of the hydrated 
[Ni(OH2)6]2+ species with E less than 10 mot1dm3cm-1. The 3T 1 g(P)~3A2g and 
3T1 g(F)~3 A2g transitions at 360 and 680 nm respectively can been seen from these 
spectra (Figure 5.22(a)-Insert) although the former is obscured by a ligand to metal 
charge transfer (LMCT) band. These two transitions at 360 and 680 nm with low 
molar extinction coefficients are typical of Ni2+ in an octahedral environment. It 
appears that at this acidic pH range the metal ion is unable to bind to the ligand's 
donor atoms. 
Above pH 3.49, a single band centred at 350 nm is observed. This is an LMCT 
transition originating either from the carbonyl oxygen, deprotonated amide nitrogen or 
the oxime nitrogen to the vacant 1 A2g orbital of the metal ion. The molar extinction 
coefficient of this band for 111, 11-1 and 11-2 species (Figure. 5.22(b)) is in the range 
of 1785.7 to 2500 mot1 dm3cm-1 in support of its CT character. 
Bojczuk et al.40 have proposed three 0-, N- and NH2~Cu2+ CT transitions 
which lie at 385, 327 and 277 nm respectively. The intra-ligand n~n* transition, on 
the other hand, occurs around 250 nm.37 Such a transition has not been observed in the 
Cu2+- and Ni2+-L1 systems1'2 which contain both the co-ordinated amino and 
deprotonated oxime groups. This suggests that this band is neither due to O-~Ni2+ nor 
NH2~Ni2+ electronic transition. 
Ni2+ has been found to be capable of deprotonating the amide groups of L2 
(section 5.1.2.2) which are absent in L1. It is more likely that this LMCT band is due 
to an electron transition from the deprotonated amide nitrogen (N-) to the vacant 1 A2g 
orbital of the metal ion. 
A two component band at 470 nm and 430 nm (Figure 5.21 (b)) is seen for the 
11-1 and 11-2 complexes respectively as a shoulder on this LMCT transition. The 
band constitutes the 1A2g~ 1A1g and 1 B 1g~ 1A1g transitions typical of square planar 
Ni2+ species. This band is also obscured by the LMCT absorption. The d-d transitions 
fall in the predicted 420-450 nm ~ange with c=l20-500 mot1 dm3 cm-1 as was 
observed for Ni-L1 system2 and recently by Enyedy et al.39 for similar ligands. It 
should be mentioned that increasing the nickel and ligand concentratios does not lead 
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to the better elucidation of the d-d transitions due to the high molar extinction of the 
LMCT band. Hence, this charge transfer band dominates the electronic spectrum of 
this system. 
The absence of absorption above 500 nm is indicative of square-planar 
[NiL2R 1r and [NiL2R 2]2- complex species. There is no observable absorption by the 
octahedral hydrated Ni2+ and 111 species above pH 3 .49 in support of the calculated 
speciation plots given in Figure 5.9(a). The continuous calculated species electronic 
spectra give confidence to the results for the potentiometric model used in the analysis 
of the data. 
In contrast to the above observations, nickel does not seem to deprotonate the 
amide nitrogens of L3 with ease. The hydrated Ni2+ and the protonated 112, 111, 110 
complexes predominate the whole acidic to neutral pH region before the onset of 
precipitation. It seems the potentiometrically determined 112, 111 and 110 complexes 
are too weak to absorb appreciably in the wavelength range studied. As a result, no 
information could be obtained from the absorption spectra of these potentiometrically 
detectable species. Moreover, Ni2+ does not seem to form the positively charged 11-1 
species with L3, which has been detected in the corresponding Cu2+ system. 
5.2.3 Discussion - UV Nis spectroscopy 
At low pH values, the calculated individual spectra of the M2+-L2/L3 systems 
are characterised by hydrated [M(OH2)6]2+ species. The presence of these hydrated 
complexes partly indicates the lower affinity of the donor atoms of these ligands 
towards these metal ions when compared with L 1• This may be viewed as the 
necessary orientation of the ligands' nitrogen lone pair electrons towards the metal ion 
to enhance complexation. 
The [ML2H_1r and [ML2R2f species of Cu2+ and Ni2+ exhibit a single band 
in the 430-480 nm region. This band indicates the presence of MN4 complexes similar 
to those of the corresponding L1 systems. The noticeable blue shift observed in the 
M2+-L2 systems is due to the stronger ligand field contributions of two deprotonated 
amide nitrogens. The ligand field created by L 2 is assisted by the sp2 hybridised nature 
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of the deprotonated amido nitrogens which results in the loss of the axially co-
ordinated water molecules. The ligand forms 5,6,5,6 (11-1) and 5,6,5 (11-2) chelate 
rings around the Cu2+ and Ni2+ metal ions. There is little movement of the d-d 
transition (L1v=150 cm-1) upon formation of [ML2H_2] from [MLH_i], This suggests 
that, in these complexes the stabilisation of the square-planar geometry is determined 
mostly by the presence of three 5,6,5 chelate rings. 
From the relative position of the Amax values of [M-L2] complex species, it 
appears that the systems undergo a change in co-ordination from octahedral 110 and 
111 to square-planar 11-1 and 11-2 species of D4h symmetry. The increase in the 
molar extinction coefficients is consistent with this hypothesis. There is no evidence 
of further absorption below 10,000 cm-1, which is also typical of square-planar Cu2+ 
and Ni2+ complexes.2'37 
The ability ofless sterically hindered L2 to form square-planar [CuL2H_i] 1- and 
[CuL2H_2]
2- complexes may be as a result of the sp2 hybridised nature of the 
deprotonated amide nitrogens. This is in sharp contrast with L 1, which forms 
tetragonally distorted octahedral complexes with the metal ion. The axial H20-Cu
2+ 
bonds are believed to be able to stretch to great extents leading to an increase in the 
stability of complexes despite the steric barrier caused by the methyl groups of the 
ligand. In such a situation the tetragonally distorted [Cu-L1R 1(0H2)2]"+ species could 
justifiably be viewed as square-planar complexes. 
The [CuL3H_1t and [CuL3R2] complexes have Amax values in the range of 
540-560 nm. The values indicate a weak co-ordinating ability of the ligand donor 
atoms towards the metal ion. An interesting feature about the two trans-
dioxopentaazamacrocycle-Cu2+ systems studied by Steenland et al. 7 lies with their 
UV /VIS spectra. The 11-2 complexes of the macrocycles exhibit a single transition at 
430 nm and 490 nm.7 The corresponding Cu2+-L3 species has a Amax which is 50 and 
110 nm higher than those of the dioxo-macrocycles. These differences can be 
explained in terms of the weak-ligand field contributions of amine (amide) nitrogen 
donor atoms in the linear L3 compared to the high-ligand field afforded by its 
macrocylic analogues. 
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The values obtained for Cu2+-L2 species also fall within this range of square-
planar MN4 type of co-ordination for two deprotonated amide and two amino groups 
in these Cu2+-dioxopentaazamacrocycles. Due to precipitation of the probably neutral 
[NiL3H_2], it was not possible to get descent spectra for this system. 
From the relative positions of the d-d band maxima it is clear that the 
tetragonal distortion towards square-planar increases in the order Cu(Namine)2CNamicte)2 
< Cu(Namine)2(Noximeh < Cu(Namide)2(Noxime)2. In fact, in the latter system it has been 
observed that the shift is due to the formation of purely square planar species. 
5.3 X-ray diffraction studies 
UVNis spectroscopy predicted the geometries of the studied Cu2+/Ni2+-L2/L3 
systems fairly accurately. However, the nature and number of the donor atoms of L3 
involved in the co-ordination with these metal ions cannot be ascertained 
unambiguously. Furthermore, the proposed structures given in Figure 6 do not give 
any information about the lowest possible energy conformations. Moreover, the 
relative orientation of the alkyl substituents relative to the molecular plane defined by 
the ligand's donor atoms is unknown. 
In order to assess fully the co-ordination nature of L 1, L 2 and L3 towards these 
metal ions, attempts were made to isolate crystals of the [MLH_i] species. However, 
these investigations were unsuccessful and only the [NiL1R 1t species was isolated. 
This cationic species (Figure 5.23) crystallised as a perchlorate salt with a molecular 
formula C13H21CIN4Ni06, Mr=429.55 glmol. The crystal system is orthorhombic with 
space group-Pbca (#61) and unit cell dimensions a=13.3960(10), b=l2.3490(10), 
c=21.9330(10), Z=8, F(OOO)=l 808. The calculated volume (U) and density of the 
crystal (De) are 3628.3(4) A3 and 1.573 Mg.m-3 respectively. 
This structure resembles the chloride mono hydrate of [NiL1R 1t which has 
been reported before by Hussain and Schlemper.41 The only significant difference lies 
with the space group, which they reported as P212121. It is believed that this space 
group is applicable to chiral molecules. There is no carbon atom in the ligand 
backbone which can endow the overall molecule with chirality. It is therefore 
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suggested that the presently reported space group is the correct one for this crystal 
system. 
Figure 5.23: Ortep presentation of the crystal structure of cationic 
[NiL1H_1 ]+ species and the perclorate (Cl04-) anion 
showing 50% probability ellipsoids and the atom 





The aza (NS and N9) and oxime (N2 and Nl2) nitrogen atoms are involved in 
an equatorial co-ordination to the metal ion with Ni-Naza and Ni-Noxi bonds of length 
1.8720(14)-1.8731(15) and 1.9238(14)-1.9332(14) A respectively. These Ni-N bond 
lengths compare quite well with those of the crystal structure of [Ni(L1)H.1]Cl l.SH20 
observed by Hussain et al.41 
There are no water molecules of crystallisation in the presently reported 
structure due to complete evaporation of the solution. The absence of co-ordinated 
water molecules in the crystal structure reported by these authors41 in spite of the 
water of crystallisation observed is firm evidence of the square-planar nature of the 
coordinated ligand nitrogen donor atoms towards the metal ion. Both these studies 
give full credibility to the square-planar geometry inferred previously from the 
----- ----- -- __ j 
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UV Nis data.2'42 The other observed differences such as the calculated density and unit 
cell dimensions are expected in view of the different counter-ions involved. The 
appendix gives a full listing of bond-lengths, angles and crystal refinement data of the 
[Ni(L1)H.1tCl04·. 
As expected, the methyl groups at C-4 and C-10 are staggered due electrostatic 
repulsion of the hydrogens. Another noticeable feature about the crystal structure of 
the [Ni(L1)H.1tCl04. is the displacement of the central methylene group of the 
propylene bridge by 0.05 A from the square-planar plane defined by the metal ion and 
the ligand's donor atoms. This may be due to the hydrogen bond which is displaced by 
the same margin in the opposite direction. 
Kozlowski et al.4 recently reported a crystal structure of [Ni(L 2)H.1t complex, 
whose Ni-N bond lengths vary between 1.96 and 1.97 A. In fact, in the [Ni(L 2)H.1t 
crystal system the Ni-Nam and Ni-Nox bond lengths are equal to within 0.005 A. This 
is an indication of an equal electron donating ability of these nitrogens towards the 
metal ion. Of particular interest is the observation that the Ni-Naza and Ni-N0x bond 
distances of the [Ni(L1)H.1t crystal system are approximately 0.1 and 0.7 A 
respectively longer than the Ni-Nam and Ni-N0x bond lengths of [Ni(L2)H.1t observed 
by these researchers.4 The shorter Ni-N bonds in L2 species compared to L1 complexes 
further indicate the high basicity of these nitrogens, hence the blue-shift in the spectra 
of the corresponding Cu2+ and Ni2+ 11-1 and 11-2 species. 
Unfortunately, it has not been possible to prepare single crystals of either 
[CuL
3
H.I] and/or [CuL3H.2] suitable for X-ray structure analysis. A precise structural 
elucidation of the co-ordinated donor atoms of this ligand towards copper must await 
more X-ray structural information. 
5.4 MM calculations and MD simulations of [M(L1)H.1t systems 
In the absence of suitable crystals for X-ray structure analysis, MM 
calculations and MD simulations may give some insight about the coordination 
behaviour of a particular ligand's donor atoms towards a given metal ion. In these 
calculations care is taken of the preferred coordination geometry of the metal ion. The 
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structures of [M(L1)H_1r systems were built and their potential energies minimised 
using the ESFF forcefield. Molecular dynamics (MD) simulations of these species 
were run in order to assess the relative orientation of the methyl groups in the energy 
minimised [M(L1)H-1t complexes. 
5.4.1 Ni(L 1)H-1t species 
Figure 5.24(a) and (b) shows the crystal structure of [Ni(L1)H_1r 
superimposed onto the simulated species. As seen from the figure, there is a very good 
agreement between the experimental determined structure and the simulated species. 
The only difference between the two lies with the relative orientation of the propylene 
bridge separating the aza nitrogens. 
Figure 5.24: Superimposed crystal (top) and simulated species 
(bottom) of [NiL1H_1 ] + in (a) ball and stick model and 
(b) stick representation (atoms at the crossing points) , 
Color code: Ni2+-pink, nitrogen-blue, oxygen-red, 
carbon-green and hydrogen-gray) . 
(a) (b) 
In the crystal structure this bridge is projecting away form molecular plane 
define by the metal ion and the nitrogen donor atoms of the ligand. The simulated 
structure, in contrast, has the propylene bridge in the same plane as the metal ion and 
the co-ordinated donor atoms. These studies indicated very little conformational 
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differences between the observed crystal and energy minimised simulated structures. 
This is a very important result in the development of force-fields for modelling of 
transition metal complexes. The force-fields can be modified to account for the Jahn 
Teller distortion normally observed for copper complexes. Furthermore, a structure of 
a particular complex can be inferred with confidence from these MM calculations and 
MD simulations in the absence of single crystals suitable for X-ray diffraction studies. 
The excellent agreement between the simulated and observed [Ni(L1)H_1t 
crystal structures led to the extension of these simulations to the corresponding Zn2+ 
and Cu2+ species. The simulations of the former system was important due the 
relatively few techniques available for its investigation. The zinc(II) ion due to its d10 
electronic configuration is spectroscopically silent. In fact, the geometries of the Zn2+ 
complexes are normally inferred from the corresponding Cu2+ and Ni2+ species. 
Although during the energy minimisation and simulations of the [ZnL1H_1t species a 
tetrahedral Zn2+ ion was assumed, the square-planar zinc(II) complex (Figure 5.25 (a)) 
was observed. 
This result is unexpected as Zn2+ prefers a tetrahedral arrangement of the 
donor atoms around itself. However, this observation is in agreement with the 
postulation made previously that the ligand's donor atoms are co-ordinated to Zn2+ in a 
square-planar fashion.2 It also confirms that the low stability constant observed for 
this system is due to the square-planar arrangement of the ligand's donor atoms forced 
on the metal ion.2 Just like the simulated [NiL1R 1t species, the methylene groups of 
the propylene bridge are within experimental error on the same plane as the co-
ordinated metal and the nitrogen donor atoms ofL1. 
MD simulations of [CuL1R 1t species (Figure 5.25(b)) indicated also a 
square-planar co-ordination of the ligand's nitrogen donor atoms towards the metal ion 
as was predicted from UV Nis data. 1'2 Furthermore, the relative orientation of the 
propylene bridge in the simulated Cu2+ complex resemble that observed in the crystal 
structure of the corresponding Ni2+ species. 
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Figure 5. 25: Simulated species of (a) [ZnL1H_i) + and (b) [CuL1H_i) +, 
Zn2+-brown, Cu2+-pink, nitrogen-blue, oxygen-red, carbon-
green and hydrogen-gray) . The atoms are at the crossing 
points. 
(a) (b) 
Overall, these simulations indicate that the conformation m the crystal 
structure is probably the stable one in solution. The design of therapeutics, in general, 
and the envisaged copper-based anti-arthritic agents in particular, will probably 
require detailed knowledge of their conformational requirements. Such 
conformational properties may be important for diffusion across the biological 
barriers as an initial step and into entering the cytosol. Biological activity of these 
complexes may also rely on their conformational requirements. These MD simulations 
serve as a first step in this direction. 
5.5 Blood-plasma simulation studies 
A justifiably conclusion that the ligands are more selective towards copper(II) 
can be drawn on the basis of the selectivity factors obtained in this study. However, 
the "high" concentrations of zinc(II) in blood plasma relative to copper(II),43 put such 
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conclusions to the test. Hence, it is always predicted that the zinc(II) complexes 
predominate in blood-plasma. 
True selectivity of the ligand towards copper(II) is investigated using the 
blood-plasma mobilising index (p.m.i.) defined as the ratio of low molecular weight 
copper complex species in the presence of a drug and on its absence. P.m.i.'s for Cu2+, 
Ni2+, Zn2+, Ca2+ and Gd3+ were calculated by incorporating the formation constants for 
the ligands into the plasma model. In the calculation, the total ligand L concentration 
was varied over the range 10-3-10-9 mo! dm-3• The results are shown in Figure 5.26 (a) 
and (b). 
Figure 5.26: P.m.i. curves for (a) Cu2+ with L1 and L2 and (b) those 
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One important observation from Figure 5.26(a) is the absence of copper(II) 
mobilising curve induced by L3. The figure indicates that L3 is devoid of any 
copper(II) mobilising ability. In fact, at a total L3 concentration of IM, the Cu2+ p.m.i. 
is less than 0.01. This is due to the weak complexes formed by the metal ion with this 
ligand. In addition, the ligand has been found to form complexes with zinc(II) and 
calcium(II). Due to the high concentration of these metal ions and the presence of 
better co-ordinating ligands in vivo, L3 is unable to increase the 1.m.w. copper(II) 
fraction. 
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In contrast, the copper(II) mobilising abilities of L1 and L2 are 6 and 3 orders 
of magnitude respectively greater than that of L3. This is indicated by the distinct 
separation of the copper mobilising curves when plotted as a function of the ligand 
concentration. The remarkably high mobilising ability of L 1 is related to the stable 
complexes it forms with Cu2+. In addition, the predominant [CuL 1H_i] species present 
under physiological pH is further stabilised by hydrogen bonding. The hydrogen bond 
in the corresponding L 2 species is very weak as discussed in section 5 .1.2 .1. 
At a total ligand concentration of 10-6 mo! dm-3 and 10-3 mo! dm-3 for L1 and L2 
respectively, Zn2+ and Ca2+ p.m.i.'s are also less than 0.01. In spite of the higher Zn2+ 
and Ca
2
+ concentrations in blood plasma and predominance of the 11-1 species of the 
former ion under physiological condition, their weak binding strength with the ligands 
make them less important as competitors of copper(II) in vivo. 
These p.m.i. calculations (Figure. 5.26(b)) reveal that the injected [GdL1H_1]
2+ 
species is also capable of surviving in vivo. However, copper is more likely to induce 
trans-metallation because of its high affinity for the nitrogen donor atoms of this 
ligand. These studies further indicate that the ligands, in their present form, will be of 
little use as contrast agents in MRI. However, modified analogues of these ligands, 
and L 
1 
m particular, incorporating pendant methylenecarboxylate and 
methylenephosphonate groups will be worthy of investigation as contrast agents in 
MRI. 
In conclusion, it is predicted that the [CuL1R 1t and [CuL2R 1r complexes are 
unlikely to release their copper to proteins and/or to other 1.m.w. chelating agents in 
biological systems. This is indicated by the ability of L 1 and L 2 ligands to bind 
copper(II) at very low concentrations. 
5.6 Octan-1-ol/water partition co-efficient studies 
Although copper(II) complexes when administered orally and intravenously do 
increase available copper, it is difficult to move this co-ordinated metal ion through a 
series of body compartments without protein binding.43 Of the various classical ways 
of drug administration such as orally, by injection intravenously, intraperitoneally etc., 
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percutaneous absorption offers one obvious advantage of being less painful and hence 
tolerable to the patient. However, the usefulness of percutaneous drug administration 
relies on the lipophilicity and molecular weight of the drug.44 
For this reason, this study also investigated the octanol/water partition 
coefficients of copper complexes with a view to establishing whether these species 
can be administered transdermally. The two component octan-1-ol/water mixture was 
used as a biophase analogue. Figure 5.27 shows the logarithms of the partition 
coefficients (logPoct/aq) of (a) Cu2+-L2 and (b) Cu2+-L3 complexes plotted as a function 
ofpH. 
Figure 5.27: LogPoct/aq of (a) Cu2+-L2 (•) and (b) Cu2+-L3 (+) complexes 
plotted against pH. Each dot or square is a mean of 
three independent observations. The errors in the mean 



































• ••• • • 
-1.4 • • 
-1.6 • ... • Q) .... Ill •• ~ 
(,) -1.8 
0 




2.5 4.5 6.5 8.5 10.5 
pH 
These logP oct/aq values were determined at 25°C and an ionic strength of 0.15 
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and for a drug to be reasonably lipophilic, the logPoctlaq value must be 
at least 0.6. 
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5.6.1 Cu-L 2 system 
One of the noticeable features about figure 5.27 (a) is the fact that all logPoctlaq 
values are negative. The negative values of the lipophilicity measure indicate that 
these complexes are largely hydrophilic. The low logP oct/aq values in the acidic pH 
range of 2.5-4.0 is expected in view of the high concentration of hydrated 
[Cu(OH2)6]
2
+ in this pH range. At pH values above 4.0, complexation begins to occur 
through the deprotonation and co-ordination of the amide and oxime groups. This 
leads to the formation of the neutral 110 species. A logPoct/aq= -1.97 is assigned to this 
species on the basis of the speciation calculations of the Cu-L2 system. 
The logPoctlaq at the physiological pH 7.4 is -1.73, which can be approximated 
as the value for [CuL2H.1f. The speciation calculations indicate that Cu2+ is 95% 
present as the mononegatively charged [CuL2H.1]" at this pH. There is a decrease in 
logPoctlaq as the pH increases above pH 8.0 and reaches a value of -1.88 at pH 10.5. 
This is due to the predominance of the dinegatively charged [CuL2H_2f complex in 
this pH range (see Figure 5.5(a) speciation curves). 
In the pH range of2.5-10.5 studied, the logPoct/aq values of the Cu2+-L2 system 
vary between -2.11 and -1.73. A difference of 0.38 (dlogPoctlaq = 0.38) between the 
maximum and minimum logP octlaq values is an indication that all three complexes of 
copper(II) with the ligand are equally lipophilic. This comes as no . surprise if one 
realises that these complexes differ from each other by two protons at most. 
Hydrogen bonding between the carbonyl oxygens and the water molecules is 
the main contributor to the decreased lipophilicity of these complexes. Although the 
110 species is electrically neutral, the presence of four co-ordinated water molecules 
also increases its hydrophilicity. It is postulated that the deprotonated oxime oxygen 
may hydrogen bond to the water molecules, thus decreasing its partitioning into the 
organic phase. The decreased lipophilicity of the 11-2 complex can be ascribed to the 
presence of negatively charged oxime oxygens which are capable of hydrogen-
bonding to water molecules. The 11-1 species is the least hydrophilic of these 
complexes probably due the absence of co-ordinated solvent molecules. Furthermore, 
the presence of the hydrogen bond in this 11-1 species leading to the formation of the 
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pseudo-macrocycle reduces the number of available oxygen sites~for hy_§rogen 
bonding. 
A logPoctlaq = -1.73 for the [CuL2H-1] complex which predominates in the pH 
6.5-8.0 means 1.86 % of the species goes into octanol phase. Since this pH range 
encompasses the pH of the skin and the blood-plasma, it is more likely that a similar 
percentage is likely to penetrate the skin when applied transdermally. 
Packard et al.46 have recently studied the partition coefficients of monocationic 
copper(II) complexes of diimine dioxime ligands L k, L
1 
and Lm. The logP oct/aq values 
of their systems varied between -2.05 and -1.60. These diimine dioxime complexes 
are as lipophilic as the Cu2+-L2 complexes investigated in this study. However, they 





logPoct/aq values are -1.78, -1,22 and -1.20 respectively. This is because L
1 
has more 




and L m. 
5.6.2 Cu2+ -L3 system 
The copper(Il) complexes formed by this metal ion with L
3 
are equally 
hydrophilic. This is revealed by the negative logPoct/aq values (Figure 5.27(b)) obtained 
throughout the pH range studied. Low logP oct/aq values at the acidic pH range of 2.5-
4.0 are due to the coexistence of the hydrated Cu
2
+ and the protonated 111 complexes. 
In fact, a logPoct/aq=-2.0 can be assigned to this ll l species. The assignment is based 
on the assumption that the contribution of [Cu(OH2)6]
2
+ to the observed logP oct/aq is 
much smaller than -2.0. This is a justifiable assumption because of the presence of at 
least two hydration shells around Cu
2
+ in the 100 species. 
In the protonated 111 complex, the ligand is postulated to be co-ordinated to 
the metal ion through one carbonyl oxygen, the central anchoring amine and one 
terminal amino group. This leaves three to four co-ordination sites on the metal ion to 
be occupied by the water molecules, hence its observed low lipophilicity. 
The di positively charged 110 is slightly more lipophilic than the 111 complex. 
This is observed as an increase in logPoct/aq as the pH is raised to 6.5 where the former 
complex predominates. A lipophilicity measure of -1. 79 is assigned to the 110 
138 
complex where the coordination of the first amide group is believed to decrease 
hydrogen bonding with water molecules. A further slight increase in logP oct/aq above 
pH 6.5 to a maximum value of -1.25 is a consequence of the steady accumulation of 
the 11-1 species where the second amide group is postulated to be coordinated to the 
metal ion. In fact, a logP oct/aq=-1.25 at pH 8.0 can be assigned to the monopositively 
charged 11-1 complex. 
Above pH 8.0 there is no change observed in logPoctlaq where the dominant 
species is the 11-2. Thus, a logP oct/a=-1.25 can also be assigned to this neutral 
complex. Co-ordination of the second terminal amine should increase the lipophilicity 
of the 11-2 complex by decreasing the number of available nucleophilic sites capable 
of hydrogen bonding. This is in support of the assumption that there is no evidence of 
co-ordination of the five nitrogen donor atoms to the metal ion. A ~logPoctlaq=0.93 
between the maximum and minimum logP octlaq values is indicative of differing 
lipophilicities of the various Cu2+-L3 complexes formed. The logPoct/aq=-1.25 for the 
11-1 complex indicates that 5.62% of the drug is likely to penetrate the skin despite its 
low thermodynamic stability 
Unlike the results which have been reported before for Ld2,8 the copper 
complexes of L3 have been found to be reasonably lipophilic. In fact, L3 and L d2 can 
be viewed as members of a homologous series differing by two methylene groups. L3 
contains two methylene groups, one on each side of the benzylamine. Leo et al.45 have 
observed that incorporation of two methylene groups to a ligand backbone adds 
approximately one log unit (~logPoct/aq=l.O) to the observed logPoct/aq· A logPoct/aq 
value of -3.4 is predicted for the (CuL3H_i] complex. This species, however, has been 
observed to be two log units more lipophilic than predicted using Leo et al.45 additive 
rule. This difference is not easy to rationalise. 
In general, the presence of alkyl groups as part of the backbone structure of a 
ligand or as substituents to it do increase its lipophilicity. The presence of benzyl and 
methyl groups on L3 should render the molecule lipophilic enough for a reasonable 
amount of its copper complexes to enter the octanol phase. A closer look at the ligand 
structure reveals that only the uncoordinated carbonyl oxygen can hydrogen bond to 
the solvent molecules. However, such interactions should be weak due to the low 
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basicity of the carbonyl oxygen. Even after deprotonation of the amide groups due to 
metal ion complexation, the negative charge is delocalised over the amide moiety 
(Figure 5 .6 (i), G) and (k)) and the proximity of the metal ion makes hydrogen 
bonding with bulk water molecules impossible. Hence, the reasonably high 
lipophilicity of Cu2+-L3 complexes should be expected in view of these 
considerations. 
5.6.3 Discussion - Partition coefficients 
The presently investigated Cu-L complexes have been observed to be largely 
hydrophilic. Four key contributions to the overall hydrophilicity of these complexes 
are: 
• the presence of co-ordinated water molecules, 
• hydrogen bonding interactions between the carbonyl oxygen atoms and the bulk 
water molecules, 
• hydrogen bonding between charged groups in these species and the solvent 
molecules, and 
• the overall charge of the 111, 110, 11-1 and 11-2 complex species. 
The low lipophilicity observed for Cu2+-L2 compared to Cu2+-L1 and Cu2+-L3 
systems is expected in view of the fact that L1 and L3 have more alkyl substituents 
than L2. Moreover, the negatively charged oxygen(s) of the hydroxyimino groups, not 
involved in bonding with the metal ion, probably decrease its partitioning into the 
organic phase. 
To demonstrate the effect of the above-mentioned factors and the role played 
by alkyl substituents on the lipophilicity of these complexes, Table 5.4 summarises 
the logP octlaq values of the [CuLH.1] species for the presently investigated ligands and 
those of similar ligand systems (Figure 1.1 ). 
Martell et al. 10•12 have recently investigated several copper(II) complexes of 
monooxo and dioxotetraazamacrocyles which are based on the cyclam backbone as 
myocardial perfusion agents. These macrocyclic ligands resemble L 1 and L2 except the 
absence alkyl subsituents on the macrocycles' backbone. Although Cu2+ forms stable 
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11-2 species with these cyclic ligands as expected from the macrocyclic effect, they 
are, however, largely hydrophilic to enter into the octanol phase. They concluded that 
although these systems are reasonably stable, they are not lipophilic as required for 
myocardial perfusion agents. 10-12 
Table 5. 4: LogPoct/aq of [CuLH_iJ species for L1 , L2 and L3 and those of 
similar ligands (PuPy=N,N'-bis(2-pyridyl)methylene-1,4-
butanediamine) so with cu2+. 
Ligand Log p Ligand Log p Ligand Log p 
L1 -1. 22 L.L -1. 60lj 0 LP 3.27" 0 
L.: -1. 73 Lm -2.05q 0 Lq 3.42" 0 
L.:s -1. 25 Ln 1. 97lj 1 Lr 3.61'lt! 
LK -1.96" 0 Lo 2. 42/jtJ Pu Py -0 • 85::>U 
In fact, it has been postulated that copper complexes with logP octlaq values 
greater than 0.6 are lipophilic enough to be regarded as promising myocardial 
perfusion agents and could possible penetrate the blood-brain barrier. 44-49 The 67 Cu-
and 64Cu-labeled [N(2-pyridylmethyl-Nl-(salicylaldimino )-1,3-propanediamine ], (L0 ) 
and pyruvaldehyde bis(N4-methylthiosemicarbazone) derivatives (L0 , U, L q and C) 
recently studied by Green and coworkers47'48 have logPoct/aq in the range of 1.97 to 
3.61 (Table 5.4). These ligands are lipophilic enough to penetrate blood-brain barrier 
and indeed, they showed a high uptake in the brain and other fatty tissues such as the 
heart and liver. 
The monocationic and an10mc copper complexes of the 
dione/diamide/diimine/ dioxime ligands Lk, L1, and Lm, on the other hand, are 
approximately three to four orders of magnitude less lipophilic when compared to 
salicylaldimino and methylthiosemicarbazone ligands.46 The former ligands were not 
found to penetrate the blood-brain barrier.46 This means that the presently investigated 
copper(II)-dione dioxime ligands could be of little use as brain and/or myocardial 
perfusion agents. 
Through control of the co-ordination geometry of the metal ion of interest such 
as changing the steric environment of the co-ordination axis using suitable 
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substituents, lipophilicity increases of several orders of magnitude can be achieved. 
Alkyl groups as substituents do control the accessibility of the axial ligands to the co-
ordinated metal ion due to their steric effect. 
The barrier to partitioning of drugs in skin and bio-membranes is always 
associated with the ordered chain region of the lipid bilayers.
43 
It is anticipated that 
the partitioning of these complexes in this biophase analogue must compare 
favourably with partitioning in these biological barriers. The results indicate that, 
overall, approximately 2-6% of the 11-1 species dominant at physiological pH is 
likely to permeate the skin and membrane when administered percutaneously and in 
the absence of proper vehicles. 
5.7 Superoxide dismutase mimetic activities of Cu
2
+-L complexes 
It has been observed that l.m.w. copper(Il) complexes are capable of catalysing 
the dismutation of the super oxide anion radical to molecular oxygen, water and/or 




+2 SOD mimics. 
Because of this property, the superoxide dismutase mimic activities of the copper(Il) 
complexes were investigated using the NBT assay. Figure 5.28 shows the percentage 
inhibition plotted against the concentration of the copper complex. From these curves 
/ the concentration of the drug required to reduce diformazan formation by 50% (also 
termed an ICso value) is easily read. 









t complexes respectively have been obtained. The ICso value of the 
native CuZn SOD is ICso=0.011 µmo! dm-3.51 The high ICso values exhibited by these 
Cu2+ complexes are indicative of their low SOD mimetic activities when compared to 
the native enzyme. 
The dismutation of the 02-· has been proposed to occur via the reversible 
binding of the superoxide anion to the metal ion. During this reaction, Cu
2
+ is reduced 
to Cu+ while the 0 2-· anion is oxidised to molecular oxygen.
51 




















r species exhibits an IC50 value which is 10000 times greater 
than that of the native enzyme. This can be rationalised in terms of the square-planar 
arrangement of the ligand donor atoms around Cu
2
+ in this species. There are, in fact, 
no available binding sites for the superoxide anion radical (02 .. ) to co-ordinate to the 
metal ion due to the high ligand field afforded by L
2
• 
On the other hand, the higher SOD mimic activity exhibited by the [CuL
1
H.1t 
complex can be ascribed to the available axially co-ordination sites usually occupied 
by water molecules. In fact, the dismutation of the superoxide ion is thought to 




value exhibited by [CuL3H.1t can be interpreted in terms of the 
possible replacement of co'.'ordinated water molecules by the 02··. Furthermore, the 
presence of protonated ligand's sites should also contribute to the dismutation of 02·· 
through hydrogen bonding. The insignificant SOD mimetic behaviour displayed by 
these [CuLH.
1
] species is further exacerbated by competition with EDT A, which has 
been used to simulate the endogenous ligands. The Cu
2
+-EDTA complex is a poor 
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mimic of the enzyme50-56 probably due its co-ordinatively saturated nature and hence 
the high ligand field provided by EDT A. 
No correlation has been found between the SOD mimetic activity of these 
complexes and their lipophilicity. This is despite the assertion that good SOD mimics 
tend to display the lowest lipophilicities. 51 Instead, the dismutation of 0 2-· seems to be 
favoured by weak complexes containing axially co-ordinated water molecules. 
Many researchers50-56 have reported IC50 values in the range of 0.09 to more 
than 20.0 µmo! dm-3 for a number of Cu2+ complexes, some of which are given in 
Table 5.5. The majority of the complexes of the anti-inflammatory drugs have ICso 
values that are approximately a 1000 times higher than the value exhibited by the 
native enzyme indicating that they are poor mimics of Cu-Zn SOD. Some of these 
complexes such as those of cryptand (Crpd)53 and hexaazamacrocyclic (Bpzp-
Bpzbiap) ligands54, however, show promising characteristics of being models of the 
enzyme. These are also worthy of further investigation as human therapeutics m 
models ofrheumatoid arthritis such as collagen induced arthritis (CIA). 
Table 5. 5: IC50 (µmol dm-
3 ) of [CuLH_i] species for L1 , L2 and L3 and 
those of similar ligands ([D-Pen-D-penicillamine, Asp-
Aspirin, Ind-Indomethacin, Car-Carprofen, Azat-
Azathioprine, Chlrq-Chloroquine, Sulph-Sulphasalazine, 
Crpd-Cryptand, Bpzp-Bpzbiap, PuPy-N,N'-bis(2-
pyridyl)methylene-l,4-butanediamine and the other ligands 
are based are PuPy] ) 50 with Cu2+. 
Ligand IC so Ligand IC so Ligand ICso 
L1 58 Car. 19:)1 PuPhePy 0 • 27:'.)U 
LL 110 Azat. >20Jl Pu-MePy 2. 2 5:'.)U 
Lei 11. 7 Chlrq. >19.5:).L Apz-Pn Q. Q 9:'.)U 
CuZnSOD 0. 01 J.L Sulph. 20J.L Py al-en 0. 4 SJU 
D-Pen 8. O".L Crpd 0. 50""' Depy 0. 45::iu 
Asp. 2o::i 1 Bpzp 0. 26"" Dpbi 0. 62"u 
Ind. 19'.'.Jl Pu Py 0. 60'.'.JU Dmbi 1. 58"u 
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It should be emphasised that no model compounds can ideally mimic the 
native copper-zinc enzyme and the IC5o values exhibited by these complexes are 
within the range expected for model compounds. In particular, the values exhibited by 
the imidazolate-bridged dinuclear copper(II) complexes of a cryptand
53 
and 
hexaazamacrocyclic ligands54 represent upper limits which can be observed for these 
mimics (Table 5.5). 
This is probably due the entatic (or "strained") nature of the enzymes, in 
general, and metallo-enzymes, in particular. 57 It is believed that the active site in an 
enzyme is constrained by the surrounding protein matrix to adopt a geometry similar 
\ 
to that of the transition state than would exist in a similar unconstrained systems, 
thereby reducing the re-organisational energy.
57 
The reactivity of this active site is also fine tuned not only by the ligands co-
ordinated to the metal ion but also by the environment provided by the folded protein. 
These differences between the native enzyme and the model systems should always be 
taken into account whenever comparisons are made. 
More recently, it has been observed by Roe et al.
58 
that the reduced Cu+2zn
2
+2 
SOD is more stable than its oxidised analogue. Thus, in the presence of paramagnetic 
0
2
·· the formation of the reduced form of the enzyme is favoured over that of the 
oxidised species. This may also explain why there is a high concentration of an 
inactive form of the enzyme in the synovial joints of arthritic patients. Under, these 
conditions the rate of 02-. production exceeds that of synthesis and/or activation of the 
enzyme. It may be viewed that the enzyme in both the reduced and oxidised states is 
co-ordinatively unsaturated. This is in sharp contrast to the high field provided by L 
1 
and L2 ligands. 




are poor mimics of the 
native enzyme because of the high IC50 values obtained. However, the low SOD 
mimic activities exhibited by these complexes in vitro can be enhanced in the synovial 
cavity due to the low complexing conditions in the latter compared to the former 
medium. 
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5.8 Biodistribution experiments on mice 
On the basis of the aforementioned encouraging in vitro results, it was deemed 
necessary to perform biodistribution experiments. Radio-labelled 64Cu-L complexes 
were injected intravenously through the tail vein on mice as animal screens. Activity 
of these complexes were measured in various excised organs after 1, 6 and 24 hours 
postinjection. Since the interest initially was the investigation of the amount of 
activity excreted through the urine, only the activity in the liver, blood, tail and muscle 
were investigated after 1 hour postinjection. Table 5.6 shows the %ID/organ and per 
gram for all complexes including the control for this 1 hour time point calculated on 
the basis of wet organ weight. 
Table 5.6: %ID/organ and per gram(g) tissue of the injected 
complexes including CuC12 1 hour postinjection. 
Organ Complex 
(%ID/org and/g CuL1 H_1 CuL'H-1 CuLjH-1 CuC1 2 
Liver 48.91 ± 1. 34 52.73 ± 0.93 51. 98 ± 2.58 65.66 
53.01 ± 4.85 50.99 ± 0.71 38.89 ± 0.99 63.1 
Blood 0.50 ± 0.06 0.50 ± 0.11 0.61 ± 0.13 0.81 
1. 36 ± 0.27 1. 07 ± 0.19 1. 31 ± 0.21 1. 72 
Carcass 47.24 ± 0.48 42.84 ± 7.69 40.82 ± 0.37 30.24 
2.78 ± 0.05 1. 72 ± 0 .13 1. 73 ± 0.01 1. 76 
Tail 1. 60 ± 0.10 1. 91 ± 0.23 1. 68 ± 0.12 1. 86 
3.46 ± 0.6 14.78 ± 4.01 40.09 ± 7.82 3.66 










The high activity in the carcass necessitated the excission of other organs in 
order to investigate the localisation of this activity. These results are reported in Table 
5.7, 5.8, 5.9 and 5.10 for [CuL1H-1], [CuL2H_i], [CuL3R 1] and [CuCb] where Int. is 
an abbreviation for intestines. One of the noticeable features about these complexes is 
their rapid clearance from the blood circulatory system. Furthermore, of importance in 
these systems is their initial rapid and high uptake by the liver. In fact, the activity 
increases from 50% after 1 hour and reaches a maximum of approximately 70% at 6 
hours. After a 24 hour period there is approximately 30% of activity in this organ. The 
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exception is the [CuL2H_i] complex where there is about 11 % of the activity still 
remammg. 
Table 5.7: %ID/organ and per gram tissue for [CuL1H_1 ] species. 
Organ 6hr (%ID/org) 6hr (%ID/g) 24hr (%ID/org) 24hr (%ID/g) 
Liver 66.89 ± 1. 77 53.45 ± 4.31 32. 81± 2.47 24.69± 1. 95 
Blood 0.48 ± 0.13 1. 71 ± 0.04 0. 96 ± 0.70 4.43 ± 1. 00 
Carcass 6.63 ± 0. 41 0.69 ± 0.09 21. 27± 1. 71 2.04 ± 0.19 
Tail 1.11 ± 0.03 2.11 ± 0.07 1. 78 ± 0.46 3.73 ± 1.18 
Muscle 0.07 ± 0.01 0.78 ± 0.13 0.14 ± 0.01 2.09 ± 0.74 
Heart 0.62 ± 0.09 3.83 ± 0.33 1. 45 ± 0.60 14.45± 6.56 
Lung 1. 27 ± 0.06 8.07 ± 0.66 1. 73 ± 0.80 9.53 ± 3.06 
Kidney 1. 59 ± 0.04 5.16 ± 0. 4 6 4.39 ± 1. 32 13.07± 4.93 
Head 1. 61 ± 0.04 0.63 ± 0.01 6.65 ± 0.55 2.85 ± 0.28 
Int. 10.65 ± 0.69 4.31 ± 0.57 22.08± 0.56 6.77 ± 0.01 
Spleen 0.27 ± 0.05 1. 97 ± 0.25 0.77 ± 0.27 6.26 ± 1. 35 
Brain 0.08 ± 0.01 0.33 ± 0.03 0.47 ± 0.01 1. 25 ± 0 .16 
Urine 1. 89 ± 0.70 4.47 ± 0.16 
Table 5.8: %ID/organ and per gram tissue for [CuL2H-1 ] species. 
Organ 6hr (%ID/org) 6hr (%ID/g) 24hr (%ID/org) 24hr (%ID/g) 
Liver 41.72 ± 2.98 29.14± 1. 81 9.48 ± 0.49 7.19 ± 0.80 
Blood 0.29 ± 0.01 1. 25 ± 0.03 0.39 ± 0.16 1.00 ± 0.09 
Carcass 4.66 ± 0.18 0.48 ± 0.06 6.12 ± 0.28 0.52 ± 0.04 
Tail 0.82 ± 0.01 1. 67 ± 0.23 0.54 ± 0.15 1. 05 ± 0.27 
Muscle 0.08 ± 0.02 0.51 ± 0.14 0.05 ± 0.003 0.68 ± 0.08 
Heart 0.33 ± 0.07 2.62 ± 0.60 0.25 ± 0.023 1. 84 ± 0.10 
Lung 0.67 ± 0.09 4.71 ± 0.55 0.57 ± 0.024 3 .11 ± 0.37 
Kidney 3. 60 ± 0.93 11. 03± 1. 50 1. 52 ± 0.17 3.84 ± 0.17 
Head 1.16 ± 0.15 0.27 ± 0.05 1. 43 ± 0.58 0.55 ± 0.23 
Int. 7.76 ± 0.09 3.00 ± 0.39 2.54 ± 0.08 0.76 ± 0.03 
Spleen 0.23 ± 0.02 1. 4 9 ± 0.32 0.17 ± 0.01 1. 22 ± 0.02 
Brain 0.07 ± 0.01 0.23 ± 0.03 0.09 ± 0.01 0.26 ± 0.01 
Urine 37.34 ± 4.05 76.02± 1. 54 
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Table 5.9: %ID/organ and per gram tissue for [CuL3H_1 ] species. 
Organ 6hr(%ID/org) 6hr ( %ID/g) 24hr(%ID/org) 24hr (%ID/org) 
Liver 64.93 ± 0.10 4 6. 43± 3.97 28. 21± 4.24 22.44± 3.19 
Blood 0.31 ± 0.003 1. 96 ± 0.02 0.22 ± 0.14 3.45 ± 0.86 
Carcass 7.98 ± 0. 4 6 0.82 ± 0.15 19.87± 4.30 1. 94 ± 0.27 
Tail 1. 26 ± 0.05 3.48 ± 0.76 1. 41 ± 0.29 3.30 ± 0.70 
Muscle 0 .11 ± 0.01 0.7 ± 0.10 0.14 ± 0.05 1. 64 ± 0.32 
Heart 0.50 ± 0.001 3. 96 ± 0. 4 6 0.83 ± 0.13 7.82 ± 1. 30 
Lung 1. 36 ± 0.07 9.34 ± 0.31 2.04 ± 0.35 13. 75± 2.60 
Kidney 1. 91 ± 0.02 6.19 ± 0.39 3.14 ± 0. 79 11. 06± 2.30 
Head 1. 74 ± 0.06 0. 72 ± 0.01 6.38 ± 1. 39 2.64 ± 0.60 
Int. 14.77± 0.72 4.85 ± 0.45 26.18± 1. 58 9.41 ± 2.15 
Spleen 0.25 ± 0.01 2.32 ± 0.34 0.52 ± 0.19 5.57 ± 2.08 
Brain 0.08 ± 0.001 0.36 ± 0.08 0.37 ± 0.22 1. 05 ± 0.17 
Urine 7. 67 ± 2.48 25.16± 2 .11 
Table 5.10: %ID/organ and per gram tissue for CuC12 . 
Organ 6hr(%ID/org) 6hr (%ID/g) 24hr (%ID/org) 24hr (%ID/org) 
Liver 73.50± 1. 89 57.75± 5.14 37.14 ± 9.20 29.66± 5.42 
Blood 0.21 ± 0.07 2.19 ± 0.18 0.70 ± 0.47 4.61 ± 1. 55 
Carcass 6.86 ± 1. 40 0.61 ± 0.06 21.87± 3.88 2.00 ± 0.44 
Tail 1. 28 ± 0.06 2.85 ± 0. 67 1. 79 ± 0.53 3.60 ± 1. 22 
Muscle 0.08 ± 0.02 0.83 ± 0.16 0.15 ± 0.05 1. 94 ± 0.80 
Heart 0.42 ± 0.06 2.73 ± 0.24 1. 07 ± 0.43 10. 4 9± 4.40 
Lung 0.85 ± 0.02 5.59 ± 0.67 1. 51 ± 0.83 10.50± 5.70 
Kidney 1. 4 7 ± 0.04 4.27 ± 0.08 3.57 ± 0.59 11. 4 4± 2.38 
Head 1. 21 ± 0 .11 0.56 ± 0.01 6.16 ± 0.64 2.63 ± 0.60 
Int. 12.10± 0.52 4 .11 ± 0.51 27.84± 4.0 8.05 ± 1. 50 
Spleen 0.23 ± 0.02 2.33 ± 0.26 0.65 ± 0.17 5.89 ± 1. 76 
Brain 0.07 ± 0.005 0.21 ± 0.02 0.43 ± 0.12 1. 03 ± 0.2 
Urine 5.16 ± 1. 41 11.16 ± 0.92 
This high activity in the liver should be expected in view of the fact that the 
copper storing proteins and its metabolism occur in this organ. Moreover, it is well 
known that lipophilic complexes generally have more uptake in the liver or in fatty 
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tissues. The high uptake of 64Cu-labeled complexes by liver has also been reported by 
many researchers.46-49 Since the muscle constitutes about 40% of the total body 
weight,46-49 the high activity in the carcass should reside in the muscle. Furthermore, 
neither the injected copper complexes nor their metabolites are bone seeking, hence 
the activity in the carcass cannot be due to accumulation of these species in the bone. 
In addition, there has been a significant uptake of these complexes by the 
heart, lung and spleen. The high uptake of these complexes by the aforementioned 
organs could be explained in part by their reasonably high lipophilicity (logP oct/aq 
varies between -1. 73 and -1.22). In addition, the high perfusion of these organs might 
have enhanced this uptake. In general, positively charged species tend to accumulate 





[64CuL3H.1t species by the mycocardium in particular should be expected. In 
contrast, no significant activity was recorded in the brain. It seems these complexes 
are unable to cross the blood-brain barrier in accordance with the observed 
lipophilicities. 
Since the liver is the centre of copper metabolism, the mode of removal of 
these complexes is by the hepatobilliary route. This accounts for the high activity 
which has been observed in the intestines (abbreviated - Int.). The activity in the 
droppings is not reported in the Tables above because of the variations in the samples 
counted due to the difficulty of correcting for activity in the droppings excreted at 
different time points. 
In contrast to earlier observations,59 the presently investigated [
64
CuLH.i] 
complexes have been found to be retained significantly by most of these organs. One 
of the reasons for this increased accumulation of these complexes in these organs is 
their high lipophilicity. This in vivo behaviour is not surprising for the monopositively 
charged [CuL1H.1] species since speciation calculations using the blood-plasma model 
suggest that this complex, which predominates at physiological pH is likely to survive 
in plasma. 
It has been suggested that the high uptake of 64Cu by the liver is due to · 
transchelation of the radioisotope by albumin and histidine. 
60 
This is because these in 
·---·-~ ·~v-4.:..: ~-.. •N·- ·- ~· 
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vivo proteins and 1.m.w. ligands bind strongly to Cu2+. The thermodynamically and 
kinetically stable 64Cu-labeled cyclam, et-cyclam, teta and DOT A derivatives recently 
investigated by Anderson et al.60 showed a biodistribution similar to that observed for 
the complexes investigated in this study. These results suggest that there is little 
correlation between the thermodynamic stability and the high liver uptake. However, 
the dissociation of the weak [CuL3H_I] complex, which showed the biodistribution 
similar to that of CuCb cannot be ruled out. In fact, the rapid accumulation of the 
control in the liver attests to this possibility. For [CuL3H_i], the transchelation process 
is preceded by the complex dissociation. The observed biodistribution of [CuL3H_i] 
should be expected since speciation calculations indicate that the complex does not 
exceed 20% at physiological pH while blood-plasma simulation studies predict that L3 
is a poor mobiliser of copper(II) in vivo. 
Although no attempts have been made so far to characterise the metabolites or 
the form of activity excreted in the urine or droppings, such studies can give a better 
insight on the true in vivo stability of these injected 64Cu-labeled species. Blower61 
and Sarkar62 have recently discussed the various forms in which Cu2+ exists in vivo 
and suggested that the metal ion may be excreted as a bile acid complex. 
Unlike [CuL3H_1], species distribution and speciation calculations using the 
blood-plasma model suggest that the [CuL28-1] complex should predominate under in 
vivo conditions. Biodistribution experiments confirmed the afore-mentioned 
prediction in that the [64CuL2Ri] species seems to be excreted predominantly by the 
renal route as expected for negatively charged species. This is because of the high 
activity observed in both the kidney and urine after 6 and 24 hours postinjection. 
However, this excreted activity is still less than the 90% urine recovered activity from 
previously reported 67Cu-labelled ligands.59 Packard et al. 46 and Anderson and 
coworkers60 have reported a similar renal elimination of the copper labelled 
complexes. 
Anderson et al.60 noted that the clearance of negatively charged 64Cu-TETA 
species by the renal route can be of profound importance in the imaging of the renal 
excretory system. This led to the investigation of the biodistribution behaviour of 
64Cu-TETA-Tyr3 -Octreotate, where octreotate is a somatostatin analogue conjugated 
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to TETA (Le).49 This compound was observed to exhibit a high uptake in 





octreotate may enable the imaging of pancreas and related glands and organs. 
Since these complexes, and [64CuL1H-1] in particular, have been observed to 
have a reasonably long biological half-life, they merit further evaluation in collagen 
induced arthritis. They can be administered orally, by injection and transdermally. The 
latter form of administration may require the development of appropriate vehicles to 
enhance percutaneous absorption. 
A water/dimethyl sulphoxide mixture as an initial vehicle model will be worth 
trying. Encapsulation of these complexes in liposomes might offer some advantages 
over the two phase water/DMSO mixture. 
It has been reported that copper complexes with logP oct/aq values greater than 
0.6 are lipophilic enough to be regarded as promising myocardial perfusion agents and 
could possibly penetrate the blood-brain barrier. Since these complexes are reasonably 
lipophilic, the corresponding ligands can be alkylated further to achieve these high 
lipophilicities. Extra-functionalisation and bioconjugation may be necessary for local 
targeting. This can be achieved by using appropriate biological indicators such as an 
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Overall discussion and Conclusion 
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6.11 Introduction 
The past two decades or so have seen a considerable surge of interest in the co-
ordination chemistry of copper(II) and gadolinium(III) in biomedical analyses. 1 In 
fact, some Cu2+ and Gd3+ complexes are currently used while others are under further 
development as diagnostic and/or therapeutic agents. This resurgence of interest in 
metal-ion therapeutics and diagnostic agents stems from an advanced understanding 
of biological structure and function. 1 
Recently, effort has been directed at the design and synthesis of 
gadolinium(III)-based contrast agents in MRI. 1 Gd3+ is ideally suited to this because of 
its high magnetic moment and hence high relaxivity resulting from its seven unpaired 
electrons. The majority of these contrast agents contain multi-chelating 
poly(aminocarboxylate) ligands to increase the thermodynamic stability of the 
complexes. Preorganised macrocyclic ligands containing pendant carboxylates are 
becoming preferred systems for this purpose. 1 
The role of copper(II) in several biological systems and processes is well 
known. 1'2 Copper(II) is normally present in low molecular weight species and in the 
active sites of metallo-enzymes such as copper-zinc SOD.2 The elevation of copper(II) 
complex species in the plasma and synovial fluids of rheumatoid arthritic (RA) 
patients is also well documented.2 This indicates some involvement of copper in this 
disease. In addition, a number of Cu2+ chelates have been shown to exhibit anti-
inflammatory activity. 1'2 
A further review of literature has shown that the metal ion is unable to reach 
ribosomes and therefore, fails to be incorporated into the relevant enzyme systems.2 
For RA sufferers, this is indicative of a defective Cu2+ 'carrier' being present only 
within the plasma resulting in the metal ion being unable to partition across the 
plasma membrane barrier as an initial step into entering the cytosol.2 
Several studies have pursued the goal of designing chemically stable copper 
complexes for their end use as anti-arthritic human pharmaceutical agents.3"5 It 
appears that a 'carrier ligand, L, which can complex copper and enhance its 
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transportation across a membrane is required. The initial goal has been to maximize 
the number of nitrogen donor atoms in the ligand, thereby increasing the stability of 
the resulting complex to in vivo dissociation. 3 This ligand should be reasonably 
lipophilic and must possess one or two dissociable protons to give neutral copper(II) 
species. These neutral and lipophilic species are known to be capable of permeating 
membrane. 
However, for this ligand to be of potential application in the treatment of RA, 
it must be able to either compete with histidine for copper in plasma or form ternary 
complexes of the type Cu-Histidine-L.2 Such a ligand must also bind copper 
selectively from calcium(II) and zinc(II), as these are potential competitors in vivo.3"5 
It is a well known fact that none of the first transition metal ions, including calcium(II) 
matches copper(II) in its ability to form stable chelates with ligands containing 
predominantly nitrogen donor atoms. Ligands of choice should resemble 3,3,9,9-
tetramethyl-4,8-diazaundecane-2,10-dione dioxime {L1) which appears to be 
promising in this regard.4'5 
The real challenge pertaining to the design of functional metal-containing 
agents is the need for a precise control of the metal-ion inner coordination sphere. 
Such control is necessary to enhance the chemical stability of the species sought in 
vivo. 1 Metal complexes that will ultimately prove successful in chemotherapy and as 
contrast agents in MRI must meet numerous criteria. These include high efficacy and 
an overall image enhancement, low toxicity in vivo, tissue and organ specificity and 
rapid clearance by the biological system. 
Despite these challenges, researchers are striving to develop new ligand 
systems that simultaneously offer biomimicry, biostability, biocompatibility and 
bioactivity. Successful research in this area will be able to produce therapeutic agents 
and biomimetic agents that will be useful and safe for in vivo applications. 1 
This study investigated the solution equilibria of H+, Cu2+, Ni2+, Zn2+, and 
Gd3+ with L2 and L3 as well as those ofGd3+ with L1 at25°C and at 0.15 mo! dm-3 er 
(Na+) using glass-electrode potentiometry. The interest is centered on the possible use 
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of the copper and gadolinium complexes in chemotherapy and as contrast agents in 
MRI respectively. 
The interest in L2 and L3 stems from the fact that these two ligands resemble 
oligopeptides. It has been observed that a variety of receptors expressed on cell 
surfaces are able to bind small peptides with high affinity.6 However, the widespread 
use of oligopeptides is limited by their short biological half-life resulting from their 
enzymatic hydrolysis. 
Furthermore, complex formation of these ligands with copper, in particular, is 
relatively instantaneous. These ligands can also be attached to biologically important 
molecules directly or indirectly using a linker for local targeting. 
6.12 Protonation and formation constants 
L 1, L 2 and L3 have been found to take up two or three protons in the pH range 
2-11. In L 1 and L3 these correspond to proton additions to the secondary and tertiary 
amino groups respectively. In contrast, for L2, these correspond to protonation of the 
negatively charged oxime oxygens. The observed protonation constants agree with 
those which had been published previously for these ligands or their analogues. 
On the basis of the complex formation and deprotonation functions, the 
constants reported in Table 5.2 where chosen as the best possible to describe the 
solution thermodynamics of these systems. Moreover, the reasonably low standard 
deviations in logppqr's and Hamilton R-factors further confirm the validity of the 
potentiometric model used in data analysis. 
Substantial variations in the determined formation constants are reflected in 
the logppqr values, which vary according to the sequence Ca2+ ~ Gd3+ < Ni2+ < Cu2+ > 
Zn2+. This is the predicted Irving-Williams stability order normally observed for 
divalent first row transition elements. 
Copper and nickel form re~sonably stable mononuclear complexes of 1: 1 ratio 
with both L2 and L3 ligands. In fact, MLH_1 and MLH-2 are the predominant species at 
pH values above 6.5. In L2 systems, these species are formed by stepwise dissociation 
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of the oxime protons following the initial deprotonation of the amide nitrogens. The 
indication from the formation constants is that Ni2+ and Cu2+ sit in a more or less 
square-planar environment of nitrogen donor atoms in [ML2H_I] and [ML2H_2]. 
On the other hand, the formation of these species in L3 complexes is as a result 
of metal ion assisted stepwise dissociation of the amide protons. For copper, however, 
the calculated second pKML-OH value defined as the difference between logP11-1 and 
logp 11 _2 is 7.78. This value is close to the hydrolysis constant of Cu
2+ which is 7.87 
and 0.56 log units lower than the second deprotonation constant (pKNtt) of the tertiary 
amine, which is equal to 8.43. For this reason it is difficult to propose with certainty 
the origin of this proton loss from potentiometric data alone. Copper(II) complexes are 
known to be destabilised by bigger membered rings such as those that can be formed 
by coordination of both terminal amines in L3. It is postulated therefore that the two 
amide nitrogens, the tertiary central amine and one of the terminal amino groups are 
all coordinated to copper in the [CuL3H_1t species. In this complex, the second 
terminal amine is protonated and the formation of the neutral [CuL3H_2]
0 is due to the 
deprotonation of this group. There is no evidence of coordination of this last amino 
group as expected for Cu2+ in a tetragonal distorted octahedral environment. 
Ni2+ forms a stable 110 complex (logP110=7.57) and the pKML-OH associated 
with its formation is 8.53. This pKML-OH is 1.5 log units lower than its first hydrolysis 
constant indicating a possibility of a metal ion promoted dissociation of the amide 
proton. It has been observed that the metal ion deprotonates these amide groups with 
difficulty indicating another possibility of an ionisation of a coordinated water 
molecule to form a 110, although unlikely from the calculated pKML-OH· Ni
2
+ does not 
seem to form the 11-1 species. Instead, the neutral 11-2 complex is formed by 
deprotonation of the second amide group. If the 11-2 species is formed by 
simultaneous deprotonation of the two amide groups, this complexation behaviour is 
reminiscent of macrocylic diamide systems. This species is believed to be stabilised 
by the coordination of all five nitrogen donor atoms. Full investigation of the Ni2+-L3 
system was limited to pH 9.0 due to precipitation of the neutral 11-2 species. 
L3 is believed to form distorted octahedral species with these metal ions. It 
appears that L3 is unable to enforce a square planar type of coordination observed with 
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LI and L2• A more likely explanation for this behaviour is the presence of the two 
contiguous six-membered rings involving the central anchoring tertiary amine. The 
folding of these less stable six-membered rings may distort the trans-equatorial 
coordination of the two amide nitrogens as shown in figure 6 (i), (j) and (k). 
With the exception of Gd3+ and LI, the other metal ions form very weak 
complex species with the studied ligands. Their equilibria as a result are characterised 
by protonated MLHxn+ (x=l,2) and mixed-hydroxo species. One possible reason for 
this weak coordinating ability of these metal ions is their inability to deprotonate the 
amide nitrogens. In fact, Co2+, Cu2+ and Ni2+ are the only first row transition elements 
which are capable of deprotonating these amide moieties. Although Gd3+ forms stable 
110, 11-1 and 11-2 complexes with LI, above pH 10, this system precipitates out of 
solution, probably as the neutral 11-3 species. 
Ligand selectivities for Cu2+ over Zn2+ and Ca2+ are 9-11 orders of magnitude 
higher. Overall, the potentiometric results confirmed the high affinity of the ligands 
donor atoms towards copper as was indicated in the introductory remarks. 
6.13 Blood-plasma simulation studies 
Zinc(II) and calcium(ll) ions being present in blood-plasma in large 
concentrations are regarded as potential competitors of copper(II) in vivo. The fact that 
calcium(II) does not form or only form very weak complexes with LI, L 2 and L3, 
precludes this ion from being a competitor of copper(II). 
It has long been postulated that Zn2+ species are likely to predominate at 
physiological pH because of its high concentration and the ability to form complex 
species at this pH. Figure 5.26 reveals that, at LI and L2 concentration of 10-6 mo! dm-3 
and 10-3 mo! dm-3 respectively, both the Zn2+ and Ca2+ p.m.i.'s are less than 0.01. In 
contrast, the calculated Cu2+ p.m.i. 's are an order of magnitude greater. L3 on the other 
hand, has no mobilising ability at these concentrations. In fact, the selectivity and 
mobilising ability order is LI > L2 > L3• These calculations indicated that the 
dipositively charged [GdLIRi]2+ is capable of surviving in vivo although Cu2+ is 
likely to induce trans-metallation because of its high affinity for LI nitrogen donor 
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atoms. Overall the Gd3+ complexes of these ligands in their present form would be of 
no use as contrast agents in MRI. 
On the basis of these calculations, it is therefore predicted that exogenously 
administered L1 and L2 ligands can compete and successfully mobilise copper(II) in 
vivo without altering the equilibria of this metal's competitors. This is an important 
result in the development of copper anti-inflammatory drugs for rheumatoid arthritis. 
6.14 UV-VIS spectroscopy 
Because copper(II) and nickel(II) form coloured chelates with these ligands, 
the co-ordination geometries of the complex species present in solution have been 
confirmed by UV/VIS spectrophotometry. The spectroscopic measurements indicate 
that both Cu2+ and Ni2+ sit in a square-planar environment of nitrogen donor atoms of 
the L 2 ligand for 11-1 and 11-2 complex species. L3, on the other hand, is believed to 
form tetragonally distorted octahedral 11-1 and 11-2 species with Cu2+. As suggested 
from potentiometric data, there is no spectroscopic evidence of coordination of five L3 
nitrogen donor atoms towards Cu2+ nor the loss of a proton from an axially 
coordinated water molecule. The geometries of potentiometrically detected Ni2+-L3 
species could not be predicted because of the low binding ability of this ligand 
towards the metal ion and precipitation above pH 9.0. 
The smooth convoluted calculated individual spectra of the complex species 
further support the correctness of the potentiometric model used in data analysis. 
6.15 Crystal structure, MM calculations and MD simulations 
The [NiL1R 1t was precipitated as a perchlorate, with a molecular formula 
(Mr) of 429.55 g/mol. This crystal system is orthorhombic with a space group-
Pbca(#61). However, Hussain and Schlemper reported the P212121 space group for the 
NiL1R 1tCLH20 system. Since, there is no chiral carbon in this molecule, it is thus 
believed that the presently reported space group is the correct one. Despite this 
discrepancy, the other differences are expected in view of the different counter-ions 
used and the presence of the water of crystallisation. 
161 
This crystal structure further attests to the square-planar N4 coordination 
postulated previously from potentiometric and UV NIS data. 5 MD simulations of 
[NiL1H_1r species indicate very little conformational changes compared to the 
observed crystal structure. The exceptions are the relative orientations of the central 
propylene carbons. These simulations indicate that the conformation in the crystal 
structure is probably the stable one in solution. 
Because of this excellent agreement between the simulated and crystal 
structures of the [NiL1R 1t species, these simulations were extended to the 
corresponding Cu2+ and Zn2+ complexes. The simulated [CuL1H-1t further confirms 
the square-planar structure predicted from UV Nis data.4 There are relatively few 
available techniques to study Zn2+ systems in aqueous solution. Because it was not 
easy to prepare [ZnL1H_1r crystals suitable for X-ray diffraction studies, these MD 
simulations were of great value in understanding the geometry of this species. In fact, 
the simulated ZnL1R 1t species indicates that the metal ion sits in a square-planar 
environment of the ligand's donor atoms. These results confirm an earlier postulation5 
that the low formation constants observed for the zinc(II) complexes are due to 
square-planar arrangement of donor atoms of the ligands around the metal ion. 
6.16 Partition coefficients 
The ligands L 2 and L3 were designed with the hope that the dominant 
copper(II) complex at pH 7.4 would be the neutral [CuLR2]
0 species. However, the 
species distribution diagrams in Figure 5.5(a) and (b) show that this metal ion is 
approximately 80% and 20% present as the single negatively and positively charged 
[MHL1] at physiological pH for L
2 and L3 respectively. This is in sharp contrast to the 
previously studied L1 ligand,4 which was observed to be approximately 100% present 
as the [CuL1H-1t in the pH range 4.0-9.0. 
In general, methyl and aryl groups are known to increase the lipophilicity of 
molecules, hence the ligands were designed with this fact in mind. Octanol/water 
partition coefficients, in the form of logP act/water, were determined as a measure the 
1ipophilicity of the copper complexes. These studies indicated that the copper(II) 
complexes of these ligands are largely hydrophilic. In fact, the observed log Pact/water 
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values varied between -2.10 and -1.25. These values are closer to the previously 
reported values for copper(II) complexes of L 1 and other diamide dioximes ligand 
systems. 
The hydrophilic nature of these complexes stems from: (i) hydrogen bonding 
between the non-coordinated neutral carbonyl oxygens and negatively charged 
oxygens and the water molecules, and (ii) the presence of coordinated water 
molecules. Hydrogen bonding to solvent water molecules is possible in complexed L2 
and L3 ligands due to the presence of deprotonated oxime group(s) and protonated 
nitrogen sites respectively. 
Although these [CuLH_1] complexes are largely hydrophilic, at least 2-6% of 
these species is extracted into the octan-1-o 1 phase. This result suggests that a similar 
amount of these complexes is likely to permeate the skin and cell membranes when 
applied transdermally. 
6.17 Superoxide Dismutase Mimic Activities 
Accumulating evidence indicates that reactive oxygen free radicals such as the 
superoxide (Oi'-) are involved in the pathogenesis of rheumatoid arthritis. It has, 
however, been observed that copper(II) complexes are able to dismute this Oi- radical 
to water and hydrogen peroxide. This study investigated whether the presently studied 
copper complexes are capable of catalysing the superoxide dismutation by making use 
of the classical NBT assay. 
The results indicate that the copper(II) complexes of these ligands exhibit IC5o 
values in the range of 8.0-110 µmol dm-3. These values are 2-4 orders of magnitude 
higher than those of the corresponding complexes of cryptand and the native Cu2Zn2-
SOD enzyme. These studies reveal that the investigated copper complexes are poor 
mimetics of the native SOD enzyme. This result should be expected since 
potentiometric studies suggest that all three ligands are reasonably stronger chelators 
of copper(II). Furthermore, the competitive binding of EDT A (used to simulate in vivo 
ligands) to Cu2+ to yield copper-EDTA complexes which are poor mimics of the 
enzyme cannot be ruled out. 
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Moreover, it is known that the enzyme is capable of accommodating both the 
Cu2+ and Cu+ in its 'entactic' state. Accumulating evidence also indicates that the 
enzyme is much more stable in its reduced state than in its oxidised form. It appears 
that Cu2+ in the enzyme is coordinatively unsaturated in contrast to the high donor 
field exhibited by the present ligands. In addition, it has been observed that the 
presence of positively charged groups at the active site increase the rate of approach of 
the 0 2·- ion towards the metal ion. 
6.18 Biodistribution studies on mice 
On the basis of the above observations it was demeed necessary to perform 
biolocalization experiments on mice as animal screens. This was accomplished by 
intravenous injection of these animals with a dilute solution of 64Cu-labeled [CuLH_i]. 
The biodistribution studies revealed a rapid clearance of these complexes from 
the blood. Significant uptake of these complexes by the liver was observed. In fact, 
more than half of the total activity was recorded in this organ six hours postinjection. 
The high uptake of these complexes by this organ is expected since copper 
metabolism occurs here. This copper is excreted by the hepatobiliary route, hence the 
observed high activity in the intestines. In addition, there was a noticeable uptake by 
the muscle, lung and heart partly due to the reasonably high lipophilicity of these 
species and the high perfused nature of these organs. 
As expected for negatively charged species, the 64Cu[CuL2H_1r was observed 
to be excreted exclusively by the renal route. This observation indicates that this 
complex or its derivatives thereof could be investigated for imaging the renal system. 
These studies further confirmed that the Cu-L1/L2 complexes are able to survive in 
vivo as reflected by their long biological half-life. In fact, these copper complexes 
merit further evaluation and development as anti-arthritic agents. 
6.19 Future studies 
The strategy of designing copper chemotherapies for RA to improve their 
therapeutic effectiveness should be re-evaluated in light of these findings. For copper 
chemotherapy various possibilities exist which include the replacement of the amide 
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moieties by amino groups. The nitrogen atoms of amide groups are poor donors for 
metal ions in general, and copper(II) in particular. The reduction of these amide 
groups and subsequent replacement by amino groups would confer an enhanced 
chemical stability to the resulting complexes. 
In fact, an increase of about two log units is expected for such modification 
from H2pap (1
2) and BIDPAP (13) to Hpap (15) and BIMPAP (16) respectively. These 
modifications are demonstrated in Figure 6.1. The 11-1 Hpap complex species would 
be further stabilised by the hydrogen bond between the hydroxyimino groups 
compared to the corresponding H2pap complex. 
Furthermore, the close proximity of this amino group to one of the nitrogens of 
the oxime moiety (15) and to the anchoring tertiary benzylamine (L 6) would enhance a 
stronger complexation behaviour of these ligands towards copper(II). In addition, the 
two contiguous six-membered rings observed in the [CuL3H_i] and [CuL
3
H_2] 
complexes have been observed to decrease the thermodynamic stability of these 
species. An increase of about 1 to 1.5 log units in the stability of the [CuL 6Ri] 
complex is predicted if one of the six-membered rings is converted to a five-
membered chelate ring. 
L1 and L2 (as well as its afore-mentioned derivative) can be further 
functionalised by incorporating one or more methyl groups in the propylene bridge 
connecting the diaza and/or diamide groups. The modifications are also demonstrated 
in L 4 and L5. These methyl groups would increase the lipophilicity of the resulting 
complexes without destabilising them. LogP oct/aq values in the range of -1.0 to 0.0 are 
expected for these methylated derivatives. 
The octanol/water partition coefficients of L 1, L 2 and 1 3 copper complexes are 
lower t~an the value (logP oct/aq=0.6) believed to be optimal for brain and/or 
myocardial uptake.7 However, it is hoped, that the above-mentioned derivatives will 
have lipophilicities meriting them for further investigation for use in myocardial 
imaging with copper radio-isotopes. The resulting complexes may also serve as 
suitable candidates for copper chemoradiotherapy. 
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Figure 6.1: Structures of ligands of future interest 
(a) 
~ ~ o~ 
NI N Ri N N Ri (CH2)n 
I I I ~ 
OH HO OH HO A /"-R1 
L4 (Me2PrAO) L5 (Me2H2~P) L6 (BMPAP) 
R = -H2N-Ala-Gly-Cys-Lys-Asn-Phe -Phe-TrpSomatostatin 
I I 
HO-Cys-Ser-Thr-Phe-Thr-Lys 
R 1 =-H2N-(D)Phen-Cys-Phen-(D)Trp 





The design of Gd3+ -based contrast agents would require the incorporation of 
pendant carboxylate and phosphonate groups in these ligands' backbone. The former 
should be used as extracellular agents while the latter could be directed towards bone-
like matrices. However, since the aqueous chemistry of Gd3+ parallels that of Ca2+ in 
many ways, these ligands are likely to co-ordinate to the latter metal ion. The high 
coordination numbers (8-9) exhibited by these ligands compatible with those of Gd3+ 
should exclude effective competition with Ca2+. This is due to the fact that Ca2+ is 
restricted to coordination numbers 4-6. Although eight (8) is a very common 
coordination number for calcium(II), the two extra binding sites are normally 
occupied by solvent (water) molecules rather than the nitrogen donor atoms of the 
ligand whereas gadolinium(III) coordinates strongly to these nitrogens. 
The results of the present study are encouraging enough to merit progression to 
the next stages of drug development. These might include the design of proper 
vehicles for enhancing copper permeation across the skin. The species can be 
incorporated into liposomes or attached to biologically relevant molecules such as the 
somatostatin analogues ( octreotide or octreotate) for local targeting. The use of the 
somatostatin analogues is important for imaging of pancreatic receptors. It should be 
emphasised that the four amino acids shown in bold-face in Figure 6.1 (a) constitute 
the bioactive receptor-binding P-turn portion of the hormone. 
The synthetic methods presented in Chapter 4.2 should be suitable for 
preparing some of these derivatives if proper starting materials are used. 
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Crysta~ system, space group 
Unit cell dimensions 
Volume 









Orthorhombic, Pbca (#61) 
a 13.3960(10) A 
b 12.3490(10) A 
c = 21.9330(10) A 
3628.3(4) A"3 





0.25 x 0.23 x 0.20 mm 




Limiting indices -17<=h<=l2, -1.6<=k<=l2, -28<=1<=28 
Reflections ~ollected I unique 
Completeness to theta 27.51 
Absorption correction 
Max. and min. transmission 
Refinement method 
Data I restraints I parameters 
Goodness-of-fit on F"2 
Final R indices [I>2sigma(I)] 
R indices (all data) 
Largest diff. peak and hole 
18035 I 4146 [R(int) 0.0397] 
99.3 % 
Empirical (Scalepack) 
0.7875 and 0.7445 
Full-matrix least-squares on F"2 
4146 I o I 236 
1. 030 
Rl 0.0294, wR2 
Rl 0.0417, wR2 
0.0664 
0.0708 
0.370 and -0.318 e.A"-3 
Table 2. Atomic coordinates ( x 10"4) and equivalent isotropic 
displacement parameters (A"2 x 10"3) for TNl NI. 




x y z U(eq) 
Ni (1) 392(1) 5271 (1) 4179(1) 18 (1) 
0(1) 599(1) 6706(1) 5191(1) 27 ( 1) 
N(2) 131 (1) 6505(1) 4649(1) 20(1) 
C(3) -514 (1) 7195(1) 4456(1) 22 (1) c (4) -968(1) 6891(1) 3848(1) 23(1) 
N (5) -871 (1) 5669(1) 3816(1) 21 ( 1 ). c (6) -1197(2) 5197(2) 3224(1) 29 ( 1) 
C(7) -949(1) 3998(1) 3190(1) 28 ( 1) c (8) 16l(l) 3799(2) 3131(1) 27 (1) 
N(9) 678(1) 3979(1) 3722(1) 21 (1) c (10) 1793(1) 3805(2) 3696(1) 28 ( 1) 
C(ll) 2183(1) 4228(2) 4298 (1) 27 ( 1) 
N (12) 1599(1) 4911(1) 4560(1) 22 (1) 
0(13) 1899(1) 5364 (1) 5097(1) 28 ( 1) 
C(l4) ·-765(2) 8221(2) 4774 (1) 33(1) 
C(l5) -:-2055(2) -7247 (2) 3802(1) 39(1) c (16) -340(2) 7412(2) 3343(1) 35(1) 
C(17) 3193(2) 3950(2) 4536(1) 41(1) 
C(l8) 2040(2) 2599(2) 3608(1) 45(1) c (19) 2246(2.) 4489(2) 3181(1) 42 ( 1) 
Cl(20) 580(1) 5745(1) 1619(1) 29(1) 
0 (21) -322(1) 5159(2) 1731(1) 61(1) 
0(22) 429(1) 6569(1) 1172 (1) 53(1) 
0(23) 1332(1) 5009(1) 1414(1) 61 (1) 
0(24) 914 ( 1) 6242(1) 2172(1) 56 (1) 
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Table 4. Anisotropic displacement parameters (AA2 x 10A3) for TNl NI. 
The anisotropic displacement factor exponent takes the form: -












32 ( 1) 
23 (1) 




18 ( 1) 











3 ( 1) 
Ul2 





c ( 4) 23 (1) 21 (1) 26(1) 1 ( 1) -3(1) N(5) 19 ( 1) 22 (1) 21(1) 0 ( 1) -1(1) c ( 6) 29 ( 1) 32 (1) 25 (1) -4 ( 1) -9(1) C(7) 27 ( 1) 2 9 (1) 27(1) -4 ( 1) -4 (1) c (8) 31 ( 1) 27 ( 1) 22(1) -4 ( 1) -1 ( 1) N ( 9) 20 ( 1) 20(1) 22(1) 0 (1) 2 ( 1) c (10) 20 (1) 32 (1) 32(1) -4 ( 1) 4 ( 1) C(ll) 21 ( 1) 28 ( 1) 33(1) 2 ( 1) 1 (1) N(l2) 20 ( 1) 25 (1) 23(1) 1 ( 1) -1(1) 0(13) 25 ( 1) 35(1) 24 (1) -3 (1) -9(1) 
C(l4) 36 (1) 27 (1) 35(1) -6 (1) 0(1) 
C(l5) 27 (1) 34 (1) 55(1) -6 (1) -11 (1) c (16) 48 ( 1) 28 (1) 27 (1) 6(1) 0 ( 1) c (17) 25 (1) 50 (1) 48 ( 1) -4 (1) -6(1) 
C(l8) 35(1) 38 (1) 64 (2) -17 (1) -2(1) c (19) 28 (1) 63 (2) 34 (1) 0 ( 1) 9 ( 1) 
· Cl (20) 32 (1) 24 ( 1) 32(1) 2 (1) 1 ( 1) 
0 (21) 40(1) 61 (1) 84 ( 1) 14 ( 1) 8 ( 1) 
0 (22) 72 (1) 4 6 (1) 41 ( 1) 16 (1) -10(1) 
0(23) 4 6 (1) 40(1) 9ff ( 2) -23(1) 10 ( 1) 
0 (24) 82 ( 1) 50(1) 35(1) -4 (1) -10(1) 
Table 5. Hydrogen coordinates ( x· 10"4) and isotropic 
displacement parameters (A"2 x 10"3) for TNl_NI. 
x y z 
H (1) 1240(20) 6120(20) 5178(13) 
H(5) -1343 5419 4094 
H(6A) -861 5582 2885 
H(6B) -1926 5297 3176 
H(7A) -1199 3634 3562 
H(7B) -1296 3675 2835 
H(2) 279 3045 2994 
H (SB) 442 4293 2819 
H (9) 448 3420 3969 
B (14A) -144.7 8179 4934 
H(l4B) -715 8827 4487 
H (14C) -298 8335 5112 
H (15A) -2443 6901 4127 
H (158) -2325 7033 3404 
H(15C) -2096 8035 3845 
H(l6A) -272 8189 3423 
H (168) -669 7304 2949 
H (16C) 323 7077 3335 
H(l 7A) 3368 4446 4867 
H (178) 3685 4014 4207 
H(l7C) 3189 3205 4690 
H (18A) 1745 2178 3941 
H(l88) 2766 2500 3609 
H(l8C) 1767 2349 3218 
H (19A) 2066 4173 2786 
H (19B) 2975 4500 3222 




2 ( 1) 
-5(1) 
1 ( 1) 
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Table 6. Torsion angles [deg] for TNl NI. 
(right-hand r~le, Klyne & Prelog. ( 1960) . Experientia,16,521) (s. u. following Stanford & Waser, Acta Cryst. (1972) .A28,213) 
Angle s.u. NS -Nil -N2 -01 161. 79 0.00 NS -Nil -N2 -C3 -18.38 0.00 N9 -Nil -N2 -01 26.97 0.07 N9 -Nil -N2 -C3 -1S3.20 0.07 Nl2 -Nil -N2 -01 -16.88 0.00 N12 -Nil -N2 -C3 162.95 0.00 N2 -Nil -NS -C4 31. 30 0.00 N2 -Nil -NS -C6 164. 4 0 0. 00 N9 -Nil -NS -C4 -150.26 0.00 N9 .-Nil . -NS -C6 -17.16 0.00 Nl2 ·-Nil -NS -C4 63.79 0.06 Nl2 -Nil -NS -C6 -163.12 0.06 N2 -Nil -N9 -ca 154.68 0.07 N2 -Nil -N9 -cio '""'72. 30 0.07 NS -Nil -N9' -ca 20 .11 0.00 N5 -Nil -N9 -ClO 153.12 0.00 Nl2 -Nil -N9 -:CB -161. 28 0.00 N12 -Nil -N9 -ClO -28.27 0.00 N2 -Nil -NJ.2 -Cll :...164.86 0.00 N2 -Nil -Nl2 -013 13. 32 0.00 NS -Nil -Nl2. -Cll 162.82 0.06 NS -Nil -N12· -013 -19.00 0.07 N9 -Nil -N12 -Cli 16.65 0.00 N9 -Nil -N12 -013 -16S.17 0.00 N2 -01 -:-Hl -013 -41. 53 0.02 Hl -01 -N2 -Nil 18.32 0. 00· Hl -01 -N2 -C3 -161.51 0.00 01 -Hl -013 -Nl2 ,37. 80 0.02 Nil -N2 -C3 -C4 ---o. 81 0.00 Nil -N2 -C3 -Cl4 -177.77 0.00 01 -N2 -C3 -C4 179.03 0.00 01 -N2 -C3 -Cl4 2.06 0.01 N2 -C3 -C4 -NS 2S.66 0.00 N2 -C3 -C4 -ClS· 146.26 0.00 N2 -C3 -C4 -Cl6 -91.48 0.00 Cl4 -C3 -C4 -NS -1S7.30 0.00 Cl4 -C3 -C4 -ClS -36.70 0.00 Cl4 -C3 -C4 -C16 BS.56 0.00 N2 -C3 -Cl4 -H14A -110. 93 0.00 N2 -C3 -Cl4 -H14B 129.07 o.oo N2 -C3 -Cl4 -H14C 9.08 0.01 C4 -C3 -C14 -Hl4A 72.36 0.01 C4 -C3 -C14 -Hl4B -47.63 0.01 C4 -C3 -Cl4 -Hl4C -167.63 0.00 C3 -C4 -NS -Nil -37.88 0.00 C3 -C4 -NS -C6 -174.76 0.00 Cl5 -C4 -NS -Nil -1S8.73 0.00 ClS -C4 -NS -C6 64.38 0.00 Cl6 -C4 -N5 -Nil 78.00 0. 00' Cl6 -C4 -NS -C6 -58.89 0.00 C3 -C4 -ClS -HlSA -S9.86 0.00 C3 -C4 -C15 -HlSB -179.86 0.00 C3 -C4 -Cl5 -HlSC 60.14 0.00 NS -C4 -ClS -H15A 56.69 0.00 NS -C4 -ClS -HlSB -63.31 0.00 NS -C4 -ClS -HlSC 176.69 0.00 
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Cl6 -C4 -Cl5 -Hl5A 179.45 0.00 Cl6 -C4 -Cl5 -Hl5B 59.45 0.00 Cl6 -C4 -Cl5 -Hl5C -60.55 0.00 C3 -C4 -Cl6 -Hl6A -S3.17 0.00 C3 -C4 -Cl6 -Hl6B -173.17 0.00 C3 -C4 -Cl6 -Hl6C 66.82 0.00 NS -C4 -Cl6 -Hl6A -166.78 0.00 N5 -C4 -Cl6 -H16B 73.22 0.00 NS -C4 -C16 -Hl6C -46.79 0.00 ClS -C4 -Cl6 -Hl6A 69.64 0.00 ClS -C4 -Cl6 -Hl6B -50.36 0.00 ClS -C4 -Cl6 -Hl6C -170.37 0.00 Nil -NS -C6 -H6A -79.66 o.oo Nil -N5 -C6 -H6B 162 .10 0.00 Nil -N5 -C6 -C7 41. 22 0.00 C4 :-NS .-C6 . -H6A 51. 00 0.00 C4: ·-NS -C6 -H6B -67.24 0.00 C4 :...NS -C6 -p 171.88 0.00 NS -C6 -C7 -H7A _50. ls 0.00 NS -C6 -C7 -H7B 167.7B 0.00 NS -C6 -C7 -CB -71. 04 0.00 H6A -C6 -C7 -H7A 171. 03 0.00 H6A -C6 -C7 -:H7B -71.34 0.01 H6A -C6 -C7 -cs 49.S4 0.00 H6B -C6 -C7 -H7A -70.74 0.01 H6B -C6 -C7 -H7B 46.89 0.01 H6B -C6 -C7 -cs 168.08 0.00 C6 -C7 -CB -H2 -163.72 0.00 C6 -C7 -cs -HBB -4S.4S 0.00 C6 -C7 -cs . -N9 7S. 41 0.00 H7A -C7 -cs -H2 75.10 0.01 H7A -C7 -C8 -H8B -166.63 0. 00· H7A -C7 -CB -N9 -4S.77 0.00 H7B -C7 -cs -H2 -42.54 0.01 H78 -C7 -cs -HBB 7S.73 0.01 H78 -C.7 -cs -N9 -163.41 0.00 C7 -cs -N9 -Nil -47. 96 0.00 C7 -cs -N9 -ClO -179.11 0.00 H2 -CB -N9 -Nil -16S.82 0. 00 : H2 -cs -N9 -ClO· 60.03 0.00 
~-88 -cs -N9 -Nil 72. 90 0.00 H_8B -cs . -N9 -ClO -58.2S 0.00 Nil -N9 -ClO -Cll 33.77 0.00 Nil -N9 -ClO -ClB 1S4.S7 0.00 Nil -N9 -ClO -C19 -82.S2 0.00 cs -N9 -cio -Cll 169.39 0.00 C8 -N9 -ClO -ClS -69.81 0.00 cs -N9 -ClO -Cl9 53.10 0.00 N9 -ClO -Cll -N12 -22.39 0.00 N9 -ClO -Cll -C17 162.69 0.00 ClS -ClO -ell -Nl2 -142.39 0.00 ClS -ClO -Cll -Cl7 42.69 0.00 C19 -ClO -Cll -Nl2 9S.21 0.00 Cl9 -ClO -Cll -Cl7 -79.71 0.00 N9 -ClO -ClS -HlSA -S7.6S 0.00 N9 -ClO -ClS -HlSB -177.64 0.00 N9 -ClO -ClS -HlSC 62.36 0.00 Cll -ClO -ClS -HlSA 58.87 0.00 Cll -cio -ClS -Hl88 -61.13 0.00 Cll -ClO -ClS -Hl8C 178.87 0.00 Cl9 -cio -ClS -HlSA 179.80 0.00 Cl9 -ClO -ClS -HlSB 59.81 0.00 
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Cl9 -ClO -Cl8 .-Hl8C -60.19 0.00 N9 -ClO -C19 -H19A -72.19 0.00 N9 -ClO -Cl9 -Hl9B 167.80 0.00 N9 -ClO -C19 -H19C 47.81 0.00 Cll -ClO -Cl9 -Hl9A 173.70 0.00 Cll -ClO -C19 -Hl9B 53.69 0.00 
Cll -ClO -Cl9 -Hl9C -66.30 o.oo Cl8 -ClO -Cl9 -Hl9A 50.65 0.00 
Cl8 -ClO -Cl9 -H19B -69.35 0.00 Cl8 -ClO -Cl9 -H19C 170.65 0.00 
ClO -Cll -Nl2 -Nil 0.26 0.00 
ClO -Cll -Nl2 -013 -178.01 0.00 
C17 -Cll -Nl2 -Nil 175 .13 0.00 
Cl7 -Cll -N12 -013 -3.13 o .. 01 
ClO -Cll -Cl7 -Hl 7A 164.39 0.00 
ClO -Cll ·-Cl 7 -H17B 44.39 0.01 cm -Cll -C17 -Hl7C -75.61 0.01 
Nl2 -c11 -Cl7 -Hl 7A -10. 07 0.01 
N12 -Cll -en -H17B -130.07 0.00 
N12 -Cll -C17 -H17C 109.93 0.00 
Nil -Nl2 -013 -Hl -11. 24 0.00 
Cll -Nl2 -013 -Hl 166.94 0.00 
Hydrogen bond details 
01 - Hl ... 013 
01 - Hl 1.135 (3) A 
Hl ... 013 1. 282 (3) A 
01 ... 013 2.415(3) A 
01 - Hl ... 013 175 (3) ( 
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